Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Dermatology

  Free Subscription


Articles published in J Dermatol

Retrieve available abstracts of 864 articles:
HTML format



Single Articles


    September 2026
  1. MURAKAMI T, Ishistsuka Y, Ueda I, Sakai H, et al
    A Case of Genital-Predominant Inverse Psoriasis With Psoriatic Arthritis Treated With Sequential IL-23/IL-17-Targeted Biologic Therapy.
    J Dermatol. 2026 Sep 30. doi: 10.1111/1346-8138.70521.
    PubMed    


  2. LIU WT, Seshimo H, Inoue T, Kurisaki M, et al
    Genomic Landscape of Primary and Secondary Cutaneous Angiosarcoma: A Single-Center Retrospective Cohort Analysis in Japan.
    J Dermatol. 2026 Sep 29. doi: 10.1111/1346-8138.70520.
    PubMed     Abstract available


  3. KADONO T, Mitsuishi T, Shimizu A, Suga Y, et al
    Investigation of the Efficacy and Safety of TO-208 in Patients 2 Years of Age or Older With Molluscum Contagiosum in Japan: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study (208-3-1) and Its Open-Label Extension.
    J Dermatol. 2026 Sep 28. doi: 10.1111/1346-8138.70517.
    PubMed     Abstract available


  4. NAKANISHI T, Ikegami R, Ohmori S, Kato H, et al
    Wound/Pressure Ulcer/Burn Guidelines (2023)-3 Guidelines for the Diagnosis and Treatment of Diabetic Skin Ulcer/Gangrene (3rd Edition).
    J Dermatol. 2026 Sep 27. doi: 10.1111/1346-8138.70491.
    PubMed     Abstract available


  5. LIN CY, Liu WT
    Response to Melanoma Surgical Excision Margins Beyond Breslow Thickness: Should Histotype Matter?
    J Dermatol. 2026 Sep 27. doi: 10.1111/1346-8138.70515.
    PubMed    


  6. DE GIORGI V, Perillo G, Cecchi G, Fazzari F, et al
    Melanoma Surgical Excision Margins Beyond Breslow Thickness: Should Histotype Matter?
    J Dermatol. 2026 Sep 25. doi: 10.1111/1346-8138.70514.
    PubMed    


  7. DIKA E, Schiavo L, Magnaterra E, Veneziano L, et al
    Association Between Anatomical Subsite and Invasive Disease in Head and Neck Lentigo Maligna and Lentigo Maligna Melanoma.
    J Dermatol. 2026 Sep 21. doi: 10.1111/1346-8138.70513.
    PubMed     Abstract available


  8. MORITA A, Kawakami Y, Miyake T, Horikawa K, et al
    Tinea Incognito Caused by Trichophyton mentagrophytes With Spongiform Pustule: A Histopathological Pitfall Mimicking Pustular Psoriasis.
    J Dermatol. 2026 Sep 21. doi: 10.1111/1346-8138.70512.
    PubMed    


  9. GOTOR-RIVERA A, Blanco-Sanchez A, Rodriguez-Sanchez B, Martinez-Lopez J, et al
    Cutaneous Toxicities of Anti-GPRC5D Bispecific Antibodies for Multiple Myeloma: Retrospective Study.
    J Dermatol. 2026 Sep 16. doi: 10.1111/1346-8138.70497.
    PubMed     Abstract available


  10. JIANG F, Chen M, Sun F, Wang J, et al
    Vunakizumab Treatment for Pediatric Generalized Pustular Psoriasis: Two Case Reports.
    J Dermatol. 2026 Sep 16. doi: 10.1111/1346-8138.70500.
    PubMed    


  11. SHIMIZU Y, Watanabe K, Ohara Y, Oiso N, et al
    Aryl Hydrocarbon Receptor Agonist-Based Phototherapy for Psoriasis: Combinational Therapy With Tapinarof and Narrowband Ultraviolet B.
    J Dermatol. 2026 Sep 4. doi: 10.1111/1346-8138.70493.
    PubMed    


  12. SHUTO T, Nakajima M, Okada E
    Eruptive Melanocytic Nevi Associated With Encorafenib and Cetuximab Therapy in Two Patients With BRAF V600E-Mutated Colorectal Cancer.
    J Dermatol. 2026 Sep 4. doi: 10.1111/1346-8138.70488.
    PubMed    


  13. TERAO M, Kawakami Y, Miyake T, Tsujino M, et al
    A Case of Subcutaneous Panniculitis-Like T-Cell Lymphoma Regressing After Biopsy.
    J Dermatol. 2026 Sep 4. doi: 10.1111/1346-8138.70489.
    PubMed    


  14. TANAKA N, Iso A, Higashime A
    Venetoclax-Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE): Implications for Diagnosis and Treatment Continuation.
    J Dermatol. 2026;53:1385-1387.
    PubMed     Abstract available


  15. TAKAHASHI T, Takahashi T, Segawa Y, Oka K, et al
    IL-17 Signaling Inhibitors in Localized Scleroderma: A Single-Center Case Series of Nine Patients.
    J Dermatol. 2026;53:1365-1370.
    PubMed     Abstract available


  16. CASCIO INGURGIO R, Alfano A, Syed A, Gargiulo L, et al
    Bullous Pemphigoid Disease Area Index Pruritus, Activity, and Damage During Biologic Therapy in Bullous Pemphigoid: An International Dual-Center Study.
    J Dermatol. 2026;53:1353-1357.
    PubMed     Abstract available


  17. YE C, Gu X, Fei C, Zhou X, et al
    Hand Eczema Referred for Patch Testing: Retrospective Study in Shanghai, China From 2018 to 2023.
    J Dermatol. 2026;53:1342-1352.
    PubMed     Abstract available


  18. YOSHINO Y, Amano M, Iino S, Omoto Y, et al
    Wound, Pressure Ulcer, and Burn Guidelines (2023)-6: Guidelines for the Management of Burns, Third Edition.
    J Dermatol. 2026;53:e688-e732.
    PubMed     Abstract available


  19. OCHIAI S, Anzawa K, Hiramatsu Y, Shimizu A, et al
    HPV29-Associated Periungual Epidermoid/Verrucous Cyst.
    J Dermatol. 2026;53:1388-1391.
    PubMed     Abstract available


  20. KAN T, Ryo S, Nomoto K, Mizuno H, et al
    Etoposide as Late-Line Therapy for Metastatic Extramammary Paget's Disease: A Case Series.
    J Dermatol. 2026;53:1371-1375.
    PubMed     Abstract available


  21. KITO M, Iwaya M, Omodaka T, Yuzuriha S, et al
    MRI-Based Surgical Margin Assessment in Dermatofibrosarcoma Protuberans: Correlation With Pathological Extent.
    J Dermatol. 2026;53:1287-1295.
    PubMed     Abstract available


  22. KISHIBE M, Noguchi A, Matsuya M, Matsumoto K, et al
    Clinical Characteristics and Treatment Patterns of Hyperhidrosis in Northern Hokkaido: A Single-Center Retrospective Descriptive Study.
    J Dermatol. 2026;53:1267-1276.
    PubMed     Abstract available


  23. BABUL A, Mehta D, Soliman Y, Hussain M, et al
    Comparative Efficacy of Janus Kinase Inhibitors Indicated for Severe Alopecia Areata: A Bayesian Network Meta-Analysis and Matching-Adjusted Indirect Comparison.
    J Dermatol. 2026;53:1395-1407.
    PubMed     Abstract available


    August 2026
  24. HOMMA M, Katsumi T, Sato H, Abe R, et al
    Interstitial Granulomatous Drug Reaction Associated With Sennosides: A Rare Cutaneous Adverse Reaction to a Commonly Used Laxative.
    J Dermatol. 2026 Aug 30. doi: 10.1111/1346-8138.70484.
    PubMed    


  25. TANG KT
    Response to: Comment on "Achieving Targeted Combined Endpoints in Patients With Atopic Dermatitis: A Real-World Study".
    J Dermatol. 2026 Aug 25. doi: 10.1111/1346-8138.70481.
    PubMed    


  26. MIYAJIMA M, Kasamatsu H, Oyama N, Suzuki K, et al
    Cutaneous Indeterminate Cell Histiocytosis in a Young Child: A Case Report and Literature Review.
    J Dermatol. 2026 Aug 25. doi: 10.1111/1346-8138.70408.
    PubMed    


  27. DENG Y, Li H
    Chronic Cutaneous Graft-Versus-Host Disease Treated With Dupilumab.
    J Dermatol. 2026 Aug 24. doi: 10.1111/1346-8138.70417.
    PubMed    


  28. KUNIMOTO K, Kaminaka C, Muraoka K, Hara T, et al
    Efficacy, Safety, and Predictive Value of Quantitative Histopathology in Picosecond Laser Therapy for Congenital Melanocytic Nevi: A Prospective Clinical Trial.
    J Dermatol. 2026 Aug 24. doi: 10.1111/1346-8138.70476.
    PubMed     Abstract available


  29. TAMURA F, Nojima I, Kunimoto R, Hosoda R, et al
    SIRT1 Activator Resveratrol Attenuates Age-Related Skin Thinning in Mice.
    J Dermatol. 2026 Aug 24. doi: 10.1111/1346-8138.70471.
    PubMed     Abstract available


  30. OHASHI S, Sakai T, Hatano Y
    Successful Dupilumab Treatment for Atopic Dermatitis Without Topical Corticosteroids in a Patient With Glaucoma.
    J Dermatol. 2026 Aug 24. doi: 10.1111/1346-8138.70472.
    PubMed    


  31. ARTIK A, Atas H, Yuksek T, Atas E, et al
    The Impact of Molluscum Contagiosum on Depression, Anxiety and Quality of Life in Children.
    J Dermatol. 2026 Aug 21. doi: 10.1111/1346-8138.70443.
    PubMed     Abstract available


  32. MATSUMOTO S, Kondo A, Shimizu T, Saito M, et al
    The First Human Case of Dermatophilus congolensis Dermatitis in Japan.
    J Dermatol. 2026 Aug 21. doi: 10.1111/1346-8138.70462.
    PubMed    


  33. MORIWAKI H, Nomura T, Katsuo K, Nishitani K, et al
    Linear IgA/IgG Bullous Dermatosis With Atypical Mixed Linear and Granular Immune Complex Deposition.
    J Dermatol. 2026 Aug 21. doi: 10.1111/1346-8138.70468.
    PubMed    


  34. DU S, Jallorina A, Yoshino T, Bao L, et al
    Advances in gammadelta T Cells: Cutaneous Biology and Therapeutic Potential for Skin Neoplasms.
    J Dermatol. 2026 Aug 21. doi: 10.1111/1346-8138.70461.
    PubMed     Abstract available


  35. LIN CY, Wu CL, Pan SC, Lee JY, et al
    Impact of Lateral Margin Adequacy on Survival in Cutaneous Melanoma: An Asian Retrospective Cohort Study.
    J Dermatol. 2026 Aug 18. doi: 10.1111/1346-8138.70469.
    PubMed     Abstract available


  36. MUKAIYAMA R, Yamamoto T
    Cardiac Sarcoidosis in Patients With Cutaneous Sarcoidosis: A Retrospective Observational Study at a Single Institution.
    J Dermatol. 2026 Aug 16. doi: 10.1111/1346-8138.70464.
    PubMed     Abstract available


  37. HAGINO T, Kanda N
    Systemic Treatment of Psoriasis: Current Evidence on Efficacy and Safety.
    J Dermatol. 2026 Aug 12. doi: 10.1111/1346-8138.70457.
    PubMed     Abstract available


  38. PAGANELLI A, Colonna L, Didona B, Pellacani G, et al
    Treatment of Vulvar Lichen Sclerosus With Topical Ruxolitinib: A Single-Center Study.
    J Dermatol. 2026 Aug 12. doi: 10.1111/1346-8138.70460.
    PubMed     Abstract available


  39. TSUCHIYA T, Ikuno Y, Yamada M, Yamaguchi A, et al
    Flare of Pre-Existing Sarcoidosis After Anti-B-Cell Maturation Antigen CAR-T Therapy: Cutaneous Lesions Mimicking Extramedullary Myeloma Relapse.
    J Dermatol. 2026 Aug 10. doi: 10.1111/1346-8138.70463.
    PubMed    


  40. KUSANO M, Igari S, Yamamoto T
    An Adolescent Case of Giant Dermatofibroma With Local Hypertrichosis Following Vaccination.
    J Dermatol. 2026 Aug 9. doi: 10.1111/1346-8138.70452.
    PubMed    


  41. IINO K, Takamura S, Fukuda T
    Real-World Effectiveness, Treatment Course, and Safety of Tapinarof Cream 1% for Atopic Dermatitis and Plaque Psoriasis in Japan.
    J Dermatol. 2026 Aug 6. doi: 10.1111/1346-8138.70448.
    PubMed     Abstract available


  42. OKUBO Y, Morita A, Tada Y, Imafuku S, et al
    Safety and Efficacy of Deucravacitinib in Japanese Patients With Moderate to Severe Plaque Psoriasis: 5-Year Analysis of the Phase 3 POETYK PSO-1, PSO-4, and Long-Term Extension Trials.
    J Dermatol. 2026 Aug 5. doi: 10.1111/1346-8138.70392.
    PubMed     Abstract available


  43. MUTO Y, Fujimura T, Kobayashi A, Segawa K, et al
    Cutaneous Squamous Cell Carcinoma Arising From Hidradenitis Suppurativa and Epidermal Cyst: Clinical Characteristics, Baseline Neutrophil-To-Lymphocyte Ratio, and Disease-Specific Survival in a Retrospective Cohort.
    J Dermatol. 2026 Aug 2. doi: 10.1111/1346-8138.70433.
    PubMed     Abstract available


  44. YAMAMURA Y, Fujii K, Kagawa N, Nakajima M, et al
    A Recurrent-Depth Multimodal Model for Skin Lesion Classification: A Feasibility Study Using Derm7pt.
    J Dermatol. 2026 Aug 2. doi: 10.1111/1346-8138.70442.
    PubMed    


  45. DING L, Chen J, Dong X
    Hepatic Steatosis in Biologic-Treated Patients With Psoriasis and Low Current Disease Activity: Prevalence and Metabolic Determinants.
    J Dermatol. 2026 Aug 2. doi: 10.1111/1346-8138.70441.
    PubMed     Abstract available


  46. KANNO K, Kobayashi Y, Fujita Y
    Nodular Scleroderma in a Patient With Anti-RNA Polymerase III-Antibody Positive Systemic Sclerosis: A Case Report and Literature Review.
    J Dermatol. 2026;53:1213-1216.
    PubMed     Abstract available


  47. UCHIDA M, Hamada T, Kawashima H, Yamada T, et al
    Apremilast for Acrodermatitis Continua of Hallopeau: Report of Two Cases and Review of the Literature.
    J Dermatol. 2026;53:1198-1202.
    PubMed     Abstract available


  48. TANEMURA A, Oiso N, Okamura K, Hiroyasu S, et al
    Second Guidelines for the Diagnosis and Treatment of Vitiligo in Japan (2025).
    J Dermatol. 2026;53:e620-e638.
    PubMed     Abstract available


  49. WONGJIRATTIKARN R, Chanprapaph K, Rerknimitr P, Chularojanamontri L, et al
    Incidence Trends and Severe in-Hospital Outcomes of Pemphigus Vulgaris: A Nationwide Cohort Study.
    J Dermatol. 2026;53:1142-1152.
    PubMed     Abstract available


  50. SATO A, Matsui Y, Kitayama S, Shimizu T, et al
    Persistence and Contemporary Clinical Applications of Mohs Paste: A Scoping Review.
    J Dermatol. 2026;53:1083-1089.
    PubMed     Abstract available


  51. PENG X, Wang Y, Xiao Y, Wang H, et al
    Arthralgia and Ultrasound Characteristics of Subclinical Psoriatic Arthritis: A Cross-Sectional Study Based on the SPAWCH Cohort.
    J Dermatol. 2026;53:1133-1141.
    PubMed     Abstract available


    July 2026
  52. WANG Y, Tan Y, Liu F
    Giant Hypertrichotic Pigmented Neurofibroma Mimicking Giant Congenital Melanocytic Nevus in Neurofibromatosis Type 1: A Rare Case Report.
    J Dermatol. 2026 Jul 30. doi: 10.1111/1346-8138.70435.
    PubMed    


  53. YAMANAKA K, Pak Y, Inda Y, Nomi T, et al
    Educational Artificial Intelligence Software to Support Assessment of Atopic Dermatitis Severity.
    J Dermatol. 2026 Jul 30. doi: 10.1111/1346-8138.70434.
    PubMed     Abstract available


  54. SEKI H, Akaza N, Nomura M, Futamura K, et al
    Association Between Chronic Facial Erythema and Cutaneous Microbiota in Women.
    J Dermatol. 2026 Jul 29. doi: 10.1111/1346-8138.70426.
    PubMed    


  55. RO C, Ormaza Vera A, Adawi W, Enos CW, et al
    Assessment of Major Adverse Cardiovascular Event Across Diverse Racial Groups of Psoriasis Patients on Biologic Therapy: A Retrospective Cohort Study.
    J Dermatol. 2026 Jul 26. doi: 10.1111/1346-8138.70396.
    PubMed     Abstract available


  56. TADA Y, Maeda Y, Hasegawa M, Sakaguchi M, et al
    Treatment Patterns and Pathways of Systemic Drug Therapy in Patients With Plaque, Erythrodermic, and Generalized Pustular Psoriasis: A Retrospective Cohort Study in Japan.
    J Dermatol. 2026 Jul 26. doi: 10.1111/1346-8138.70406.
    PubMed     Abstract available


  57. KATO A, Kawamoto A, Murase D, Yoshida H, et al
    Claudin-3 Deficiency Potentially Permits Epidermal Nerve Infiltration and Contributes to Sensitive Skin Pathophysiology.
    J Dermatol. 2026 Jul 26. doi: 10.1111/1346-8138.70403.
    PubMed    


  58. MORITA A, Imafuku S, Torii H, Peetluk L, et al
    Topical Cycling and Systemic Eligibility in Patients With Psoriasis in Japan.
    J Dermatol. 2026 Jul 24. doi: 10.1111/1346-8138.70395.
    PubMed     Abstract available


  59. ANUTRAUNGKOOL T, Choonhakarn C, Chaowattanapanit S, Wongjirattikarn R, et al
    The Vinyl Adhesive Tape Technique With Methylene Blue for Diagnosis of Superficial Fungal Skin Infections.
    J Dermatol. 2026 Jul 23. doi: 10.1111/1346-8138.70420.
    PubMed     Abstract available


  60. SAGARA C, Yihan Y, Rokunohe D, Terada A, et al
    Mosaic RASopathy Caused by a Somatic HRAS p.Gly12Ser Variant in a Patient With Malignant Melanoma.
    J Dermatol. 2026 Jul 23. doi: 10.1111/1346-8138.70421.
    PubMed     Abstract available


  61. SUZUKI K, Uehara J, Takeda K, Ishizuki S, et al
    Cytokine Release Syndrome Induced by Combination Therapy With Nivolumab and Ipilimumab in Lower Palpebral Conjunctival Melanoma: A Case Report.
    J Dermatol. 2026 Jul 23. doi: 10.1111/1346-8138.70413.
    PubMed     Abstract available


  62. HOSOI M, Takahashi M, Maru R, Tsuchihashi H, et al
    Pregnancy-Associated Pityriasis Lichenoides et Varioliformis Acuta Responsive to Clarithromycin.
    J Dermatol. 2026 Jul 23. doi: 10.1111/1346-8138.70409.
    PubMed    


  63. YAMAMOTO Y, Imawari H, Sakai N, Uchiyama M, et al
    A Case of Cutaneous Pili Migrans Caused by a Canine Hair.
    J Dermatol. 2026 Jul 22. doi: 10.1111/1346-8138.70400.
    PubMed    


  64. OIWA E, Mizuno H, Takahagi S
    Cutaneous Granulomatous Reaction Associated With Adalimumab Accompanied by Elevated Serum TARC and Eosinophilic Infiltration: A Case Report.
    J Dermatol. 2026 Jul 22. doi: 10.1111/1346-8138.70422.
    PubMed    


  65. KANAYA M, Mitsui Y, Sasaki S, Ochi A, et al
    Granulomatous Vasculitis in Cutaneous Hydrophilic Polymer Embolism.
    J Dermatol. 2026 Jul 17. doi: 10.1111/1346-8138.70376.
    PubMed     Abstract available


  66. OKUDA K, Nakamura M, Nakamura R, Takagi S, et al
    Early Intervention Effects and Risk Factors for Residual Skin Changes in Infantile Hemangiomas.
    J Dermatol. 2026 Jul 16. doi: 10.1111/1346-8138.70388.
    PubMed     Abstract available


  67. YAMAI T, Yamamoto-Hanada K, Yonemichi H, Yamamoto S, et al
    Restraint-Free Initiation of Dupilumab in a Child With Autism Spectrum Disorder: Overcoming Procedural Barriers in Atopic Dermatitis.
    J Dermatol. 2026 Jul 14. doi: 10.1111/1346-8138.70394.
    PubMed     Abstract available


  68. KAGOYAMA K, Makino T, Tsuritani M, Furukawa F, et al
    Fractional CO(2) Laser in Lichen Amyloidosis With Rapid Pruritus Resolution and Long-Term Remission: Serial PGP9.5 and Dylon Observations With Touch Sensitivity Assessment.
    J Dermatol. 2026 Jul 8. doi: 10.1111/1346-8138.70385.
    PubMed     Abstract available


  69. KOMORI T, Nakano E, Kiniwa Y, Mori S, et al
    Efficacy of Adjuvant Interferon-beta Versus Observation for Resected Nail Apparatus Melanoma: A Multicenter Retrospective Study.
    J Dermatol. 2026 Jul 6. doi: 10.1111/1346-8138.70375.
    PubMed     Abstract available


  70. TANAKA Y, Aoki N, Yamamoto M, Nakai K, et al
    Exacerbation of Psoriasis Following Recurrence of Lymphangioma: A Case Report.
    J Dermatol. 2026 Jul 6. doi: 10.1111/1346-8138.70384.
    PubMed    


  71. ASADA S, Hoshina D
    Pembrolizumab-Associated Lichen Striatus in an Adult.
    J Dermatol. 2026 Jul 6. doi: 10.1111/1346-8138.70381.
    PubMed    


  72. AOYAMA M, Hagihara E, Furuya Y, Koshikawa S, et al
    Occupational Primary Red Meat Allergy With Sensitization to Serum Albumins, Sus s 1, and Bos d 6.
    J Dermatol. 2026 Jul 6. doi: 10.1111/1346-8138.70379.
    PubMed     Abstract available


  73. CHEN YW, Chen YH, Yen TH, Chen YJ, et al
    Achieving Targeted Combined Endpoints in Patients With Atopic Dermatitis: A Real-World Study.
    J Dermatol. 2026 Jul 3. doi: 10.1111/1346-8138.70369.
    PubMed     Abstract available


  74. WATANABE T, Yamakawa K, Kobayashi M, Saigusa Y, et al
    Risk Factors for Cutaneous Immune-Related Adverse Events in the Japanese Population: A Retrospective Single-Center Cohort Study.
    J Dermatol. 2026 Jul 2. doi: 10.1111/1346-8138.70370.
    PubMed     Abstract available


  75. KATAOKA Y, Etoh T, Saeki H, Katoh N, et al
    Characterization of Prurigo Nodules in Adults With Moderate-To-Severe Atopic Dermatitis in Japan: A 2-Year Observational Study.
    J Dermatol. 2026 Jul 2. doi: 10.1111/1346-8138.70345.
    PubMed     Abstract available


  76. CHIHIRO I, Hagino T, Takahashi Y, Yoneyama M, et al
    Real-World Effectiveness of Tildrakizumab in Japanese Patients With Psoriasis: Analyses Stratified by Prior Systemic Therapy, Maintenance of Early Responses, and Achievement of Delayed Responses.
    J Dermatol. 2026 Jul 1. doi: 10.1111/1346-8138.70367.
    PubMed     Abstract available


  77. USUI M, Ikuno Y, Kobayashi S, Yamada M, et al
    Sparing of the Nipple-Areolar Complex and Periareolar Skin as a Diagnostic Clue for Radiation-Induced Morphea of the Breast.
    J Dermatol. 2026 Jul 1. doi: 10.1111/1346-8138.70368.
    PubMed    


  78. TERUI T, Kobayashi S, Yamamoto T, Okubo Y, et al
    Treatment Guidance for Palmoplantar Pustulosis 2022.
    J Dermatol. 2026;53:e510-e566.
    PubMed     Abstract available


  79. WALTER T, Burckhardt BB
    Broadening the View: Substance P and Its Metabolism in Pruritus-Related Diseases.
    J Dermatol. 2026;53:967-979.
    PubMed     Abstract available


  80. PUIG L, Tsai TF, Soriano ER, Bhutani T, et al
    Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease.
    J Dermatol. 2026;53:1026-1031.
    PubMed     Abstract available


  81. JENG YC, Liu WT, Hsu CK, Yang CC, et al
    Real-World Experience With Single Ultra-Low Dose Rituximab for Remission Induction in Pemphigus.
    J Dermatol. 2026;53:1057-1061.
    PubMed     Abstract available


  82. INOUE T, Watabe D, Sato T, Yasuhira S, et al
    Baseline Nail Thickness and Great Toenail Involvement Are Associated With Poor Response to Topical Antifungal Therapy for Onychomycosis: A Lesion-Level Generalized Estimating Equations Analysis.
    J Dermatol. 2026;53:1013-1019.
    PubMed     Abstract available


  83. OTSUKA A, Tsunemi Y, Nonaka Y
    Patient Characteristics Associated With Sensitivity to Message Framing: A Within-Subject Comparison Study Using Data From the Illuminating Dialogues and Insights in Onychomycosis Management (IDIOM) Survey.
    J Dermatol. 2026;53:1067-1071.
    PubMed     Abstract available


  84. MARUYAMA A, Sotozono A, Fukumoto T
    Acquired Idiopathic Generalized Anhidrosis as a Late-Onset Immune-Related Adverse Event of Pembrolizumab in a Patient With Lung Adenocarcinoma: A Case Report and Review of the Literature.
    J Dermatol. 2026;53:1072-1076.
    PubMed     Abstract available


  85. ASHIDA M, Nakahara T, Murota H
    Persistent Blood Dioxins and Sensory Impairment Assessed by Quantitative Sensory Testing in 115 Yusho Patients 57 Years After Exposure.
    J Dermatol. 2026;53:1053-1056.
    PubMed     Abstract available


  86. SUZAKI Y, Aoyama Y
    Drug-Induced Blaschkitis Associated With Dipeptidyl Peptidase-4 Inhibitor: A Case Report and Review of the Literature.
    J Dermatol. 2026;53:1048-1052.
    PubMed     Abstract available


  87. NISHIDA M, Shimauchi T, Ishikawa Y, Ogura Y, et al
    Pustular Mycosis Fungoides Triggered by Systemic Interferon-gamma.
    J Dermatol. 2026;53:1032-1035.
    PubMed     Abstract available


  88. ZHANG S, Pang Z, Liu J
    Mycosis Fungoides Following IL-17 Inhibitor Treatment: A Case Series of Five Patients.
    J Dermatol. 2026;53:1036-1042.
    PubMed     Abstract available


    June 2026
  89. DURSUN P, Saribas Yildirim AN, Yazici A
    Demodex Infestation in Patients With Atopic Dermatitis Treated With Dupilumab: A Case-Control Study.
    J Dermatol. 2026 Jun 28. doi: 10.1111/1346-8138.70372.
    PubMed     Abstract available


  90. NISHIMURA K, Oyama N, Hasegawa T, Kasamatsu H, et al
    A Serum N-Glycan Ratio Associated With Disease Severity and Treatment Response in Psoriasis.
    J Dermatol. 2026 Jun 23. doi: 10.1111/1346-8138.70316.
    PubMed     Abstract available


  91. MORI T, Otsuka M, Yamamoto T
    Therapeutic Effectiveness of Radiotherapy for Lymph Node Metastases of Cutaneous Squamous Cell Carcinoma: A Single-Center Retrospective Analysis.
    J Dermatol. 2026 Jun 23. doi: 10.1111/1346-8138.70363.
    PubMed     Abstract available


  92. PARK JY, Lee HJ, Huh CH
    A Case of SREBF1-Associated Ichthyosis Follicularis, Alopecia, and Photophobia Syndrome With Recurrent Alopecia.
    J Dermatol. 2026 Jun 23. doi: 10.1111/1346-8138.70360.
    PubMed    


  93. HU ZM, He W, Hu B, Zou L, et al
    Cutaneous and Subcutaneous Hyalohyphomycosis Caused by Purpureocillium Lilacinum in a Tertiary Referral Hospital in Central China.
    J Dermatol. 2026 Jun 22. doi: 10.1111/1346-8138.70366.
    PubMed     Abstract available


  94. MAKINO T, Takemoto K, Mizawa M, Shimizu T, et al
    Platelet-Rich Plasma Therapy for Refractory Skin Ulcers: A Case Series of 12 Patients and Concise Review of the Literature.
    J Dermatol. 2026 Jun 19. doi: 10.1111/1346-8138.70365.
    PubMed     Abstract available


  95. CHANG CY, Li CY, Wang TH, Tsai CH, et al
    Recurrence Patterns and Prognostic Factors in Sentinel Lymph Node-Negative Melanoma in a Taiwanese Cohort With Predominant Acral Melanoma.
    J Dermatol. 2026 Jun 17. doi: 10.1111/1346-8138.70358.
    PubMed     Abstract available


  96. TAKIWAKI M, Kunimoto K, Nakatani Y, Miyazaki K, et al
    Analysis of Phosphorylated MEK1 Expression Pattern in Cutaneous Dilated Vessels of Capillary Malformations.
    J Dermatol. 2026 Jun 15. doi: 10.1111/1346-8138.70355.
    PubMed     Abstract available


  97. SAITO R, Sasaki W, Watanabe H, Hashimoto M, et al
    Extended-Interval Dosing and Discontinuation of Dupilumab in Atopic Dermatitis: A Real-World Retrospective Study.
    J Dermatol. 2026 Jun 11. doi: 10.1111/1346-8138.70350.
    PubMed     Abstract available


  98. OGUMA R, Koizumi S, Saeki Y, Aoyama K, et al
    Phenotypic Analysis of 26 Cultured TILs Derived From Japanese Melanoma Tissues.
    J Dermatol. 2026 Jun 10. doi: 10.1111/1346-8138.70346.
    PubMed     Abstract available


  99. YAHAGI Y, Fujimura T, Yoshida A, Asano Y, et al
    Hypopigmented Mycosis Fungoides With Childhood-Onset and Middle-Aged Onset: Two Case Reports Focusing on the Cutaneous Immune Microenvironment.
    J Dermatol. 2026 Jun 8. doi: 10.1111/1346-8138.70343.
    PubMed     Abstract available


  100. ARAKAWA H, Watanabe T, Ototake Y, Imai S, et al
    Predictors of Immunosuppressive Treatment in Cutaneous Arteritis: Analysis of Clinical Characteristics in 42 Patients.
    J Dermatol. 2026 Jun 4. doi: 10.1111/1346-8138.70339.
    PubMed     Abstract available


  101. TSUNEMI Y, Igarashi A, Ishido T, Saeki H, et al
    Real-World Maintenance of Remission in Atopic Dermatitis Patients With Upadacitinib: A Multicenter Retrospective Study in Japan (ROADMAP Study).
    J Dermatol. 2026 Jun 4. doi: 10.1111/1346-8138.70299.
    PubMed     Abstract available


  102. CHIBA K, Nakano S, Fukuchi O, Kawase M, et al
    Pediatric Recurrent Circinate Erythematous Psoriasis Successfully Treated With Secukinumab: A Case Report.
    J Dermatol. 2026 Jun 2. doi: 10.1111/1346-8138.70337.
    PubMed    


  103. HASHIMOTO S, Yoshioka A, Hanafusa H, Kubo A, et al
    Sebaceous Nevus Harboring an HRAS p.Ala11_Gly12dup Variant.
    J Dermatol. 2026 Jun 2. doi: 10.1111/1346-8138.70323.
    PubMed    


  104. PARK S, Jo SJ
    Sequential Paradoxical Eczema Following Interleukin-23, Interleukin-17, and Tyrosine Kinase 2 Inhibitors in a Single Psoriasis Patient.
    J Dermatol. 2026 Jun 1. doi: 10.1111/1346-8138.70335.
    PubMed    


  105. TATEISHI F, Murayama N, Nakamuta R, Watanabe M, et al
    Erythropoietic Protoporphyria and Surgery: A Case of Successful Mastectomy With Perioperative Light Shielding Strategies Based on Light-Induced Hemolytic Threshold Assessment.
    J Dermatol. 2026;53:930-933.
    PubMed     Abstract available


  106. YAMAMOTO A, Enomoto Y, Sakurai M, Watanabe O, et al
    Efficacy of Minimal Blistering Dose-Based Versus Conventional Excimer Laser Therapy for Vitiligo.
    J Dermatol. 2026;53:925-929.
    PubMed     Abstract available


  107. MORADI A, Shakoei S, Hamzelou S, Nasimi M, et al
    Efficacy of 0.5% Timolol Maleate Eye Drops for the Treatment of Facial Rosacea: A Randomized, Triple-Blind, Placebo-Controlled Clinical Trial.
    J Dermatol. 2026;53:880-887.
    PubMed     Abstract available


  108. ANDO T, Kamiya K, Kishimoto M, Sugihara N, et al
    Refractory Psoriatic Lesions in Japanese Patients With Biologics.
    J Dermatol. 2026;53:914-924.
    PubMed     Abstract available


  109. PENG Y, Guan Y, Lv K, Yang C, et al
    Mutation Analysis in Ten Cases With PNPLA1-Nonsyndromic Epidermal Differentiation Disorder: Evidence of a Founder Effect.
    J Dermatol. 2026;53:896-904.
    PubMed     Abstract available


    May 2026
  110. NAKAHARA T, Kaneko S, Katoh N, Ozawa M, et al
    Prevalence, Severity, and Clinical Course of Atopic Dermatitis in Japan: A Web-Based Questionnaire Survey.
    J Dermatol. 2026 May 25. doi: 10.1111/1346-8138.70329.
    PubMed     Abstract available


  111. ADACHI N, Watanabe Y, Ototake Y, Takamura N, et al
    Progressive Ocular Involvement in Toxic Epidermal Necrolysis Despite Early and Intensive Multidisciplinary Management: A Case Report.
    J Dermatol. 2026 May 24. doi: 10.1111/1346-8138.70324.
    PubMed    


  112. TEZUKA J, Tanabe H
    Granular C3 Dermatosis With Intraepidermal Blister Formation.
    J Dermatol. 2026 May 22. doi: 10.1111/1346-8138.70319.
    PubMed    


  113. IWATA S, Takamura S, Fukuda T
    Differential Cutaneous Responses to Baricitinib in Concomitant Lichen Planus and Localized Eczematous Dermatitis in an Atopic Patient.
    J Dermatol. 2026 May 15. doi: 10.1111/1346-8138.70315.
    PubMed    


  114. JINNIN M, Ishihara R, Hosoda A
    Oral Intake of Rice Bran Oil Enriched With gamma-Oryzanol and Phytosterol Esters Improves Skin Conditions: A Placebo-Controlled, Randomized, Double-Blind, Parallel-Group Comparative Study.
    J Dermatol. 2026 May 15. doi: 10.1111/1346-8138.70307.
    PubMed     Abstract available


  115. SAITO S, Yasuda M, Kosaka Y, Kano R, et al
    Favorable Outcome of Umbilical Melanoma With Bilateral Inguinal Lymph Node Metastases Treated With Lymph Node Dissection and Adjuvant Nivolumab: A 37-Month Recurrence-Free Case.
    J Dermatol. 2026 May 12. doi: 10.1111/1346-8138.70308.
    PubMed    


  116. KATO M, Shigehara Y, Moriwaki R, Honda I, et al
    Spesolimab for Generalized Pustular Psoriasis in the Late Second Trimester of Pregnancy.
    J Dermatol. 2026 May 11. doi: 10.1111/1346-8138.70286.
    PubMed    


  117. KONDO M, Mori S, Habe K, Yamanaka K, et al
    Recurrent Cutaneous Mycobacterium chelonae Infection With an IgM-Predominant Antibody Response in DiGeorge Syndrome.
    J Dermatol. 2026 May 7. doi: 10.1111/1346-8138.70302.
    PubMed     Abstract available


  118. HORISAKI K, Goto K, Tsutsumida A, Hiraki T, et al
    Melanoma Dissemination Through Bullous Solar Elastosis: Previously Undescribed Pattern of Cancer Dissemination.
    J Dermatol. 2026 May 4. doi: 10.1111/1346-8138.70303.
    PubMed     Abstract available


  119. NAGATAKE M, Horikawa H, Kakuta R, Adachi T, et al
    A Case of Annular Pustular Psoriasis Possibly Triggered by Cabozantinib and Edoxaban During Nivolumab Therapy.
    J Dermatol. 2026 May 3. doi: 10.1111/1346-8138.70301.
    PubMed    


  120. KIMURA A, Ishii T, Hatta N
    Efficacy and Cosmetics of Secondary Intention Healing for Facial Skin Cancer: A Single-Center Retrospective Study.
    J Dermatol. 2026 May 3. doi: 10.1111/1346-8138.70298.
    PubMed     Abstract available


  121. YOSHIZAKI A, Wada Y, Andoh M, Egawa G, et al
    A Case of Tsutsugamushi Mite Infestation With Multiple Larvae Visibly Attached to the Skin.
    J Dermatol. 2026 May 3. doi: 10.1111/1346-8138.70300.
    PubMed    


  122. KISHIMOTO M, Kimura-Sashikawa M, Komine M
    Immunohistochemistry Revealed Distinct IL-36gamma Localization Among Different Skin Diseases.
    J Dermatol. 2026 May 3. doi: 10.1111/1346-8138.70291.
    PubMed     Abstract available


  123. COOK K, Elbuluk NM, Adiri R, Lejeune A, et al
    Risk of Safety Events in Vitiligo Patients: A Retrospective Real-World Data Study in the US.
    J Dermatol. 2026;53:758-773.
    PubMed     Abstract available


  124. SUN LD, Behl A, Danilov PN, Agiri FY, et al
    Healthcare Resource Utilization and Use of Biologics in Chronic Spontaneous Urticaria.
    J Dermatol. 2026;53:832-836.
    PubMed     Abstract available


  125. HAYASHI R, Takamura S, Fukuda T
    Real-World Outcomes of Baricitinib and Ritlecitinib in Refractory Alopecia Areata: Response Predictors and Relapse After Discontinuation or Dose Reduction.
    J Dermatol. 2026;53:746-757.
    PubMed     Abstract available


  126. VENTURI F, Falkowska U, Magnaterra E, Gualandi A, et al
    The Role of Imaging Techniques in Pigmented Bowen Disease and Lentigo Maligna of the Head and Neck: A Comparative Dermoscopic and Reflectance Confocal Microscopy Study.
    J Dermatol. 2026;53:856-860.
    PubMed     Abstract available


  127. ZHANG J, Liu Y, Liu J, Mo R, et al
    Development of an ARMS-qPCR Strategy for the Rapid Genetic Diagnosis of Nagashima-Type Palmoplantar Keratoderma.
    J Dermatol. 2026;53:824-831.
    PubMed     Abstract available


  128. FUJINO K, Umemoto N, Kakurai M, Yabe H, et al
    A Case of Disseminated Trichophytosis With Vascular Invasion and Multiple Ulcers: Case Report and Literature Review.
    J Dermatol. 2026;53:845-850.
    PubMed     Abstract available


  129. MIYAZAWA H, Natsuga K, Seo T, Ujiie H, et al
    Washcloth Withdrawal and Pruritus: A Single-Center Retrospective Observational Study.
    J Dermatol. 2026;53:774-779.
    PubMed     Abstract available


  130. YAO H, Gao X, Xiang W
    The Role of Macrophages in Pigmentary Disorders.
    J Dermatol. 2026;53:719-732.
    PubMed     Abstract available


    April 2026
  131. TSUJI G, Fuyuno Y, Kawamura K, Yumine A, et al
    Tapinarof as a Therapeutic Aryl Hydrocarbon Receptor-Modulating Agent in the Treatment of Atopic Dermatitis.
    J Dermatol. 2026 Apr 29. doi: 10.1111/1346-8138.70295.
    PubMed     Abstract available


  132. KIM BR, Nam J, Lee J, Kang S, et al
    Long-Term Particulate Matter Exposure and Risk of Psoriasis Incidence, and Short-Term Exposure and Risk of Exacerbation: A Nationwide Cohort Study.
    J Dermatol. 2026 Apr 28. doi: 10.1111/1346-8138.70283.
    PubMed     Abstract available


  133. TAKAMOTO K, Goto K, Nishitani K, Tsujihana K, et al
    Unilateral Mosaic Pattern of Cutaneous Immune-Related Adverse Event Induced by Pembrolizumab: A Case Report.
    J Dermatol. 2026 Apr 21. doi: 10.1111/1346-8138.70287.
    PubMed    


  134. SHIBUYA C, Shimauchi T, Fujihiro M, Baba S, et al
    Cutaneous Involvement of Waldenstrom Macroglobulinemia With MYD88 L265P Mutation Identified in Lesional Skin.
    J Dermatol. 2026 Apr 21. doi: 10.1111/1346-8138.70285.
    PubMed    


  135. TANG JY, Tsai TF
    Psoriasis and Comorbid Moyamoya Angiopathy: Report of Three Chinese Patients and Review of the Literature.
    J Dermatol. 2026 Apr 20. doi: 10.1111/1346-8138.70284.
    PubMed    


  136. TOMIO S, Fujimoto M, Yoshimura A, Kawakita H, et al
    A Case of Granular C3 Dermatosis Initially Suspected as Neutrophilic Dermatosis.
    J Dermatol. 2026 Apr 20. doi: 10.1111/1346-8138.70282.
    PubMed    


  137. SAKAI A, Yamashita Y, Tanaka I, Noda E, et al
    Cutaneous Lesions and Lung Squamous Cell Carcinoma Both Successfully Controlled With Chemoradiotherapy in a Patient With Cancer-Associated Clinically Amyopathic Dermatomyositis With Anti-Nuclear Matrix Protein 2 Antibodies.
    J Dermatol. 2026 Apr 20. doi: 10.1111/1346-8138.70281.
    PubMed    


  138. HAYASHI M, Kohri N, Yoshida S, Yatsuzuka K, et al
    Anti-Laminin-332 Subepidermal Autoimmune Blistering Disease With Extensive Cutaneous Involvement: A Case Report.
    J Dermatol. 2026 Apr 19. doi: 10.1111/1346-8138.70288.
    PubMed    


  139. SAKURA H, Nozaki H, Igawa S, Ishida-Yamamoto A, et al
    A Case of Areolar Sebaceous Hyperplasia Coexisting With an Epidermoid Cyst and Soft Fibroma.
    J Dermatol. 2026 Apr 19. doi: 10.1111/1346-8138.70275.
    PubMed    


  140. ISHITSUKA Y, Fujimoto M
    Selective Reduction in Scale Thickness After IL-13 Blockade with Lebrikizumab in a Lamellar Ichthyosis Phenotype.
    J Dermatol. 2026 Apr 19. doi: 10.1111/1346-8138.70280.
    PubMed    


  141. WATABE H, Miyagaki T, Go K, Oba S, et al
    Hemoglobin A1c is Associated With Advanced Liver Fibrosis in Psoriasis Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.
    J Dermatol. 2026 Apr 15. doi: 10.1111/1346-8138.70274.
    PubMed     Abstract available


  142. MATSUMOTO S, Moriwaki M, Tanaka A, Tanaka M, et al
    Hydroxychloroquine for Cutaneous Kikuchi-Fujimoto Disease: A Case Report.
    J Dermatol. 2026 Apr 14. doi: 10.1111/1346-8138.70270.
    PubMed    


  143. TAKANO E, Nakazato S, Otsuka T, Horiuchi M, et al
    Primary Cutaneous Secretory Carcinoma of the Eyelid Margin: A Case Report.
    J Dermatol. 2026 Apr 14. doi: 10.1111/1346-8138.70273.
    PubMed    


  144. GANGA R, Mishra S, Behera AK, Ravina M, et al
    Cutaneous and Chest X-Ray Manifestation in a Patient With Chronic Systemic Mercury Poisoning With Embolism.
    J Dermatol. 2026 Apr 14. doi: 10.1111/1346-8138.70271.
    PubMed    


  145. INOUE T, Yoshioka W, Watabe D, Amano H, et al
    Nemolizumab for Lichen Amyloidosis With Serial Serum Interleukin-31 Levels: A Case Report.
    J Dermatol. 2026 Apr 10. doi: 10.1111/1346-8138.70263.
    PubMed     Abstract available


  146. OHATA M, Fukumoto T, Ishii N, Hashimoto T, et al
    Serological Examination in a Case of Pemphigus With Oral Erosions and Foliaceus Skin Lesions.
    J Dermatol. 2026 Apr 10. doi: 10.1111/1346-8138.70267.
    PubMed    


  147. NISHIMURA K, Kimura A, Nakamura A, Takatsuka S, et al
    Tumor-Related Determinants of Reconstructive Method After Excision of Facial Basal Cell Carcinoma.
    J Dermatol. 2026 Apr 8. doi: 10.1111/1346-8138.70248.
    PubMed     Abstract available


  148. WAKI Y, Ebihara T, Omura K, Asahina A, et al
    Clinical Features of Nasal and Paranasal Mucosal Melanomas in the Era of Immune Checkpoint Inhibitors: Insights From a Single-Institution Analysis.
    J Dermatol. 2026 Apr 7. doi: 10.1111/1346-8138.70258.
    PubMed     Abstract available


  149. TAKAHASHI T, Takahashi T, Segawa Y, Oka K, et al
    Circumscribed Morphea Successfully Treated With Excimer Laser: Analysis of Histopathological Changes.
    J Dermatol. 2026;53:691-695.
    PubMed     Abstract available


  150. YAMASAKI K, Hayashi N, Hayashi H, Fukuya Y, et al
    An Attempt to Establish the Consensus Regarding the Diagnosis, Classification, and Treatment of Rosacea in Japan Using a Modified Delphi Method: The Japan Rosacea Consensus.
    J Dermatol. 2026;53:605-618.
    PubMed     Abstract available


  151. YUASA A, Kamei K, Saito S, Mikami M, et al
    Cost-Effectiveness Analysis of Ritlecitinib Compared With No Treatment in Patients With Severe Alopecia Areata in Japan.
    J Dermatol. 2026;53:619-631.
    PubMed     Abstract available


  152. HONDA A, Mori T, Asano T, Kiko Y, et al
    Anti-SAE Antibody-Positive Dermatomyositis Presenting With Widespread Erythema Complicated by Rosai-Dorfman Disease.
    J Dermatol. 2026;53:700-703.
    PubMed     Abstract available


  153. TAKAHASHI Y, Hagino T, Saeki H, Fujimoto E, et al
    Effectiveness of Apremilast in Patients With Palmoplantar Pustulosis: A 28-Week Real-World Study.
    J Dermatol. 2026;53:704-707.
    PubMed     Abstract available


  154. PARK JY, Kim MJ, Paik K, Shin JM, et al
    Nail Involvement Is a Key Determinant of Treatment Persistence in Palmoplantar Pustulosis.
    J Dermatol. 2026;53:673-682.
    PubMed     Abstract available


  155. ZHANG X, Gong X, Chen J, Lu Z, et al
    Elbow Gottron's Sign as a Predictor of Dermatomyositis With Respiratory System as the Initial Manifestation: A Retrospective Study.
    J Dermatol. 2026;53:662-672.
    PubMed     Abstract available


  156. LIU J, Zhou B, Chen Z, Li S, et al
    Functional Characterization of a Novel In-Frame Indel and a Founder Variant in SERPINB7 Associated With Palmoplantar Keratoderma.
    J Dermatol. 2026;53:655-661.
    PubMed     Abstract available


  157. UEKI R, Mizuashi M, Harada K, Zhang X, et al
    Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO-2b/3 and ALLEGRO-LT Clinical Studies for Alopecia Areata.
    J Dermatol. 2026;53:578-586.
    PubMed     Abstract available


  158. VAHABI SM, Heidari S, Pourgholi E, Memari H, et al
    Janus Kinase Inhibitors for the Treatment of Prurigo Nodularis: A Systematic Review of 211 Patients.
    J Dermatol. 2026;53:556-577.
    PubMed     Abstract available


  159. HONDA R, Hamada T, Sugaya M
    Mycosis Fungoides Is a Proliferation of Multiple Mutational Subclones.
    J Dermatol. 2026;53:539-546.
    PubMed     Abstract available


  160. HASHIMOTO A, Noda Y, Inaba Y, Kunimoto K, et al
    Clinical and Pathological Significance of GLUT-1 Expression in Angiosarcoma and Other Vascular Tumors.
    J Dermatol. 2026;53:632-639.
    PubMed     Abstract available


  161. LIN BS, Chung CH, Weng TH, Tsai CT, et al
    Elevated Risk of Herpes Zoster in Vitiligo Patients: A Nationwide Population-Based Cohort Study of Taiwan.
    J Dermatol. 2026;53:596-604.
    PubMed     Abstract available


  162. TSURUTA N, Imafuku S, Arima H
    Effectiveness and Continuous 2-Week Dosing of Ixekizumab in Practice: A Multicenter Study.
    J Dermatol. 2026;53:640-644.
    PubMed     Abstract available


  163. YANG LY, Zuo YG
    Updates in Pathogenesis of Pemphigus Vulgaris.
    J Dermatol. 2026;53:547-555.
    PubMed     Abstract available


    March 2026
  164. BENITEZ GARCIA E, Gonzalez Rodriguez J, de la Rosa Fernandez E, Garcia Silvera D, et al
    Severe Local Skin Reaction to Topical 5-Fluorouracil.
    J Dermatol. 2026 Mar 31. doi: 10.1111/1346-8138.70240.
    PubMed    


  165. YAMADA Y, Yoshihara S
    Serum TARC Levels Reflect the Severity and Prognosis of Atopic Dermatitis in Infants Under 6 Months of Age: A Retrospective Study in a Pediatric Primary Care Practice.
    J Dermatol. 2026 Mar 30. doi: 10.1111/1346-8138.70245.
    PubMed     Abstract available


  166. SAKAI Y, Ogata D, Kurisaki M, Kase M, et al
    Docetaxel for Pembrolizumab-Refractory Recurrent Basal Cell Carcinoma.
    J Dermatol. 2026 Mar 27. doi: 10.1111/1346-8138.70244.
    PubMed    


  167. YAMADA R, Takamura S, Fukuda T
    Enfortumab Vedotin-Related Cutaneous Adverse Events: Two Cases Highlighting Ring Mitosis and Severity-Guided Management.
    J Dermatol. 2026 Mar 26. doi: 10.1111/1346-8138.70242.
    PubMed    


  168. KATO M, Otsuka A, Dummer R
    Pediatric Skin Cancer: Melanoma, Basal and Squamous Cell Carcinomas, and Dermatofibrosarcoma Protuberans.
    J Dermatol. 2026 Mar 26. doi: 10.1111/1346-8138.70243.
    PubMed     Abstract available


  169. OZAKI M, Hayama K, Fujita H
    Comparison of Severity Assessment Methods in Generalized Pustular Psoriasis: A Single-Center Study.
    J Dermatol. 2026 Mar 25. doi: 10.1111/1346-8138.70232.
    PubMed     Abstract available


  170. OGURA Y, Honda T
    Serum Cytokine Dynamics in Dupilumab-Induced Psoriasiform Dermatitis: A Case Report.
    J Dermatol. 2026 Mar 25. doi: 10.1111/1346-8138.70237.
    PubMed    


  171. GOTO M, Goto H, Bito T, Kawai R, et al
    Analysis of Medical Costs of Melanoma Using a Japanese National Database.
    J Dermatol. 2026 Mar 25. doi: 10.1111/1346-8138.70227.
    PubMed     Abstract available


  172. UCHIYAMA A, Yokoyama Y, Sekiguchi A, Shibusawa Y, et al
    A Familial Case of CYLD Cutaneous Syndrome With a Novel Nonsense Mutation in Japanese.
    J Dermatol. 2026 Mar 18. doi: 10.1111/1346-8138.70224.
    PubMed    


  173. MORI Y, Yamamoto A, Watanabe O, Enomoto Y, et al
    Successful Discontinuation of Systemic Corticosteroids With Secukinumab in a Pediatric Case of Generalized Pustular Psoriasis Harboring an IL36RN Mutation.
    J Dermatol. 2026 Mar 17. doi: 10.1111/1346-8138.70199.
    PubMed    


  174. CONDE G, Carmenate Y, Bello G, Armstrong AW, et al
    Concordance Between Patient- and Physician-Reported Improvement With Dupilumab in Atopic Dermatitis.
    J Dermatol. 2026 Mar 13. doi: 10.1111/1346-8138.70202.
    PubMed     Abstract available


  175. YAMATE T, Goto M, Nishida H, Anan T, et al
    Erythroderma-Like Manifestations and High Fever in Palisaded Neutrophilic and Granulomatous Dermatitis Without Any Underlying Systemic Immunological Disease.
    J Dermatol. 2026 Mar 8. doi: 10.1111/1346-8138.70207.
    PubMed     Abstract available


  176. BASTOS T, Ito M, Kamata M, Shimizu T, et al
    A 308-nm Excimer Lamp Ameliorates MC903-Induced Atopic Dermatitis With Reductions of Intraepidermal Nerve Fiber Density and Expression of Thymic Stromal Lymphopoietin.
    J Dermatol. 2026 Mar 7. doi: 10.1111/1346-8138.70209.
    PubMed     Abstract available


  177. KITAGAWA H, Mizutani Y, Hayashi A, Yamanaka K, et al
    Childhood Granulomatous Periorificial Dermatitis With Extrafacial Involvement.
    J Dermatol. 2026 Mar 6. doi: 10.1111/1346-8138.70208.
    PubMed    


  178. YOSHIHARA K, Seyama S, Hayashi N, Horiuchi Y, et al
    Combination Effects of Clindamycin and Benzoyl Peroxide Against Cutibacterium acnes.
    J Dermatol. 2026;53:528-531.
    PubMed     Abstract available


  179. ALIOTTA GE, Lo Vecchio S, Tanaka R, Batsberg NS, et al
    Spatial and Temporal Summation of Histaminergic and Non-Histaminergic Itch.
    J Dermatol. 2026;53:518-523.
    PubMed     Abstract available


  180. USUKI H, Hagino T, Takahashi Y, Saeki H, et al
    The Maintenance of Early Responses and Achievement of Delayed Responses to Deucravacitinib Treatment in Psoriais: A 104-Week Real-World Study in Japan.
    J Dermatol. 2026;53:506-513.
    PubMed     Abstract available


  181. MIYASHITA A, Fukushima S, Yoshino K, Kato H, et al
    Real-World Efficacy of Chemotherapy in Patients With Advanced Unresectable Extramammary Paget Disease: A Retrospective Multicenter Study of 138 Japanese Patients.
    J Dermatol. 2026;53:478-487.
    PubMed     Abstract available


  182. OKAZAKI T, Takahashi T, Wada-Irimada M, Sekine M, et al
    Ritlecitinib in Alopecia Areata: A 24-Week Real-World Experience Contrasting JAK Inhibitor-Naive and JAK Inhibitor-Experienced Patients.
    J Dermatol. 2026;53:470-477.
    PubMed     Abstract available


    February 2026
  183. TAKEDA K, Takeuchi M, Hashizume H, Kuriyama N, et al
    Cardiovascular Risk in Psoriasis Compared With Atopic Dermatitis: The Shizuoka Kokuho Database.
    J Dermatol. 2026 Feb 25. doi: 10.1111/1346-8138.70197.
    PubMed     Abstract available


  184. OKAMOTO H, Nakamura Y
    Dysbiosis in the Pathogenesis of Atopic Dermatitis.
    J Dermatol. 2026 Feb 20. doi: 10.1111/1346-8138.70191.
    PubMed     Abstract available


  185. ADAMS MJ, Garza J, Chong BF
    Lupus Erythematosus Panniculitis Patients With Overlying Discoid Lupus Erythematosus Have Higher Rates of Head and Neck Involvement Than Those Without.
    J Dermatol. 2026 Feb 19. doi: 10.1111/1346-8138.70193.
    PubMed    


  186. IRIE K, Igari S, Endo M, Mukaiyama R, et al
    A Case of Pseudomyogenic Hemangioendothelioma Clinically Mimicking Whitlow With Subsequent Cutaneous Metastasis.
    J Dermatol. 2026 Feb 17. doi: 10.1111/1346-8138.70188.
    PubMed     Abstract available


  187. TATENO Y, Nobeyama Y
    Severe Infectious Skin Necrosis on Bilateral Superior Eyelids.
    J Dermatol. 2026 Feb 16. doi: 10.1111/1346-8138.70190.
    PubMed    


  188. KUMAGAI H, Ototake Y, Watanabe T, Takamura N, et al
    A Case of Bullous Pemphigoid Coexisted With Psoriasis Vulgaris Successfully Treated by Apremilast.
    J Dermatol. 2026 Feb 16. doi: 10.1111/1346-8138.70189.
    PubMed    


  189. YONEYAMA M, Hagino T, Uchiyama A, Saeki H, et al
    Seventy-Two-Week Real-World Outcomes of Tralokinumab Treatment for Moderate-To-Severe Atopic Dermatitis: Analyses Stratified by Baseline Rash and Itch Severity.
    J Dermatol. 2026 Feb 16. doi: 10.1111/1346-8138.70187.
    PubMed     Abstract available


  190. HORISAKI K, Yoshikawa S, Omata W, Tsutsumida A, et al
    Clinical Outcomes of Dacarbazine After Failure of Immune Checkpoint Inhibitors: A Case Study of 15 Japanese Patients With Malignant Melanoma.
    J Dermatol. 2026 Feb 13. doi: 10.1111/1346-8138.70181.
    PubMed    


  191. KINJO K, Takahashi T, Fujii H, Asano Y, et al
    Adalimumab-Induced Folliculitis-Like Lichenoid Sarcoidosis.
    J Dermatol. 2026 Feb 12. doi: 10.1111/1346-8138.70182.
    PubMed    


  192. SHIBA M, Hagino T, Uchiyama A, Saeki H, et al
    Effectiveness of Anti-IL-13 Antibodies on Head and Neck Lesions in Atopic Dermatitis: 48-Week Outcomes by Lebrikizumab and Tralokinumab.
    J Dermatol. 2026 Feb 11. doi: 10.1111/1346-8138.70183.
    PubMed     Abstract available


  193. MIYAZAKI N, Ibusuki A, Higashi Y, Yoshizaki A, et al
    Thoracic SMARCA4-Deficient Undifferentiated Tumor Diagnosed From a Rapidly Enlarging Cutaneous Metastasis.
    J Dermatol. 2026 Feb 11. doi: 10.1111/1346-8138.70180.
    PubMed    


  194. ISHIHARA R, Hagino T, Takahashi Y, Saeki H, et al
    Two-Year Real-World Effectiveness of Deucravacitinib in Psoriasis: The Analysis Stratified by Prior Apremilast or Biologic Therapy.
    J Dermatol. 2026 Feb 9. doi: 10.1111/1346-8138.70175.
    PubMed     Abstract available


  195. TSUBOI S, Yatsuzuka K, Kohri N, Yoshida S, et al
    Severe Generalized Pustular Psoriasis With Systemic Capillary Leak Syndrome Successfully Treated With Spesolimab: A Case Report.
    J Dermatol. 2026 Feb 6. doi: 10.1111/1346-8138.70176.
    PubMed    


  196. KATOH N
    The Pathogenesis of Atopic Dermatitis-Trends for the Future.
    J Dermatol. 2026 Feb 3. doi: 10.1111/1346-8138.70164.
    PubMed    


  197. WATANABE H, Kawashima S, Yoshino K, Matsuzawa T, et al
    A Case of Melanoma of the Glans With BRAF(V600E) Mutation Successfully Treated With Dabrafenib and Trametinib.
    J Dermatol. 2026 Feb 2. doi: 10.1111/1346-8138.70167.
    PubMed    


  198. TANAKA R, Hiki K, Sato T, Mashiko R, et al
    Treatment Beyond Progressive Disease With Pazopanib for Cutaneous Angiosarcoma: A Case Report.
    J Dermatol. 2026 Feb 2. doi: 10.1111/1346-8138.70165.
    PubMed    


  199. XIANG W, Luo H, Song D, Zhang X, et al
    Novel POLR3A Gene Mutation Results in Wiedemann-Rautenstrauch Syndrome With Striking Cutis Laxa and Myelofibrosis.
    J Dermatol. 2026;53:357-361.
    PubMed     Abstract available


  200. SOUZA BCE, Miyashiro D, Cury-Martins J, Valente NYS, et al
    Immunoprofiling Reveals GATA3 as a Prognostic Marker in Transformed Mycosis Fungoides.
    J Dermatol. 2026;53:304-308.
    PubMed     Abstract available


  201. BETTOLINI L, Maronese CA, Bighetti S, Genovese G, et al
    Amicrobial Pustulosis of the Folds Successfully Treated With Apremilast: Report of Two Cases and Review of the Literature.
    J Dermatol. 2026;53:339-350.
    PubMed     Abstract available


  202. ZHENG Y, Zhu Y, Qiao J
    Generalized Linear Porokeratosis Treated With Ixekizumab.
    J Dermatol. 2026;53:e146-e148.
    PubMed     Abstract available


  203. LIN YH, Wang YC, Chen TL, Jaun LC, et al
    Association Between Prurigo Nodularis and Malignancy: A Real-World Multicenter Retrospective Cohort Study.
    J Dermatol. 2026;53:281-287.
    PubMed     Abstract available


  204. OGAWA S, Tayama J, Kamudoni P, Salek S, et al
    Development and Validation of the Japanese Version of the Hyperhidrosis Quality of Life Index.
    J Dermatol. 2026;53:210-218.
    PubMed     Abstract available


  205. OHYACHI K, Takamura S, Iino K, Saito S, et al
    Sex Differences in Response and Persistence to Biologic Therapy in Psoriatic Arthritis: A 52-Week Analysis With Extended Long-Term Outcomes.
    J Dermatol. 2026;53:219-230.
    PubMed     Abstract available


  206. OCHIAI S, Ono H, Shimizu A, Togi S, et al
    A Case of Multifocal Venous Malformation With Two Somatic Pathogenic Variants in the TEK Gene.
    J Dermatol. 2026;53:314-317.
    PubMed     Abstract available


  207. INOUE S
    Pathogenesis of Vitiligo: Integrating Immune and Non-Immune Cell Crosstalk.
    J Dermatol. 2026;53:188-199.
    PubMed     Abstract available


  208. KOHRI N, Yatsuzuka K, Ishii N, Yoshida S, et al
    Tear Fluid Indirect Immunofluorescence for Assessing Disease Activity in Ocular Mucous Membrane Pemphigoid: First Report of a New Method for Monitoring Disease Progression.
    J Dermatol. 2026;53:334-338.
    PubMed     Abstract available


  209. CHIEOSILAPATHAM P, Youngchim S, Chongkae S, Tovanabutra N, et al
    Atypical Presentation of Rupioid-Like Tinea Corporis due to a Rare Nannizzia Incurvata Infection.
    J Dermatol. 2026;53:323-329.
    PubMed     Abstract available


  210. UEDA K, Sumigama A, Watanabe N, Kodama D, et al
    A Case of Endocrine Mucin-Producing Sweat Gland Carcinoma Which Recurred 8 Years After Excision, and Exhibited Infiltrative Growth Pattern Without Any Mucinous Carcinoma.
    J Dermatol. 2026;53:330-333.
    PubMed     Abstract available


  211. OISO N, Mizoro Y, Kamei K, Yamanaka K, et al
    Health-Related Quality of Life and Psychological Burden of Patients With Vitiligo in Japan.
    J Dermatol. 2026;53:200-209.
    PubMed     Abstract available


  212. KURODA Y, Yang L, Katayama I
    Pathogenesis of Chemical Leukoderma and Chemical-Induced Vitiligo.
    J Dermatol. 2026;53:180-187.
    PubMed     Abstract available


  213. CHEN H, Hou PC, Hsu SH, Huang HY, et al
    Revisiting the Pathology of Bullous Pemphigoid: Basal Cell Necrosis as a Diagnostic Clue and Its Pathogenic Role.
    J Dermatol. 2026;53:245-252.
    PubMed     Abstract available


  214. OKAMURA K, Suzuki T
    Genetic Pigmentary Disorders: From Molecular Mechanisms to Clinical Manifestations.
    J Dermatol. 2026;53:169-179.
    PubMed     Abstract available


    January 2026
  215. ONISHI S, Yasutomi Y, Tsedendorj O, Morizane S, et al
    Cytokine Milieu Relevant to Atopic Dermatitis Enhances Epidermal Trypsin-Like Serine Protease Activity, Which Is Pharmacologically Suppressed in Human Keratinocytes.
    J Dermatol. 2026 Jan 27. doi: 10.1111/1346-8138.70160.
    PubMed    


  216. OKADA-JOKAKU M, Ohara Y, Kido C, Watanabe K, et al
    Effectiveness of Combinational Therapy With Tapinarof and Narrowband Ultraviolet B for Atopic Dermatitis.
    J Dermatol. 2026 Jan 27. doi: 10.1111/1346-8138.70158.
    PubMed    


  217. MATSUMOTO S, Watanabe H, Saito R, Moriwaki M, et al
    A Case of Multiple Recalcitrant Verruca Vulgaris Associated With Atopic Dermatitis Successfully Treated With Nemolizumab and Topical Imiquimod.
    J Dermatol. 2026 Jan 18. doi: 10.1111/1346-8138.70145.
    PubMed    


  218. BAE SB, Heo JW, Cho BK, Kim HJ, et al
    JAK Inhibition Restores Epidermal Homeostasis and Modulates Immune Responses in Dermatomyositis Skin: A Spatial Transcriptomic Pilot Study.
    J Dermatol. 2026 Jan 16. doi: 10.1111/1346-8138.70149.
    PubMed    


  219. TSAI WL, Huang YJ, Fang FM
    Biophysical Skin Response in Head and Neck Cancer: Longitudinal Comparison of Modern Photon and Proton Radiotherapy.
    J Dermatol. 2026 Jan 14. doi: 10.1111/1346-8138.70146.
    PubMed     Abstract available


  220. WATANABE H, Ogawa Y, Yamaguchi Y, Nakajima S, et al
    Guidelines for the Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis 2025 Supplement.
    J Dermatol. 2026 Jan 8. doi: 10.1111/1346-8138.70136.
    PubMed    


  221. KITAYAMA S, Makino T, Takemoto K, Mizawa M, et al
    Apremilast Associated Clinical Improvement in Bullous Pemphigoid With Plaque Psoriasis.
    J Dermatol. 2026 Jan 8. doi: 10.1111/1346-8138.70132.
    PubMed    


  222. FUTAMURA M, Kang Y, Singh A, Danjo J, et al
    Treatment Patterns and Healthcare Utilization on Pediatric Atopic Dermatitis With Allergic Comorbidities: A Japanese Claims-Based Study.
    J Dermatol. 2026 Jan 8. doi: 10.1111/1346-8138.70102.
    PubMed     Abstract available


  223. SAGARA C, Rokunohe D, Akasaka E
    Spontaneous Resolution of Cutaneous Siderosis Caused by Extravasation of Intravenous Ferric Derisomaltose: Two Case Reports.
    J Dermatol. 2026 Jan 8. doi: 10.1111/1346-8138.70134.
    PubMed    


  224. HORISAKI K, Yoshikawa S, Omata W, Tsutsumida A, et al
    Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Stage IV Melanoma Receiving Immune Checkpoint Inhibitors: A Single-Center Retrospective Study.
    J Dermatol. 2026 Jan 7. doi: 10.1111/1346-8138.70131.
    PubMed     Abstract available


  225. OKABE Y, Hagino T, Takahashi Y, Saeki H, et al
    Two-Year Real-World Effectiveness of Deucravacitinib 6 mg in Psoriasis: A Single-Center Analysis Stratified by Body Mass Index or Age in a Japanese Cohort.
    J Dermatol. 2026 Jan 5. doi: 10.1111/1346-8138.70137.
    PubMed     Abstract available


  226. SHIBA M, Hagino T, Uchiyama A, Saeki H, et al
    Long-Term, Site-Specific Effectiveness of Tralokinumab in Atopic Dermatitis: A 72-Week Real-World Study.
    J Dermatol. 2026 Jan 5. doi: 10.1111/1346-8138.70138.
    PubMed     Abstract available


  227. CRAVO JM, Vieitez-Frade J, Almeida-Silva G, Correia M, et al
    Acute Myocarditis During a Generalized Pustular Psoriasis Flare: A Possible Pharmacogenetic Interaction in the Setting of Severe Systemic Inflammation?
    J Dermatol. 2026 Jan 5. doi: 10.1111/1346-8138.70135.
    PubMed     Abstract available


  228. WATABE H, Ishibashi Y, Go K, Nakajima K, et al
    Clinical Profiles of Psoriasis Patients With Coronary Artery Calcification and Assessment of Acute Coronary Syndrome Risk Factors Using Coronary Computed Tomography Angiography-Estimated Fractional Flow Reserve.
    J Dermatol. 2026 Jan 5. doi: 10.1111/1346-8138.70133.
    PubMed     Abstract available


  229. ISHIDA N, Matsuda KM, Kotani H, Sumida H, et al
    Isolated Anti-SS-A Antibody Seropositivity as a Poor Prognostic Factor in Systemic Sclerosis: Insights From a Cohort of 307 Cases.
    J Dermatol. 2026;53:41-53.
    PubMed     Abstract available


  230. OTERO-FERNANDEZ MN, Munoz-Bellido FJ, Laffond-Yges E, Lazaro-Sastre M, et al
    Minocycline-Induced Delayed Dermographism With Tolerance to Doxycycline.
    J Dermatol. 2026;53:145-148.
    PubMed     Abstract available


  231. SAITO R, Furutani K, Mihara S, Numata T, et al
    Disease Duration of Urticaria: A Sub-Analysis of a Survey on Subtypes and Clinical Characteristics of 1061 Patients With Urticaria in the Primary Care Institutes in Japan.
    J Dermatol. 2026;53:131-134.
    PubMed     Abstract available


  232. KITAO R, Matsumoto Y, Kubo A, Fukumoto T, et al
    Severity Scorings for Prurigo Nodularis With Review of Treatment Outcome in 22 Cases.
    J Dermatol. 2026;53:110-116.
    PubMed     Abstract available


  233. CHEN F, Zhang B, Cui S, Liu Y, et al
    Clinical Predictors of Steroid Resistance in Moderate-to-Severe Bullous Pemphigoid Patients: A 15-Year Retrospective Study.
    J Dermatol. 2026;53:86-93.
    PubMed     Abstract available


  234. WEN H, Kong T, Lin J, Shen Y, et al
    Development of a Nomogram Model for Predicting Anxiety Risk in Patients With Hyperhidrosis: A Study Involving 234 Patients.
    J Dermatol. 2026;53:63-70.
    PubMed     Abstract available


    December 2025
  235. MORITA A, Tada Y, Tsunemi Y, Komine M, et al
    Real-World Safety Profile of Spesolimab in Generalized Pustular Psoriasis: Insights From Japan as Part of a Multinational Expanded Access Program (EAP).
    J Dermatol. 2025 Dec 30. doi: 10.1111/1346-8138.70122.
    PubMed     Abstract available


  236. HAYAKAWA T, Komai T, Yotsuyanagi T, Shimizu T, et al
    Anaphylaxis to Total Parenteral Nutrition Components Diagnosed by Skin Tests.
    J Dermatol. 2025 Dec 27. doi: 10.1111/1346-8138.70127.
    PubMed     Abstract available


  237. KAWAI T, Hama N, Nakamura R, Yamaguchi S, et al
    A Fatal Case of Enfortumab Vedotin-Caused Cutaneous Adverse Reaction Mimicking Toxic Epidermal Necrolysis With Myelosuppression: Distinct Clinical and Histopathological Features.
    J Dermatol. 2025 Dec 22. doi: 10.1111/1346-8138.70121.
    PubMed    


  238. KYONO K, Tsushima E, Urushidate S, Goto S, et al
    Risk Factors for Microscopic Margin Positivity in Basal Cell Carcinoma Excision With a 2-mm Surgical Margin: A Japanese Retrospective Study.
    J Dermatol. 2025 Dec 21. doi: 10.1111/1346-8138.70118.
    PubMed     Abstract available


  239. FAN X, Liu R, Cao X, Zhang Z, et al
    The Predictive Value of Inflammatory Markers in the Severity and Mortality Risk of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
    J Dermatol. 2025 Dec 19. doi: 10.1111/1346-8138.70116.
    PubMed     Abstract available


  240. KATO H, Tamagawa-Mineoka R, Nakatani E, Yoshimura K, et al
    Safety Evaluation of Fine Bubble Shower Washing for Patients With Atopic Dermatitis: A Double-Blind, Randomized, Prospective Crossover Clinical Trial.
    J Dermatol. 2025 Dec 17. doi: 10.1111/1346-8138.70117.
    PubMed     Abstract available


  241. SAKAI T
    Stratum Corneum Ceramide Abnormalities in Atopic Dermatitis: Pathophysiology and Implications for Disease Management.
    J Dermatol. 2025 Dec 15. doi: 10.1111/1346-8138.70098.
    PubMed     Abstract available


  242. ITO T, Yamamoto T
    A Unique Case of Nodular Cutaneous Lupus Mucinosis With Discoid Lupus Erythematosus-Like Changes in a Patient With Systemic Lupus Erythematosus and Sjogren Syndrome.
    J Dermatol. 2025 Dec 10. doi: 10.1111/1346-8138.70100.
    PubMed    


  243. PARK HS, Kim YH, Kim JY, Choi JW, et al
    Staphylococcus Enrichment in Cutaneous Melanoma.
    J Dermatol. 2025 Dec 10. doi: 10.1111/1346-8138.70110.
    PubMed    


  244. TAKAI T, Kadono T, Fujimoto N, Yoden E, et al
    Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Cutaneous Squamous Cell Carcinoma 2025.
    J Dermatol. 2025 Dec 10. doi: 10.1111/1346-8138.70104.
    PubMed     Abstract available


  245. KITAO R, Kubo A, Fukumoto T
    Evaluation of Skin Biopsy Techniques for the Diagnosis of Systemic Amyloidosis.
    J Dermatol. 2025 Dec 10. doi: 10.1111/1346-8138.70099.
    PubMed     Abstract available


  246. NOMURA C, Miyagaki T, Oba S, Go K, et al
    Development of Descending Thoracic Aortic Aneurysm in a Psoriasis Patient Under Guselkumab Treatment.
    J Dermatol. 2025 Dec 5. doi: 10.1111/1346-8138.70107.
    PubMed    


  247. ISHIGURO A, Ogata D, Ishiyama K, Oguma J, et al
    Treatment Outcomes of Surgery and ICI Therapy in 52 Patients With Esophageal Melanoma: A Retrospective Single-Center Cohort Study.
    J Dermatol. 2025 Dec 5. doi: 10.1111/1346-8138.70097.
    PubMed     Abstract available


  248. NIRENBERG A, Williams R, Steinman H, Anderson S, et al
    The Melanoma Pathology Report: What to Expect and How to Interpret It.
    J Dermatol. 2025 Dec 3. doi: 10.1111/1346-8138.70071.
    PubMed     Abstract available


  249. TANI Y, Makihara S, Morito A, Ohyama M, et al
    Minoxidil Promotes Hair Growth in a Mouse Model of Telogen Effluvium Induced by Lipopolysaccharide.
    J Dermatol. 2025;52:1864-1868.
    PubMed     Abstract available


  250. SUZUKI S, Goto K, Kajimoto K, Adachi K, et al
    Folliculosebaceous Poromas With PAK2 and PAK3 Rearrangements: A Report of Two Cases and Review of the Literature.
    J Dermatol. 2025;52:1902-1905.
    PubMed     Abstract available


  251. KOUMAKI D, Gregoriou S, Evangelou G, Chlouverakis G, et al
    Familial Hidradenitis Suppurativa on the Island of Crete: Distinct Patterns in Clinical Characteristics.
    J Dermatol. 2025;52:1840-1846.
    PubMed     Abstract available


  252. GREGOIRE S, Biba U, Sanchez K, Mesinkovska NA, et al
    The Financial and Time Burden of Alopecia Areata.
    J Dermatol. 2025;52:1892-1896.
    PubMed     Abstract available


  253. IINO K, Takamura S, Fukuda T
    Perinatal Management and Clinical Outcomes of Hereditary Angioedema in Japan: A Case Series and Comprehensive Literature Review.
    J Dermatol. 2025;52:1881-1887.
    PubMed     Abstract available


  254. SESHIMO H, Uchiyama M, Suzuki R, Numata T, et al
    Clinical and Histopathological Features of Hair Loss in 17 Japanese Patients With Hematologic Disorders Following Hematopoietic Stem Cell Transplantation and Chemotherapy: A Case Series.
    J Dermatol. 2025;52:1874-1880.
    PubMed     Abstract available


  255. MURAI O, Chiba M, Suzuki K, Suwabe K, et al
    An Analysis of IgG Antibody to Periodontopathic Bacteria in Serum of Palmoplantar Pustulosis Patients With Periodontitis.
    J Dermatol. 2025;52:1811-1818.
    PubMed     Abstract available


  256. IKUMI N, Fujita H
    Effectiveness of Brodalumab for Guselkumab-Resistant Pustulotic Arthro-Osteitis in Patients With Palmoplantar Pustulosis: Case Series.
    J Dermatol. 2025;52:1869-1873.
    PubMed     Abstract available


  257. FUKUNAGA A, Kishi Y, Sunaga Y, Arima K, et al
    Prevalence, Comorbidities, and Current Management of Chronic Spontaneous Urticaria in Japan: Retrospective Claims Database Study.
    J Dermatol. 2025;52:1775-1787.
    PubMed     Abstract available


  258. SESHIMO H, Mae K, Ishiguro A, Irisawa R, et al
    Intra-Arterial Infusion Chemotherapy and Radiotherapy for Right Axillary Advanced Basal Cell Carcinoma Treatment.
    J Dermatol. 2025 Dec 1. doi: 10.1111/1346-8138.70095.
    PubMed    


    November 2025
  259. KOIKE Y, Morisaki H, Motooka D, Matsumoto M, et al
    Postauricular Skin Mycobiome Profiles in Atopic Dermatitis Treated With Dupilumab or Cyclosporine A: A Descriptive Case Series.
    J Dermatol. 2025 Nov 28. doi: 10.1111/1346-8138.70083.
    PubMed     Abstract available


  260. ENDO M, Yamamoto T
    Lichen Nitidus in a Patient With Systemic Sarcoidosis.
    J Dermatol. 2025 Nov 28. doi: 10.1111/1346-8138.70087.
    PubMed    


  261. JIAO S, Su D, Si S, Zhang N, et al
    Risk Factors for Drug-Induced Severe Cutaneous Adverse Reactions: A Real-World Pharmacovigilance Analysis.
    J Dermatol. 2025 Nov 27. doi: 10.1111/1346-8138.70063.
    PubMed     Abstract available


  262. HIRAISHI A, Kamiya K, Sugihara N, Komine M, et al
    A Case of Palmoplantar Psoriasis Successfully Treated With Tapinarof Cream.
    J Dermatol. 2025 Nov 27. doi: 10.1111/1346-8138.70079.
    PubMed    


  263. IRIE K, Yamamoto M, Yamamoto T
    Disseminated Fibrous Papules of the Lip.
    J Dermatol. 2025 Nov 27. doi: 10.1111/1346-8138.70064.
    PubMed    


  264. KATAYAMA S, Nishihara K, Kohri N, Yoshida S, et al
    Successful Treatment of BRAF(V600R)-Mutant Melanoma of Unknown Primary Identified by Liquid Biopsy With BRAF/MEK Inhibitors.
    J Dermatol. 2025 Nov 27. doi: 10.1111/1346-8138.70080.
    PubMed    


  265. TOYOSHIMA R, Aso S, Matsui H, Fushimi K, et al
    Comparative Impact of NSAIDs Versus Acetaminophen on Mortality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Retrospective Cohort Study of 2484 Patients From a Nationwide Inpatient Database.
    J Dermatol. 2025 Nov 26. doi: 10.1111/1346-8138.70082.
    PubMed     Abstract available


  266. OKAZAKI T, Terui H, Takahashi T, Kobayashi A, et al
    Coronary Artery Disease Assessment in Psoriasis Patients Well-Controlled Under Systemic Anti-Inflammatory Treatments-A Real-World Observational Study From a Single Center.
    J Dermatol. 2025 Nov 24. doi: 10.1111/1346-8138.70069.
    PubMed     Abstract available


  267. MINAKAWA S, Matsuzaki Y, Hashimoto T, Ishii N, et al
    Lichenoid Drug Eruption due to Telmisartan-Hydrochlorothiazide Combination Progressing to Bullous Pemphigoid: A Case Report.
    J Dermatol. 2025 Nov 24. doi: 10.1111/1346-8138.70068.
    PubMed    


  268. SEISHIMA M, Ikemoto C, Dozen Y, Matsuo M, et al
    Verrucous Cutaneous Candidiasis on the Dorsum of the Finger.
    J Dermatol. 2025 Nov 21. doi: 10.1111/1346-8138.70074.
    PubMed    


  269. HOASHI T, Ishikawa M, Uehara J, Kamitani N, et al
    Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Basal Cell Carcinoma 2025.
    J Dermatol. 2025 Nov 16. doi: 10.1111/1346-8138.70050.
    PubMed     Abstract available


  270. AIBA S
    Three Cases of Skin Tags on the Neck Treated With a Novel and Minimally Invasive Approach Using a 2-mm Ring Curette.
    J Dermatol. 2025 Nov 16. doi: 10.1111/1346-8138.70056.
    PubMed     Abstract available


  271. MORITA K, Sagara C, Yoshikawa M, Mikami H, et al
    Amoxicillin-Triggered Flare of Generalized Pustular Psoriasis in a Patient With Homozygous IL36RN Pathogenic Variant Treated With Spesolimab and Cyclosporin A.
    J Dermatol. 2025 Nov 16. doi: 10.1111/1346-8138.70054.
    PubMed    


  272. CHANG YH, Hsueh YY, Hsu CK
    Cutaneous Vegetating Candidiasis in Keratitis-Ichthyosis-Deafness Syndrome.
    J Dermatol. 2025 Nov 16. doi: 10.1111/1346-8138.70049.
    PubMed    


  273. YAMAMOTO-HANADA K, Kawada Y, Okamoto K, Matsukawa M, et al
    Barriers to Accurate Diagnosis of Infantile Atopic Dermatitis: Insights From a Survey of Pediatricians.
    J Dermatol. 2025 Nov 14. doi: 10.1111/1346-8138.70052.
    PubMed     Abstract available


  274. WATABE H, Miyagaki T, Nakajima K, Go K, et al
    Clinical Profile of Psoriasis Patients With Comorbid Fatty Liver and Risk Factors for Advanced Liver Fibrosis in Those With Metabolic Dysfunction-Associated Steatotic Liver Disease.
    J Dermatol. 2025 Nov 14. doi: 10.1111/1346-8138.70047.
    PubMed     Abstract available


  275. TSUKAMOTO T, Iwata Y, Sugiura K
    Successful Treatment of Post-Transplant Generalized Pustular Psoriasis With Apremilast.
    J Dermatol. 2025 Nov 14. doi: 10.1111/1346-8138.70061.
    PubMed    


  276. TAJIRI M, Takeichi T, Teye K, Fukaura R, et al
    Susceptibility to Dermatophytosis in SDR9C7-Nonsyndromic Epidermal Differentiation Disorder: Observation of Cutaneous Inflammation Involving IRF4 and IL-17.
    J Dermatol. 2025 Nov 11. doi: 10.1111/1346-8138.70048.
    PubMed     Abstract available


  277. HASHIMOTO M, Hayakawa R, Fukuyama M, Ohyama M, et al
    Nemolizumab Treatment for Severe Atopic Dermatitis Led to the Simultaneous Improvement of Coexisting Refractory Alopecia Areata: A Case Report.
    J Dermatol. 2025 Nov 11. doi: 10.1111/1346-8138.70051.
    PubMed    


  278. HU B, Liu T, Jiang RL, Chen Q, et al
    Verruciform Xanthoma, Fungal Infection and Cutaneous Squamous Cell Carcinoma in a Patient With Homozygous Mutation in PERP (c.137C>A, p.S46*).
    J Dermatol. 2025 Nov 10. doi: 10.1111/1346-8138.70041.
    PubMed    


  279. HAMADA T, Sugaya M, Sakaida T, Hirai Y, et al
    Japanese Dermatological Association Guidelines: Outlines of Japanese Guidelines for the Management of Primary Cutaneous Lymphomas 2025.
    J Dermatol. 2025 Nov 7. doi: 10.1111/1346-8138.70037.
    PubMed     Abstract available


  280. INOUE S, Hasegawa J, Sou M, Ikari M, et al
    Safe and Effective Use of Nivolumab Monotherapy for Locally Advanced Cutaneous Squamous Cell Carcinoma in a 100-Year-Old Patient.
    J Dermatol. 2025 Nov 5. doi: 10.1111/1346-8138.70044.
    PubMed    


  281. HEO JW, Kang HJ, Lim Y
    Experience With Janus Kinase Inhibitors in Acquired Perforating Dermatosis in Older Adults: A Case Series and Review of Literature.
    J Dermatol. 2025;52:1722-1726.
    PubMed     Abstract available


  282. MOCHIZUKI R, Miyazaki R, Nakatani S, Takai T, et al
    Pulmonary Tumor Thrombotic Microangiopathy Secondary to Extramammary Paget's Disease: An Autopsy Case Report.
    J Dermatol. 2025;52:1727-1731.
    PubMed     Abstract available


  283. NAKAMURA M, Nagase K, Kato J, Yasuda M, et al
    Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Merkel Cell Carcinoma 2025.
    J Dermatol. 2025;52:e954-e967.
    PubMed     Abstract available


  284. CHUNG KB, Sung HJ, Kim EH, Jang H, et al
    Roflumilast for Oral Ulcers in Behcet's Disease and Recurrent Aphthous Stomatitis.
    J Dermatol. 2025;52:1713-1717.
    PubMed     Abstract available


  285. ZHU Y, Yao Y, Shi J, Sun J, et al
    Novel Reported Case of Human Subcutaneous Mycosis Caused by Zasmidium citri-griseum: Diagnosis and Treatment Insights.
    J Dermatol. 2025;52:1736-1740.
    PubMed     Abstract available


  286. SEKINE M, Takahashi T, Okuda S, Hatchome N, et al
    A Case of Taxane-Induced Scleroderma Presenting in a Unilateral Upper Limb and a Literature Review.
    J Dermatol. 2025;52:1746-1749.
    PubMed     Abstract available


  287. ITO Y, Okusa T, Nakada T, Sueki H, et al
    Argyria Induced by Prolonged Ingestion of Silver Ionized Water: A Scanning Transmission Electron Microscopy With Energy-Dispersive X-Ray Analysis Utilizing a Simplified Sample Preparation Method.
    J Dermatol. 2025;52:1741-1745.
    PubMed     Abstract available


  288. AHMED S, Cesarato N, Li Y, Xiong X, et al
    Bi-Allelic DSG1 Splice-Site Variant Identified in a Family With Non-Syndromic Striate Palmoplantar Keratoderma.
    J Dermatol. 2025;52:1709-1712.
    PubMed     Abstract available


  289. AKIN G, Akarsu S, Avci C, Lebe B, et al
    Tissue Eosinophil Counts: A Promising Marker for Optimizing Omalizumab Treatment in Bullous Pemphigoid.
    J Dermatol. 2025;52:1691-1697.
    PubMed     Abstract available


  290. NAKAMURA R, Nakamura M, Okuda K, Takagi S, et al
    Quantitative Evaluation of Successful Combination Therapy With Dye Laser and Long-Pulse Alexandrite Laser for Papulopustular Rosacea.
    J Dermatol. 2025;52:1648-1655.
    PubMed     Abstract available


  291. YONEKURA K, Muto I, Takenaka M, Aoi J, et al
    An Open-Label, Multicenter, Phase II Study of Bexarotene in Patients with Adult T-Cell Leukemia/Lymphoma.
    J Dermatol. 2025;52:1619-1628.
    PubMed     Abstract available


    October 2025
  292. YAMAZAKI E, Fujimura T, Kambayashi Y, Takahashi-Watanabe M, et al
    Three Cases of Advanced Melanoma With Severe irAE Colitis With Rapid Tumor Progression Following Infliximab Administration.
    J Dermatol. 2025 Oct 28. doi: 10.1111/1346-8138.70039.
    PubMed     Abstract available


  293. HEERFORDT IM, Middelboe M, Haerskjold A, Horwitz A, et al
    Toxic Epidermal Necrolysis and Mortality: A Danish Cohort Study With 30 Years of Follow-Up.
    J Dermatol. 2025 Oct 27. doi: 10.1111/1346-8138.70040.
    PubMed     Abstract available


  294. SHIMIZU T, Kamata M, Uratsuji H, Okada Y, et al
    Combined Maxacalcitol/Betamethasone Butyrate Propionate Ointment Possesses Long-Term Sustained Effects of Inducing Regulatory T Cells and Downregulating the Th17 Response, Even After Discontinuation of Its Application in Imiquimod-Induced Psoriasiform
    J Dermatol. 2025 Oct 25. doi: 10.1111/1346-8138.70031.
    PubMed     Abstract available


  295. GOTO Y, Suzuki T, Honda T
    Dupilumab-Induced Psoriasis-Like Eruption With JAK1-STAT3 Activation Successfully Treated With Upadacitinib.
    J Dermatol. 2025 Oct 23. doi: 10.1111/1346-8138.70035.
    PubMed    


  296. LU YY, Liu YC, Chiu YW, Lin SF, et al
    Decreased Plasmacytoid Dendritic Cells in Cutaneous Squamous Cell Carcinoma Arising From Subacute Cutaneous Lupus Erythematosus: A Case Report.
    J Dermatol. 2025 Oct 21. doi: 10.1111/1346-8138.70017.
    PubMed     Abstract available


  297. YAMAMURA Y, Fujii K, Nakashima C, Usui S, et al
    Advanced Verrucous Malignant Melanoma Arising on the Plantar Arch.
    J Dermatol. 2025 Oct 18. doi: 10.1111/1346-8138.70029.
    PubMed    


  298. WATANABE A, Kamata M, Okada Y, Suzuki S, et al
    Clinical Outcomes of Tralokinumab and Lebrikizumab in Japanese Atopic Dermatitis Patients With Persistent Head and Neck Dermatitis After Long-Term Treatment With Dupilumab: A Single-Center Retrospective Study.
    J Dermatol. 2025 Oct 16. doi: 10.1111/1346-8138.70026.
    PubMed    


  299. HATCHO Y, Kiniwa Y, Katsuie S, Kitamura S, et al
    Two Cases of BRAF V600K Melanoma With Recurrence During Adjuvant Dabrafenib Plus Trametinib Therapy.
    J Dermatol. 2025 Oct 16. doi: 10.1111/1346-8138.70018.
    PubMed    


  300. WEN W, Yang C, Lin Z
    Multiple Cutaneous Cysts in Nevoid Basal Cell Carcinoma Syndrome.
    J Dermatol. 2025 Oct 16. doi: 10.1111/1346-8138.70025.
    PubMed    



  301. Correction to "Safety and Effectiveness of Ixekizumab in Japanese Patients with Psoriasis Vulgaris, Psoriatic Arthritis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis: Post-marketing Surveillance".
    J Dermatol. 2025 Oct 13. doi: 10.1111/1346-8138.17976.
    PubMed    


  302. HAYASHI W, Kinoshita-Ise M, Mizukawa Y, Ohyama M, et al
    Hyperpigmented Drug Eruption Caused by Sanshishi (Gardenia Fruit): A Rare and Potentially Overlooked Skin Manifestation.
    J Dermatol. 2025 Oct 10. doi: 10.1111/1346-8138.70006.
    PubMed    


  303. NAKANO E, Kage Y, Ogata D, Yamazaki N, et al
    Real-World Efficacy and Safety of MEK Inhibitor for Patients With Advanced NRAS-Mutant Melanoma: A Single-Center Retrospective Study in Japan.
    J Dermatol. 2025 Oct 8. doi: 10.1111/1346-8138.70009.
    PubMed     Abstract available


  304. PENG G, Abudouwanli A, Sun Q, Tan Y, et al
    Role of Antimicrobial Peptides in the Pathogenesis of Atopic Dermatitis.
    J Dermatol. 2025 Oct 8. doi: 10.1111/1346-8138.17975.
    PubMed     Abstract available


  305. HORISAKI K, Yoshikawa S, Omata W, Tsutsumida A, et al
    C-Reactive Protein Kinetics as Prognostic Biomarkers in Stage IV-Melanoma Treated With Immune Checkpoint Inhibitors in the Japanese Population: A Single-Center, Retrospective Cohort Study.
    J Dermatol. 2025 Oct 7. doi: 10.1111/1346-8138.70002.
    PubMed     Abstract available


  306. INOUE S, Shojiguchi N, Murayama Y, Koizumi S, et al
    Recycled Skin Grafting for Reconstruction Following Wide Local Excision of Liposarcoma.
    J Dermatol. 2025 Oct 7. doi: 10.1111/1346-8138.70003.
    PubMed    


  307. DANIEL MB, Lucia MG, de la Maria Sierra GP, Salvador AS, et al
    The Impact of Cutaneous Lupus Erythematosus on Major Life-Changing Decisions: A Cross-Sectional Study.
    J Dermatol. 2025 Oct 7. doi: 10.1111/1346-8138.70010.
    PubMed     Abstract available


  308. OHTSUKA K, Nakazato S, Hiraki T, Horiuchi M, et al
    PAK2-Fused Porocarcinoma In Situ Presenting With a Cutaneous Horn: A Case Report.
    J Dermatol. 2025 Oct 7. doi: 10.1111/1346-8138.70001.
    PubMed    


  309. AOKI M, Fujii K, Yonekura K, Nishida H, et al
    Efficacy and Safety of Helical Tomotherapy Combined With Paclitaxel in Cutaneous Angiosarcoma.
    J Dermatol. 2025 Oct 3. doi: 10.1111/1346-8138.17981.
    PubMed     Abstract available


  310. MITANI A, Suzuki Y, Yamamura K, Ishii N, et al
    Sudden Death in a Case of Nonbullous Pemphigoid With Immunoglobulin G Anti-120 kDa Linear IgA Bullous Dermatosis Antigen Autoantibodies.
    J Dermatol. 2025 Oct 2. doi: 10.1111/1346-8138.70000.
    PubMed    


  311. KUMA Y, Kido-Nakahara M, Kuba-Fuyuno Y, Matsumoto T, et al
    Enfortumab Vedotin-Related Skin Toxicities: Insights From Clinical and Histopathological Analysis.
    J Dermatol. 2025;52:1584-1588.
    PubMed     Abstract available


  312. ITAMOTO S, Tu WT, Chang CY, Watanabe M, et al
    Oral Statin Therapy in KRT16- and KRT17-Associated Palmoplantar Epidermal Differentiation Disorder (Pachyonychia Congenita).
    J Dermatol. 2025;52:1608-1611.
    PubMed     Abstract available


  313. NOZAKI H, Honma M, Kishibe M, Fujita Y, et al
    Serum Anti-Drug Antibodies in Psoriasis Patients Undergoing Biologic Therapy in Real-World Clinical Practice: A Single-Center Retrospective Study.
    J Dermatol. 2025;52:1598-1602.
    PubMed     Abstract available


  314. CHEN X, Wang Z, Li X, Liu G, et al
    A Missense Variant Within the Helix Termination Motif of KRT71 Causes Autosomal Dominant Woolly Hair/Hypotrichosis in a Chinese Family.
    J Dermatol. 2025;52:1603-1607.
    PubMed     Abstract available


  315. KOGA M, Yoshinaga A, Ehara Y, Tsuge I, et al
    A Retrospective Study of Diffuse Plexiform Neurofibroma With Surgical Intervention in Neurofibromatosis 1.
    J Dermatol. 2025;52:1589-1592.
    PubMed     Abstract available


  316. MORIZANE S, Mukai T, Sunagawa K, Hasui KI, et al
    Biologics and Small-Molecule Therapies in Netherton Syndrome: A Comprehensive Review.
    J Dermatol. 2025;52:1483-1493.
    PubMed     Abstract available


  317. WANG Y, Gao J, Li F, Li L, et al
    Comparative Effectiveness and Safety of Adalimumab, Secukinumab, and Upadacitinib in Psoriatic Arthritis: A Prospective Cohort Study Based on PARWCH Cohort.
    J Dermatol. 2025;52:1527-1535.
    PubMed     Abstract available


  318. NAIK H, Balwani M, Colwell HH, Mathias SD, et al
    The Burden of Erythropoietic Protoporphyria (EPP): Results From the EPP Life Impact and Genetic Health Trajectory (LIGHT) Study.
    J Dermatol. 2025;52:1576-1583.
    PubMed     Abstract available


  319. ZHANG K, Qiu T, Zhou J, Gong X, et al
    Comparison of Infantile Hemangiomas in Male and Female Infants: A Prospective Study.
    J Dermatol. 2025;52:1555-1560.
    PubMed     Abstract available


  320. HUANG Y, Ke C, Chen M
    Safety Assessment of Ritlecitinib Based on the FDA Adverse Event Reporting System (FAERS) Database: A Real-World Pharmacovigilance Study.
    J Dermatol. 2025;52:1561-1569.
    PubMed     Abstract available


  321. OHYAMA M, Ito T, Amoh Y, Inui S, et al
    Japanese Dermatological Association's Clinical Practice Guidelines for Alopecia Areata 2024: A Complete English Translated Version.
    J Dermatol. 2025;52:e876-e907.
    PubMed     Abstract available


  322. NATSUGA K, Tsuruta D, Takashima S, Tateishi C, et al
    Efficacy and Safety of the Topical Gene Therapy Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Study of Japanese Subjects With Dystrophic Epidermolysis Bullosa.
    J Dermatol. 2025;52:1494-1502.
    PubMed     Abstract available


    September 2025
  323. MATSUSHITA T, Nakao M, Kudo K, Nishio J, et al
    GAVE in Systemic Sclerosis: A Japanese Cohort Study Highlighting Links to Diffuse Cutaneous Subtype and Anti-RNAPIII Antibodies.
    J Dermatol. 2025 Sep 30. doi: 10.1111/1346-8138.17980.
    PubMed     Abstract available


  324. IRITAS SY, Iritas I
    Ocular Comorbidities in Psoriasis: A Retrospective Study on Dry Eye Syndrome, Keratoconus, and Cataract Development.
    J Dermatol. 2025 Sep 29. doi: 10.1111/1346-8138.17977.
    PubMed     Abstract available


  325. ITO H, Iwata Y, Sugiura M, Arima M, et al
    AID Expression in Vulvar SCC Arising From Lichen Sclerosus et Atrophicus: A Retrospective Study.
    J Dermatol. 2025 Sep 26. doi: 10.1111/1346-8138.17935.
    PubMed     Abstract available


  326. LIU G, Huang T, Gao XJ, Ding RL, et al
    Expression of Co-Inhibitory Molecules on Lymphocytes of Patients With Psoriasis.
    J Dermatol. 2025 Sep 24. doi: 10.1111/1346-8138.17937.
    PubMed     Abstract available



  327. WITHDRAWAL: Autoimmune Progesterone Dermatitis Treated With Dienogest: A Case Report.
    J Dermatol. 2025 Sep 24. doi: 10.1111/1346-8138.17963.
    PubMed     Abstract available


  328. KAMIYA K, Yamaguchi Y, Saeki H, Kodera M, et al
    Prospective, Open-Label, Multicenter Study of Apremilast as Maintenance Therapy for Psoriasis Patients in Remission With Biologics.
    J Dermatol. 2025 Sep 19. doi: 10.1111/1346-8138.17968.
    PubMed     Abstract available


  329. MUTO Y, Fujihara M, Ogawa Y, Oishi N, et al
    Case of Primary Cutaneous Gamma-Delta T-Cell Lymphoma in Which Brentuximab Vedotin-Based Polychemotherapy Failed to Achieve Durable Remission.
    J Dermatol. 2025 Sep 18. doi: 10.1111/1346-8138.17967.
    PubMed    


  330. TAKAHASHI Y, Hagino T, Saeki H, Fujimoto E, et al
    A 104-Week Real-World Outcome of Bimekizumab Treatment for Psoriasis: Biologic-Naive Versus -Experienced Patients.
    J Dermatol. 2025 Sep 18. doi: 10.1111/1346-8138.17962.
    PubMed     Abstract available


  331. MATSUOKA K, Nakamura Y, Miki H, Nomura T, et al
    Cutaneous Metaplastic Synovial Cyst With Immunohistochemical Studies for Synovial Cell Markers: A Case Report.
    J Dermatol. 2025 Sep 17. doi: 10.1111/1346-8138.17969.
    PubMed    


  332. KATO K, Kato H, Magara T, Morita A, et al
    Postoperative Complications and Risk Factors in Skin Tumor Excision With Simple Suturing Under Local Anesthesia: A Multicenter Retrospective Study in Japan.
    J Dermatol. 2025 Sep 15. doi: 10.1111/1346-8138.17958.
    PubMed     Abstract available


  333. YAMADA K, Imanishi H, Mine M, Kunimoto H, et al
    Establishment of a Nail Psoriasis Mouse Model by Topical Application of Imiquimod After Nail Removal.
    J Dermatol. 2025 Sep 15. doi: 10.1111/1346-8138.17956.
    PubMed     Abstract available


  334. ZHOU W, Cao Y, Wu C, Zhou K, et al
    Should Be Removed or Taken Biopsy in Early Stage: A Retrospective Study of 953 Cases of Nevus Sebaceous From a Single Center.
    J Dermatol. 2025 Sep 10. doi: 10.1111/1346-8138.17941.
    PubMed     Abstract available



  335. Correction to "A Case of Metastasis of Giant Basal Cell Carcinoma in Oculocutaneous Albinism".
    J Dermatol. 2025 Sep 9. doi: 10.1111/1346-8138.17955.
    PubMed    


  336. TAKAMURA S, Saito S, Sugai S, Shiko Y, et al
    Biologic Therapy and Malignancy Risk in Psoriasis: A Retrospective Cohort Study.
    J Dermatol. 2025 Sep 8. doi: 10.1111/1346-8138.17950.
    PubMed     Abstract available


  337. DEKIO I, Katsuta M, Ishiuji Y, Nobeyama Y, et al
    Discontinuation Reasons and Drug Survival of Dupilumab in Real-World Adult Atopic Dermatitis Patients in Three Healthcare Facilities in Tokyo and Yokohama (2018-2023).
    J Dermatol. 2025 Sep 8. doi: 10.1111/1346-8138.17927.
    PubMed     Abstract available


  338. AHN HK, Oh S, Yoon HS
    Treatment Persistence After Major Cardiovascular Events in Psoriasis: A Retrospective Cohort Study Comparing Biologic, Systemic, and Phototherapy.
    J Dermatol. 2025 Sep 8. doi: 10.1111/1346-8138.17949.
    PubMed     Abstract available


  339. ZHANG Y, Cheng C, Xu Z, Yang D, et al
    Indole-3-Lactic Acid Inhibits Keratinocyte Proliferation Through the Aryl Hydrocarbon Receptor in Psoriasis.
    J Dermatol. 2025 Sep 5. doi: 10.1111/1346-8138.17947.
    PubMed     Abstract available


  340. HORISAKI K, Yoshikawa S, Omata W, Tsutsumida A, et al
    Prognosis and Toxicity Stratified by Best Tumor Burden Change in Japanese Patients With Advanced Melanoma Treated With First-Line Programmed Cell Death Protein 1 Monotherapy.
    J Dermatol. 2025 Sep 5. doi: 10.1111/1346-8138.17938.
    PubMed     Abstract available


  341. KIM DH, Kim YJ, Moon IJ, Lee WJ, et al
    The Association Between Melanoma and Autoimmune Diseases: A Nationwide Population-Based Study in the Republic of Korea.
    J Dermatol. 2025 Sep 4. doi: 10.1111/1346-8138.17945.
    PubMed     Abstract available


  342. KUDO M, Shirato R, Yanagi T, Yamagata W, et al
    Brain Metastasis From Angiosarcoma of the Scalp: Report of Three Cases.
    J Dermatol. 2025;52:1456-1460.
    PubMed     Abstract available


  343. ENDO K, Higaki Y, Cho A, Sugimoto Y, et al
    Disease Impact and Burden of Psoriasis Vulgaris in Visible Body Areas in Japan: A Qualitative Study.
    J Dermatol. 2025;52:1439-1446.
    PubMed     Abstract available


  344. MATSUO M, Asahina R, Tawada C, Tanaka K, et al
    A Case of Local Relapse of Pemphigus Vegetans Detected IL-17A(+) Tissue-Resident Memory T Cells in Lesional Skin.
    J Dermatol. 2025;52:1452-1455.
    PubMed     Abstract available


  345. WANG QX, He HY, Niu YL, Fang S, et al
    Tofacitinib for the Treatment of Primary Localized Cutaneous Amyloidosis.
    J Dermatol. 2025;52:1461-1464.
    PubMed     Abstract available


  346. SUZUKI Y, Tanahashi K, Kobayashi Y, Kinoshita F, et al
    A Cross-Sectional Questionnaire Survey on the Impact of Congenital Ichthyosis on Lifelong Education and Career.
    J Dermatol. 2025;52:1470-1474.
    PubMed     Abstract available


  347. BRUCKNER AL, Murrell D, Lee LW, Sprecher E, et al
    Reduction in Dressing Change Burden in Patients With Epidermolysis Bullosa-Impact of Oleogel-S10.
    J Dermatol. 2025;52:1447-1451.
    PubMed     Abstract available


  348. MATSUSHITA S, Kajihara I, Tsutsui K, Hirai I, et al
    Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Extramammary Paget Disease 2025.
    J Dermatol. 2025;52:e795-e814.
    PubMed     Abstract available


  349. XUE S, He Y, Pei L, Xu H, et al
    Progress of Biologics and Small Molecule Drugs in the Treatment of Hidradenitis Suppurativa.
    J Dermatol. 2025;52:1337-1350.
    PubMed     Abstract available


  350. MATSUNAGA-NAKASHIMA H, Sawamura S, Myangat TM, Yamamoto T, et al
    Circulating Interleukin-6 and Janus Kinase 2 DNA Copies in Serum Cell-Free DNA Are Elevated in Patients With Systemic Sclerosis.
    J Dermatol. 2025;52:1430-1438.
    PubMed     Abstract available


  351. KANNO K, Kishibe M, Honma M, Ishida-Yamamoto A, et al
    Pathogenesis of Pseudocheckerboard Pattern in Mechanic's Hands.
    J Dermatol. 2025;52:1418-1423.
    PubMed     Abstract available


  352. MOTEGI SI, Uchida-Yamada M, Shima Y, Shimada T, et al
    The Prevalence and Severity of Pain in Patients With Systemic Sclerosis.
    J Dermatol. 2025;52:1382-1394.
    PubMed     Abstract available


  353. OHYAMA M, Irisawa R, Uchiyama M, Mori M, et al
    Use of 5% Topical Minoxidil Application for Telogen Effluvium: An Open-Label Single-Arm Clinical Trial.
    J Dermatol. 2025;52:1351-1359.
    PubMed     Abstract available


  354. LI POMI F, d'Aloja A, Rottura M, Vaccaro M, et al
    Tirbanibulin 1% Ointment for the Treatment of Hyperkeratotic Actinic Keratosis.
    J Dermatol. 2025;52:1395-1403.
    PubMed     Abstract available


  355. FUJIWARA H, Irisawa R, Otsuka M, Kako T, et al
    Wound, Pressure Ulcer, and Burn Guidelines (2023)-2: Guidelines for the Diagnosis and Treatment of Pressure Ulcers, Third Edition.
    J Dermatol. 2025;52:e744-e794.
    PubMed     Abstract available


    August 2025
  356. FUJIWARA M, Oda A, Ohtake R, Namiki T, et al
    Hydroxychloroquine-Induced Generalized Pustular Psoriasis Successfully Treated With Secukinumab: A Case Report.
    J Dermatol. 2025 Aug 29. doi: 10.1111/1346-8138.17936.
    PubMed    


  357. MATSUMURA R, Fukuchi K, Honda T
    Multiple Lichen Striatus Accompanied by Cytomegalovirus Infection.
    J Dermatol. 2025 Aug 27. doi: 10.1111/1346-8138.17934.
    PubMed    


  358. ABE M, Igarashi A, Kitajima H, Toyama H, et al
    Treatment Satisfaction, Efficacy, and Safety of Delgocitinib Ointment Following Switch From Topical Corticosteroids for Trunk and Extremity Rash in Atopic Dermatitis.
    J Dermatol. 2025 Aug 27. doi: 10.1111/1346-8138.17915.
    PubMed     Abstract available


  359. MARTINS F, Mano F
    Primary Cutaneous Endometriosis of the Umbilicus.
    J Dermatol. 2025 Aug 23. doi: 10.1111/1346-8138.17925.
    PubMed    


  360. AOKI A, Hatamiya Y, Fukamatsu H, Sugiyama S, et al
    Panton-Valentine Leukocidin-Producing Community-Acquired Methicillin-Resistant Staphylococcus aureus in Skin and Soft Tissue Infections: Clinical and Epidemiological Insights From Japan.
    J Dermatol. 2025 Aug 23. doi: 10.1111/1346-8138.17920.
    PubMed     Abstract available


  361. ITO K, Yoshida A, Kishi A, Yamamoto G, et al
    A Case of Necrobiotic Xanthogranuloma Undergone Several Systemic Treatments for Multiple Myeloma: Follow-Up Report of "Necrobiotic Xanthogranuloma With Paraproteinemia Successfully Treated With Melphalan, Prednisolone and Skin Graft".
    J Dermatol. 2025 Aug 21. doi: 10.1111/1346-8138.17922.
    PubMed    


  362. KAWAI K, Uchida Y, Kanekura T
    Prognostic Significance of TBX21 and GATA3 Subtype Classification in Indolent Adult T-Cell Leukemia-Lymphoma With Cutaneous Lesions.
    J Dermatol. 2025 Aug 20. doi: 10.1111/1346-8138.17917.
    PubMed     Abstract available


  363. MATSUI Y, Kato J, Hida T, Horimoto K, et al
    Extended-Interval Dosing of an Immune Checkpoint Inhibitor Following a Complete Response in Melanoma: A Case Report.
    J Dermatol. 2025 Aug 20. doi: 10.1111/1346-8138.17899.
    PubMed    


  364. MATSUMURA R, Kageyama R, Kageyama H, Shimauchi T, et al
    Ulcerative Sarcoidosis With Cutaneous Sarcoid Granulomatous Vasculitis Successfully Treated by Combination Therapy of Tranilast and Roxithromycin.
    J Dermatol. 2025 Aug 15. doi: 10.1111/1346-8138.17916.
    PubMed    


  365. HE J, Weng T, Bai J, Zhu W, et al
    Nail Lichen Planus in 81 Patients: A Retrospective Study of Clinical Characteristics, Histopathological Features, and Long-Term Treatment Outcomes.
    J Dermatol. 2025 Aug 14. doi: 10.1111/1346-8138.17907.
    PubMed     Abstract available


  366. MATSUMOTO M, Matsudate Y, Kuroo Y, Okazaki H, et al
    A Case of Superimposed Linear Psoriasis That Was Successfully Treated With Secukinumab.
    J Dermatol. 2025 Aug 12. doi: 10.1111/1346-8138.17910.
    PubMed    


  367. GERDES S, Weisenseel P, Gross D, Ostendorf R, et al
    Long-Term Impact of Guselkumab on Skin, Sexuality, and Perceived Stigmatization in Patients With Psoriasis in Routine Clinical Practice: Week 76 Effectiveness and Safety Results From the Prospective German Multicenter G-EPOSS Study.
    J Dermatol. 2025 Aug 9. doi: 10.1111/1346-8138.17866.
    PubMed     Abstract available


  368. KAKURAI M, Akashi T, Moriyama Y
    Spontaneous Regression of Cutaneous Angiosarcoma: A Case Report.
    J Dermatol. 2025 Aug 8. doi: 10.1111/1346-8138.17903.
    PubMed    


  369. HANAMI Y, Nakamura T, Irie K, Mishima H, et al
    Familial Cases of Aicardi-Goutieres Syndrome Presenting With Cutaneous Manifestations of Facial Lipodystrophy and Puffy Digits.
    J Dermatol. 2025 Aug 7. doi: 10.1111/1346-8138.17898.
    PubMed    


  370. KASHANI AN, Yazdanparast T, Amiri F, Kashani MN, et al
    Biophysical and Ultrasonographic Findings of Cutaneous Macular Amyloidosis Lesions in Comparison With Uninvolved Skin.
    J Dermatol. 2025 Aug 6. doi: 10.1111/1346-8138.17824.
    PubMed     Abstract available


  371. NOGAMI K, Nishikawa Y, Mochida K, Terada T, et al
    Maximum Standard Uptake Value of Pre-Therapeutic (18)F-Fluorodeoxyglucose Positron Emission Tomography Predicts Outcomes in Indolent Adult T-Cell Leukemia/Lymphoma Patients With Cutaneous Involvement.
    J Dermatol. 2025 Aug 6. doi: 10.1111/1346-8138.17867.
    PubMed     Abstract available


  372. AZUMA S, Inaba Y, Tateishi C, Hashimoto T, et al
    A Case of Granular C3 Dermatosis With Methemoglobinemia After Administration of Dapsone.
    J Dermatol. 2025 Aug 5. doi: 10.1111/1346-8138.17887.
    PubMed    


  373. MATSUO M, Takagi H, Iwata H
    A Case of Atopic Dermatitis Accompanied by Prurigo Nodularis Developed Eosinophilic Pneumonia on Dupilumab Therapy.
    J Dermatol. 2025 Aug 5. doi: 10.1111/1346-8138.17892.
    PubMed    


  374. ZHU K, Lu Z, Cao L, Wu P, et al
    Relationships Between Secukinumab Concentrations, Disease Activity, and IL-17A Levels in Psoriasis: A Cross-Sectional Observational Study.
    J Dermatol. 2025 Aug 5. doi: 10.1111/1346-8138.17893.
    PubMed     Abstract available


  375. KIM MJ, Kim BR, Lee KH, Ju HJ, et al
    Exploration of Drugs Associated With the Development of Bullous Pemphigoid: A Nationwide Study.
    J Dermatol. 2025;52:1304-1313.
    PubMed     Abstract available


  376. SAITO N, Kamei K, Gautier G, Kurosky SK, et al
    Perceived Stigma and Mental Health Disorders Among Adults With Alopecia Areata Living in Japan.
    J Dermatol. 2025;52:1255-1262.
    PubMed     Abstract available


  377. HU X, Liu L, Huang Y, Zhang Y, et al
    Novel Molecular Subtyping Revealed Molecular Pathways That Contribute to the Pathogenesis of Rosacea.
    J Dermatol. 2025;52:1285-1296.
    PubMed     Abstract available


  378. HARVEY LF, Kingston P, Kikuchi R, Manasyan A, et al
    Do female patients see their physicians differently? A population-based study evaluating perception of physician communication by patients with hidradenitis suppurativa.
    J Dermatol. 2025;52:1263-1273.
    PubMed     Abstract available


  379. YANG MC, Tu WT, Hong YK, Lin YC, et al
    Missense and Inframe Pathogenic Variants in PLEC Lead to Minimal or Delayed-Onset Muscular Dystrophy in Autosomal Recessive Epidermolysis Bullosa Simplex: A Genotype-Phenotype Correlation in Nine Cases.
    J Dermatol. 2025;52:1274-1284.
    PubMed     Abstract available


  380. LEE J, Lee JS, Kim JY, Bae JM, et al
    Dermoscopic Features and Their Association With Breslow Thickness of Facial Lentigo Maligna in Koreans: A Multi-Center Retrospective Study.
    J Dermatol. 2025;52:1243-1254.
    PubMed     Abstract available


  381. NAKAYAMA Y, Kiyohara E, Nojima S, Fujimoto M, et al
    Primary Cutaneous Peripheral T-Cell Lymphoma, Not Otherwise Specified With a T-Follicular Helper Phenotype Treated by Rituximab and Low-Dose Prednisolone: A Case Report.
    J Dermatol. 2025 Aug 1. doi: 10.1111/1346-8138.17890.
    PubMed    


    July 2025
  382. SOTO-MORENO A, Olivares-Guerrero M, Lopez-Delgado D, Arias-Santiago S, et al
    PTEN Hamartoma Tumor Syndrome/Cowden Syndrome With Diffuse Sebaceous Gland Hyperplasia: Description of an Atypical Phenotype and a Previously Undescribed Pathogenic Variant.
    J Dermatol. 2025 Jul 25. doi: 10.1111/1346-8138.17880.
    PubMed    


  383. KAMIYA K, Okubo Y, Tada Y, Saeki H, et al
    Questionnaire Survey on the Treatment of Psoriasis Patients Who Achieved Remission With Biologics.
    J Dermatol. 2025 Jul 25. doi: 10.1111/1346-8138.17871.
    PubMed     Abstract available


  384. MATSUZAKI Y, Uehara J, Shibahara T, Suzuki K, et al
    A Case of Metastatic Pigmented Basal Cell Carcinoma With Low Tumor Mutation Burden Responding to Nivolumab.
    J Dermatol. 2025 Jul 24. doi: 10.1111/1346-8138.17881.
    PubMed    


  385. SASAKI W, Saito R, Suzuki K, Watanabe D, et al
    Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in Japan.
    J Dermatol. 2025 Jul 23. doi: 10.1111/1346-8138.17877.
    PubMed     Abstract available


  386. TAKAMURA S, Sugai S, Fukuda T
    Long-Term Clinical Courses and Stratified Management of Dupilumab-Associated Inflammatory Arthritis in Atopic Dermatitis: Two Japanese Cases With Over 200 Weeks of Follow-Up and Musculoskeletal Ultrasound Assessment.
    J Dermatol. 2025 Jul 22. doi: 10.1111/1346-8138.17873.
    PubMed    


  387. MATSUI Y, Nakano E, Ogata D, Yamazaki N, et al
    Response to Imatinib in Metastatic Esophageal Melanoma Harboring a KIT L576P (Exon 11) Mutation After Treatment Failure of Immune Checkpoint Inhibitors: A Case Report.
    J Dermatol. 2025 Jul 22. doi: 10.1111/1346-8138.17875.
    PubMed    


  388. OIKAWA A, Natsuga K, Watanabe M, Matsukawa T, et al
    Dermoscopic Rosettes in Cutaneous Chronic Graft-Versus-Host Disease.
    J Dermatol. 2025 Jul 21. doi: 10.1111/1346-8138.17870.
    PubMed    


  389. IKOMA T, Amagata Y, Fujii K, Aoki M, et al
    Outcomes of Free Tarsoconjunctival Grafts in Lower Eyelid Reconstruction Following Basal Cell Carcinoma Surgery.
    J Dermatol. 2025 Jul 21. doi: 10.1111/1346-8138.17872.
    PubMed     Abstract available


  390. FUJISAWA Y, Yoshioka Y, Yoshino K, Fujimura T, et al
    Secondary Publication of Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Cutaneous Angiosarcoma 2025.
    J Dermatol. 2025 Jul 19. doi: 10.1111/1346-8138.17856.
    PubMed     Abstract available


  391. ROGGO A, Wuest Y, Dummer R, Ramelyte E, et al
    Pruritus Is an Indicator for Quality of Life in Cutaneous T-Cell Lymphoma.
    J Dermatol. 2025 Jul 18. doi: 10.1111/1346-8138.17847.
    PubMed     Abstract available


  392. ZHANG J, Ding Y, Wang P, Li L, et al
    Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Asian Patients With Moderate to Severe Psoriasis: Improvements in Patient-Reported Outcomes in a Randomized Trial.
    J Dermatol. 2025 Jul 17. doi: 10.1111/1346-8138.17834.
    PubMed     Abstract available


  393. KIMURA H, Hasegawa A, Kawai T, Ogawa K, et al
    Iatrogenic Kaposi's Sarcoma in a Patient With Chronic Kidney Disease.
    J Dermatol. 2025 Jul 15. doi: 10.1111/1346-8138.17862.
    PubMed    


  394. MATSUDA I, Kato J, Fujie C, Horimoto K, et al
    Acral Melanoma Successfully Treated With Dacarbazine Following Anti-PD-1 Antibody Therapy: A Case Report and Literature Review.
    J Dermatol. 2025 Jul 14. doi: 10.1111/1346-8138.17861.
    PubMed    


  395. KIMURA H, Oginezawa M, Hama N, Watanabe Y, et al
    Efficacy and Safety of Etanercept in Japanese Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Unresponsive to Systemic Steroid Therapy: A Multicenter, Open-Label, Single-Arm Study.
    J Dermatol. 2025 Jul 14. doi: 10.1111/1346-8138.17860.
    PubMed     Abstract available


  396. CHEN HC, Chen YC, Chuang MH, Chien WC, et al
    Increased Risk of Chronic Kidney Disease in Atopic Dermatitis: A Nationwide, Population-Based Cohort Analysis.
    J Dermatol. 2025 Jul 10. doi: 10.1111/1346-8138.17841.
    PubMed     Abstract available


  397. MAIONE V, Venturuzzo A, Bighetti S, Romano C, et al
    NEVIGRAV Study: A Case-Control Analysis on Changes in Melanocytic Nevi During Pregnancy.
    J Dermatol. 2025 Jul 7. doi: 10.1111/1346-8138.17848.
    PubMed     Abstract available


  398. WATABE D, Tsunoda K, Amano H
    Exacerbation of Psoriasis During Treatment With Ofatumumab for Multiple Sclerosis.
    J Dermatol. 2025 Jul 2. doi: 10.1111/1346-8138.17846.
    PubMed    


  399. YOKOI K, Kiyohara E, Fujimoto M
    Multifocal Cutaneous Amyloidosis Mimicking Scleroderma Associated With Primary Cutaneous Marginal Zone Lymphoma.
    J Dermatol. 2025 Jul 2. doi: 10.1111/1346-8138.17850.
    PubMed    


  400. LIM JH, Kang DH, Moon H, Kwon SH, et al
    The Role of T-Helper 17 Cells and Regulatory T Cells in Acute Diffuse and Total Alopecia: The Increased Function of Regulatory T Cells May Explain the Favorable Prognosis.
    J Dermatol. 2025;52:1138-1145.
    PubMed     Abstract available


  401. HORISAKI K, Yoshikawa S, Omata W, Tsutsumida A, et al
    Predictors of Dermal Invasion and Sentinel Lymph Node Metastasis in Patients With Extramammary Paget's Disease Without Clinical Lymph Node Enlargement.
    J Dermatol. 2025;52:1152-1158.
    PubMed     Abstract available


  402. DOU L, Chen F, He W, Wang J, et al
    Efficacy and Safety of Dupilumab Monotherapy in Patients With Dystrophic Epidermolysis Bullosa: A Retrospective Study of 8 Cases.
    J Dermatol. 2025;52:1159-1165.
    PubMed     Abstract available


    June 2025
  403. FUKUDA A, Kishikawa S, Nakano E, Matsumoto Y, et al
    A Case of Microinvasive Malignant Hidroacanthoma Simplex/Porocarcinoma With Folliculo-Sebaceous Differentiation Only at Lymph Nodes Metastases With Absence of YAP1, PAK1/2/3 Fusions.
    J Dermatol. 2025 Jun 30. doi: 10.1111/1346-8138.17839.
    PubMed    


  404. MISHLAB S, Horowitz N, Bergman R
    Refractory Facial Cutaneous B-Cell Pseudolymphoma in an Atopic Patient Responsive to Dupilumab.
    J Dermatol. 2025 Jun 28. doi: 10.1111/1346-8138.17842.
    PubMed    


  405. MUKAIYAMA R, Yamamoto T
    Subcutaneous Sarcoidosis of the Lower Legs Mimicking Sclerosing Panniculitis in a Rheumatoid Arthritis Patient Under Golimumab Therapy.
    J Dermatol. 2025 Jun 27. doi: 10.1111/1346-8138.17836.
    PubMed    


  406. ABE M, Igarashi A, Kitajima H, Toyama H, et al
    Treatment Satisfaction, Efficacy, and Safety of Delgocitinib Ointment for Atopic Dermatitis-Induced Rash on the Face and Neck: Efficacy at Reducing Local Side Effects of Topical Steroid and Tacrolimus Ointment.
    J Dermatol. 2025 Jun 26. doi: 10.1111/1346-8138.17817.
    PubMed     Abstract available


  407. KITANO T, Horii M, Kudo K, Nishio J, et al
    Disrupted B-Cell Cytokine Homeostasis in Psoriasis: The Impact of Elevated IL-6 and Impaired IL-10 Production.
    J Dermatol. 2025 Jun 20. doi: 10.1111/1346-8138.17804.
    PubMed     Abstract available


  408. HASE T, Fujita Y, Miyamoto K, Shimizu S, et al
    Refractory Post-Zoster Eosinophilic Dermatitis of the Eyelids Successfully Treated With Mycophenolate Mofetil.
    J Dermatol. 2025 Jun 20. doi: 10.1111/1346-8138.17833.
    PubMed     Abstract available


  409. FUKUSHIMA S, Ito T, Asai J, Igaki H, et al
    Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Melanoma 2025.
    J Dermatol. 2025 Jun 13. doi: 10.1111/1346-8138.17740.
    PubMed     Abstract available


  410. KIM MC, Gu MJ, Park YS, Kim JG, et al
    Cutaneous Mature Plasmacytoid Dendritic Cell Proliferation in Primary Myelofibrosis: A Case Report.
    J Dermatol. 2025 Jun 12. doi: 10.1111/1346-8138.17803.
    PubMed    


  411. YOSHIKAWA S, Kikuchi K, Nozawa K, Nakai Y, et al
    Facial Skin With Conspicuous Enlarged Pores Closely Related to Severity of Facial Acneiform Rash and Therapeutic Effects of EGFR Inhibitors in RAS Wild-Type Metastatic Colorectal Cancer: Ancillary Analysis of FAEISS Study (NCCH1512).
    J Dermatol. 2025 Jun 12. doi: 10.1111/1346-8138.17813.
    PubMed     Abstract available


  412. KADONO T, Yamamoto M, Aoyama Y, Nakajima K, et al
    CARD14-Associated Papulosquamous Eruption (CAPE) With Ichthyosis and Malignant Melanoma.
    J Dermatol. 2025 Jun 11. doi: 10.1111/1346-8138.17807.
    PubMed    


  413. KAWASE K, Mizutani Y, Inoue M, Akita H, et al
    A Case of Facial-Type Acquired Dermal Melanocytosis on the Lips Successfully Treated With Laser Therapy.
    J Dermatol. 2025 Jun 11. doi: 10.1111/1346-8138.17800.
    PubMed    


  414. KAWAKAMI D, Hagihara E, Hata T, Hasegawa J, et al
    Coconut Anaphylaxis Induced by Occupational Sensitization to Cosmetics via the Skin in a Spa Therapist.
    J Dermatol. 2025 Jun 11. doi: 10.1111/1346-8138.17820.
    PubMed    


  415. SHIBA M, Hagino T, Saeki H, Fujimoto E, et al
    The Sustainability of Week 16 Responses to Deucravacitinib Treatment for Patients With Psoriasis.
    J Dermatol. 2025 Jun 2. doi: 10.1111/1346-8138.17812.
    PubMed    


  416. MAEKAWA T, Ito T, Idezuki T, Ota M, et al
    Wound, Pressure Ulcer and Burn Guidelines (2023)-5: Guidelines for the Management of Lower Leg Ulcers/Varicose Veins, Third Edition Wound/Pressure Ulcer/Burn Guidelines Drafting Committee (Lower Leg Ulcers/Varicose Veins Group).
    J Dermatol. 2025;52:e481-e528.
    PubMed     Abstract available


  417. ISEI T, Abe M, Ikegami R, Kato H, et al
    Wound, pressure ulcer, and burn guidelines - 3: Guidelines for the diagnosis and treatment of diabetic ulcers and gangrene, second edition.
    J Dermatol. 2025;52:e391-e429.
    PubMed     Abstract available


  418. LEE BH, Chung KB, Jang H, Jung YW, et al
    HLA-B51 Positivity Correlates With Symptom Completeness From Recurrent Aphthous Stomatitis to Complete Behcet's Disease.
    J Dermatol. 2025;52:1001-1007.
    PubMed     Abstract available


  419. TONE Y, Matsui M, Park A, Otani S, et al
    A Case of Stevens-Johnson Syndrome Induced by Selpercatinib.
    J Dermatol. 2025;52:1066-1069.
    PubMed     Abstract available


  420. AVALLONE G, Maronese CA, Zussino M, Muratori S, et al
    Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort Study.
    J Dermatol. 2025;52:983-1000.
    PubMed     Abstract available


  421. WANG L, Zhang J, Liu Y, Chen Z, et al
    A novel LSS variant leading to hypotrichosis with pseudoainhum.
    J Dermatol. 2025;52:1103-1106.
    PubMed     Abstract available


  422. SUEKI H, Sugiyama S, Aoyama Y, Yamamoto T, et al
    Comparing immunopathogenesis of non-human immunodeficiency virus immune reconstitution inflammatory syndrome and immune-related adverse events: A prospective multicenter cohort study.
    J Dermatol. 2025;52:1015-1030.
    PubMed     Abstract available


  423. OTSUKA A, Tsunemi Y, Nonaka Y
    Impact of shared decision-making in onychomycosis treatment: A cross-sectional study based on the Illuminating Dialogues and Insights in Onychomycosis Management (IDIOM) survey.
    J Dermatol. 2025;52:1031-1038.
    PubMed     Abstract available


  424. NORIMATSU Y, Hamada T, Ito K, Kimura E, et al
    The importance of pseudohyperchloremia for the diagnosis of bromoderma.
    J Dermatol. 2025;52:1078-1082.
    PubMed     Abstract available


  425. LU L, Feng J, Zhang S, He H, et al
    Vitiligo associated with type 2 immune inhibitors: FAERS analysis and literature review.
    J Dermatol. 2025;52:1008-1014.
    PubMed     Abstract available


    May 2025
  426. SUGAI S, Takamura S, Fukuda T
    Effect of IL-23p19 Inhibitors for Psoriasis With Bullous Pemphigoid: Clinical Insights From Two Cases.
    J Dermatol. 2025 May 30. doi: 10.1111/1346-8138.17805.
    PubMed    


  427. YAMAZAKI K, Tomita K, Masuda Y, Yagi H, et al
    Successful Treatment of Both Cutaneous and Extracutaneous Lesions in Systemic Sarcoidosis With Tranilast.
    J Dermatol. 2025 May 23. doi: 10.1111/1346-8138.17765.
    PubMed    


  428. LIU Y, He H, Zhang C, Pan W, et al
    A Wool Hat-A Case of Scalp Psoriasis.
    J Dermatol. 2025 May 23. doi: 10.1111/1346-8138.17793.
    PubMed    


  429. NAKANO E, Ogata D, Namikawa K, Yamazaki N, et al
    Real-World Efficacy and Safety of Anti-PD-1 Antibody Therapy for Patients With Advanced Cutaneous Squamous Cell Carcinoma: A Single-Center Retrospective Study in Japan.
    J Dermatol. 2025 May 23. doi: 10.1111/1346-8138.17799.
    PubMed     Abstract available


  430. HIRANO S, Ikuno Y, Yamaguchi A, Takahashi T, et al
    Early-Stage Limited Cutaneous Systemic Sclerosis Successfully Treated With Guselkumab: Possibility of Early Intervention in the Pathogenesis.
    J Dermatol. 2025 May 22. doi: 10.1111/1346-8138.17796.
    PubMed    


  431. CHARBEL N, Saade D, Maalouly M, Kreidieh F, et al
    Kaposi Sarcoma's Silent Symphony: An Atypical Auricular Presentation.
    J Dermatol. 2025 May 22. doi: 10.1111/1346-8138.17797.
    PubMed    


  432. YATSUZUKA K, Muto J, Kohri N, Yoshida S, et al
    Complete Resolution of Residual Psoriasis by Adding Tapinarof Cream to Tildrakizumab: A Case Report.
    J Dermatol. 2025 May 20. doi: 10.1111/1346-8138.17792.
    PubMed    


  433. JIA DD, Xu Y, Ren ZW, Li LQ, et al
    Is One Year Enough? Extended Adjuvant Dabrafenib Plus Trametinib for Chinese Patients With Resected Stage III Melanoma.
    J Dermatol. 2025 May 14. doi: 10.1111/1346-8138.17779.
    PubMed     Abstract available


  434. OHTSUKI M, Okubo Y, Saeki H, Igarashi A, et al
    Clinical Characteristics and Safety Profiles of Japanese Psoriasis Patients Who Continued Apremilast Treatment for 6 and 12 Months: A Post Hoc Analysis of an Apremilast Postmarketing Surveillance Study.
    J Dermatol. 2025 May 10. doi: 10.1111/1346-8138.17764.
    PubMed     Abstract available


  435. TSUBOI S, Yatsuzuka K, Kohri N, Yoshida S, et al
    Severe Exacerbation of Psoriasis Vulgaris With Topical Imiquimod Therapy: A Case Report.
    J Dermatol. 2025 May 10. doi: 10.1111/1346-8138.17782.
    PubMed    


  436. NISHIMURA K, Kimura A, Nakamura A, Takatsuka S, et al
    Impact of Surgical Delay on Prognosis in Patients With Cutaneous Melanoma: A Single-Institution Retrospective Study in Japan.
    J Dermatol. 2025 May 10. doi: 10.1111/1346-8138.17773.
    PubMed     Abstract available


  437. IWATA Y, Saito K, Matsushima J, Sugiura K, et al
    Generalized Pustular Psoriasis-Like Eruption Triggered by a G-CSF-Producing Lung Adenocarcinoma.
    J Dermatol. 2025 May 9. doi: 10.1111/1346-8138.17780.
    PubMed    


  438. TAKAYAMA E, Ijuin K, Yoshioka A
    Postherpetic Isotopic Response Manifesting as Granulomatous Dermatitis With Maculopapular Rash, Induced by Immune Checkpoint Inhibitor Use.
    J Dermatol. 2025 May 8. doi: 10.1111/1346-8138.17776.
    PubMed    


  439. MURAYAMA Y, Shojiguchi N, Kawasaki T, Inoue S, et al
    Metastatic Cutaneous Apocrine Adenocarcinoma Successfully Treated With Nivolumab.
    J Dermatol. 2025 May 8. doi: 10.1111/1346-8138.17777.
    PubMed    


  440. JENG YC, Liao YC, Hong YK, Cheng HC, et al
    Immunoproteomic Response to IL-17A Blockade in a Patient With Generalized Pustular Psoriasis: New Insights From Plasma Olink Profiling.
    J Dermatol. 2025 May 6. doi: 10.1111/1346-8138.17772.
    PubMed    


  441. JO SJ, Kim BS, Kim DH, Kim JH, et al
    Disease features, treatments, and burden of palmoplantar pustulosis in Korea: The EPPPIK study.
    J Dermatol. 2025;52:802-811.
    PubMed     Abstract available


  442. NISHIDA E, Morita A
    The required absolute PASI score to achieve DLQI remission.
    J Dermatol. 2025;52:947-949.
    PubMed     Abstract available


  443. LI C, Dai M, Gu Q, Lu K, et al
    Incidence of the Stevens-Johnson syndrome spectrum and its patterns in urban China.
    J Dermatol. 2025;52:897-906.
    PubMed     Abstract available


  444. TANEMURA C, Nunotani M, Kawabata K, Morooka Y, et al
    Development of Japanese versions of the Autoimmune Bullous Disease Quality of Life and Treatment of Autoimmune Bullous Disease Quality of Life questionnaires.
    J Dermatol. 2025;52:812-830.
    PubMed     Abstract available


  445. MATSUO M, Kato H, Kobayashi K, Nagai M, et al
    A case of pseudoangiomatous spindle-cell lipoma with unique MRI manifestations corresponding to distinct histological features.
    J Dermatol. 2025;52:943-946.
    PubMed     Abstract available


  446. KAWAMOTO H, Fujii K, Aoki M, Goto K, et al
    Ultrasound findings of endocrine mucin-producing sweat gland carcinoma mimicking epidermal cysts: A case series and diagnostic challenges.
    J Dermatol. 2025;52:939-942.
    PubMed     Abstract available


  447. HAMAGUCHI Y, Ueda-Hayakawa I, Kaneko U, Shimizu M, et al
    Nationwide epidemiological and clinical survey of juvenile-onset morphea in Japan.
    J Dermatol. 2025;52:860-871.
    PubMed     Abstract available


  448. MATSUO M, Zang X, Im D, Tanaka K, et al
    A case of multiple warty dyskeratomas overexpressing SERCA2 in acantholytic cells.
    J Dermatol. 2025;52:925-928.
    PubMed     Abstract available


  449. XU Y, Yang Y, Zhan W, Zhao J, et al
    Associations of chronic kidney disease with hidradenitis suppurativa: A bidirectional Mendelian randomization study.
    J Dermatol. 2025;52:922-924.
    PubMed     Abstract available


  450. TANEMURA A, Ma Y, Sakaki-Yumoto M, Hiro S, et al
    Clinical patterns of vitiligo in Japan: A descriptive study using the JMDC claims database.
    J Dermatol. 2025;52:831-840.
    PubMed     Abstract available


    April 2025
  451. OKUBO Y, Morita A, Imafuku S, Tada Y, et al
    Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Japanese Patients With Plaque Psoriasis: In-Depth Analysis of Efficacy and Safety in the Phase 3 POETYK PSO-4 Trial.
    J Dermatol. 2025 Apr 30. doi: 10.1111/1346-8138.17744.
    PubMed     Abstract available


  452. SHIN BS, Kim M, Suh MK, Lee YB, et al
    Effectiveness and Safety of Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis in Real-World Practice in Korea: A Prospective, Multicenter, Observational, Postmarketing Surveillance Study.
    J Dermatol. 2025 Apr 28. doi: 10.1111/1346-8138.17757.
    PubMed     Abstract available


  453. ASANO Y, Asai J, Ishii T, Iwata Y, et al
    Wound, pressure ulcer, and burn guidelines (2023)-4: Guidelines for the management of connective tissue disease/vasculitis-associated skin ulcers, third edition.
    J Dermatol. 2025 Apr 28. doi: 10.1111/1346-8138.17703.
    PubMed    



  454. Correction to "Clinical Background of Patients With Psoriasiform Skin Lesions due to Tumor Necrosis Factor Antagonist Administration at a Single Center".
    J Dermatol. 2025 Apr 27. doi: 10.1111/1346-8138.17751.
    PubMed    


  455. HACINECIPOGLU F, Celik G, Kartal SP
    Efficacy and Safety of IL-17 and IL-23 Inhibitors in Elderly Patients With Plaque Psoriasis: A Real-World Study.
    J Dermatol. 2025 Apr 26. doi: 10.1111/1346-8138.17755.
    PubMed     Abstract available


  456. TESHIMA R, Saito-Sasaki N, Hara N, Itamura M, et al
    Adult-Onset Langerhans Cell Histiocytosis Mimicking Erosive Pustular Dermatosis of the Scalp.
    J Dermatol. 2025 Apr 24. doi: 10.1111/1346-8138.17762.
    PubMed    


  457. NAKAZATO S, Fujita Y, Anan T
    Microcystic Pseudoglandular Cutaneous Neurofibroma: The First Japanese Case of a Rare Neurofibroma Variant.
    J Dermatol. 2025 Apr 24. doi: 10.1111/1346-8138.17761.
    PubMed    


  458. NAKAJIMA K, Miyagaki T, Okano T, Kadono T, et al
    Active Switch From a Single Dose of Bimekizumab to Risankizumab in Psoriasis: A Pilot Study.
    J Dermatol. 2025 Apr 22. doi: 10.1111/1346-8138.17760.
    PubMed    


  459. TOYOSHIMA R, Shibata S, Kakumoto T, Sato S, et al
    A Case of Parkinsonism Manifested by Exacerbation of Generalized Pustular Psoriasis.
    J Dermatol. 2025 Apr 21. doi: 10.1111/1346-8138.17750.
    PubMed    


  460. LIAO V, Lavin L, Ong MM, Pulitzer MP, et al
    Oral and Topical Janus Kinase Inhibitors in Patients With Cutaneous T-Cell Lymphoma: A Real-World Single-Center Experience.
    J Dermatol. 2025 Apr 16. doi: 10.1111/1346-8138.17747.
    PubMed     Abstract available


  461. MORTATO E, Marcelli L, Tofani L, Belcastro A, et al
    Effects of Guselkumab on the FIB-4 Index in Psoriasis Patients (EGIPT): A Three-Year Study.
    J Dermatol. 2025 Apr 16. doi: 10.1111/1346-8138.17752.
    PubMed     Abstract available


  462. SHEN MH, An HY, Shih CL
    Increased Incidence of COVID-19 Infection in Atopic Dermatitis Patients: A Real-World Cohort Study With Risk Factor Analysis.
    J Dermatol. 2025 Apr 12. doi: 10.1111/1346-8138.17738.
    PubMed     Abstract available


  463. IGARI S, Ishikawa M, Ohtsuka M, Yamamoto T, et al
    Multiple Dermatofibromas and Solitary Basal Cell Carcinoma in a Patient With Sarcoidosis.
    J Dermatol. 2025 Apr 9. doi: 10.1111/1346-8138.17735.
    PubMed    


  464. ADHANOM R, Kim C, Strong J, Martinez S, et al
    Cutaneous manifestations of WHIM syndrome.
    J Dermatol. 2025 Apr 9. doi: 10.1111/1346-8138.17733.
    PubMed     Abstract available


  465. KASE Y, Hayashi R, Shimada K, Tsutsui Y, et al
    A Case of Pediatric Cutaneous Sarcoid Vasculitis.
    J Dermatol. 2025 Apr 9. doi: 10.1111/1346-8138.17736.
    PubMed    


  466. FUJISHIGE A, Seko N
    Safety and effectiveness of secukinumab in Japanese patients with generalized pustular psoriasis: A post-marketing surveillance.
    J Dermatol. 2025 Apr 3. doi: 10.1111/1346-8138.17648.
    PubMed     Abstract available


  467. YAMAMURA S, Myangat TM, Sawamura S, Shimada S, et al
    Serum circulating S100A7 and S100A15 DNA copies are elevated in patients with psoriasis and atopic dermatitis.
    J Dermatol. 2025 Apr 1. doi: 10.1111/1346-8138.17727.
    PubMed     Abstract available


  468. ZHANG X, Ye Y, Sun W, Sheng Y, et al
    Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial.
    J Dermatol. 2025;52:603-614.
    PubMed     Abstract available


  469. OKUBO Y, Murakami M, Kobayashi S, Tsuji S, et al
    Risankizumab in Japanese patients with moderate-to-severe palmoplantar pustulosis: Results from the randomized, phase 3 JumPPP study.
    J Dermatol. 2025;52:593-602.
    PubMed     Abstract available


  470. LI YH, Chuang SH, Yang HJ
    Systematic review and meta-analysis of peripheral blood inflammatory markers in hidradenitis Suppurativa.
    J Dermatol. 2025;52:583-592.
    PubMed     Abstract available


  471. KOGA H, Ishii N, Tsutsumi M, Teye K, et al
    Correlation of BP180, BP230, and type VII collagen antibody titers in serum, blister fluid, erosion, and saliva in pemphigoid diseases.
    J Dermatol. 2025;52:744-748.
    PubMed     Abstract available


  472. CHEN Y, Li J, Tang Y, Chong S, et al
    Corticosteroids combined with low-dose methotrexate in the treatment of pemphigus vulgaris: A retrospective cohort study.
    J Dermatol. 2025;52:695-700.
    PubMed     Abstract available


  473. TOCHIGI M, Takamiya Y, Ochiai S, Anzawa K, et al
    A case of warts in toe webs due to HPV type 7: Case report and literature review.
    J Dermatol. 2025;52:754-757.
    PubMed     Abstract available


  474. MIYAZAKI K, Kunimoto K, Yasue S, Endo S, et al
    Biomarkers associated with progression of infantile hemangioma: Exploratory study.
    J Dermatol. 2025;52:712-725.
    PubMed     Abstract available


  475. WADA-IRIMADA M, Takahashi T, Sekine M, Okazaki T, et al
    Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single center.
    J Dermatol. 2025;52:701-711.
    PubMed     Abstract available


  476. CHEN X, Zhang B, Mao X, Wang Y, et al
    Clinical characteristics of bullous pemphigoid patients of different ages and the possible mechanism.
    J Dermatol. 2025;52:672-681.
    PubMed     Abstract available


  477. SUGAYA M, Nagashima A, Nakamura R, Yano M, et al
    Treatment of facial reactive B-cell rich lymphoid proliferation with dapsone.
    J Dermatol. 2025;52:735-739.
    PubMed     Abstract available


  478. MIURA G, Maeda T, Ujiie H
    Dermoscopic findings in two cases of trichogerminoma.
    J Dermatol. 2025;52:730-734.
    PubMed     Abstract available


  479. MIZAWA M, Makino T, Furukawa F, Shimizu T, et al
    Clinical characterization of mycosis fungoides with abnormal light reactions induced by narrow-band UVB therapy: A review of a single-center experience.
    J Dermatol. 2025;52:726-729.
    PubMed     Abstract available


    March 2025
  480. TADA Y, Sugiura Y, Kamishima M, Takahashi S, et al
    Real-world safety and effectiveness of guselkumab in patients with psoriasis: A post-marketing surveillance study through up to week 52 in Japan.
    J Dermatol. 2025 Mar 29. doi: 10.1111/1346-8138.17710.
    PubMed     Abstract available


  481. LIU Z, Cheng N, Zheng S, Chen L, et al
    Persistent exanthema mainly on the trunk with pathologically dermal interstitial mucin as anti-HMGCR myopathy-associated skin rash: Case series.
    J Dermatol. 2025 Mar 28. doi: 10.1111/1346-8138.17717.
    PubMed     Abstract available


  482. LIU T, Chang J
    Lichen nitidus on the penis.
    J Dermatol. 2025 Mar 26. doi: 10.1111/1346-8138.17719.
    PubMed    


  483. CHO YT, Chou HI, Chan TC, Chen YC, et al
    Disease burden and treatment preference for moderate-to-severe atopic dermatitis in Taiwan: A discrete-choice experiment.
    J Dermatol. 2025 Mar 26. doi: 10.1111/1346-8138.17721.
    PubMed     Abstract available


  484. KIMURA A, Ito T, Abe R, Ujiie H, et al
    Toxic epidermal necrolysis resulting in lip synechiae.
    J Dermatol. 2025 Mar 26. doi: 10.1111/1346-8138.17715.
    PubMed    


  485. AMAGAI R, Fujimura T, Kambayashi Y, Takahashi-Watanabe M, et al
    Two cases of advanced melanoma with BRAF L597 mutation: Options for systemic treatment.
    J Dermatol. 2025 Mar 25. doi: 10.1111/1346-8138.17718.
    PubMed     Abstract available


  486. YAMAMOTO K, Okamura K, Saito T, Suzuki T, et al
    Hypopigmented malignant melanoma in a patient with oculocutaneous albinism type 4.
    J Dermatol. 2025 Mar 20. doi: 10.1111/1346-8138.17711.
    PubMed    


  487. MAKI T, Murakami M, Takeichi T, Noda T, et al
    Cutaneous inflammation with upregulated interleukin-36gamma and TNFalpha in a patient with loricrin keratoderma.
    J Dermatol. 2025 Mar 19. doi: 10.1111/1346-8138.17708.
    PubMed    


  488. ONDA M, Hagino T, Saeki H, Fujimoto E, et al
    Long-term maintenance of responses to bimekizumab treatment in moderate-to-severe psoriasis: A real-world comparison of Q4W versus Q8W dosing or bio-naive versus bio-switched patients.
    J Dermatol. 2025 Mar 14. doi: 10.1111/1346-8138.17700.
    PubMed     Abstract available


  489. IGARI S, Yamamoto T
    A unique case of systemic lupus erythematosus presenting with interstitial granulomatous dermatitis at onset and palisaded neutrophilic granulomatous dermatitis at relapse.
    J Dermatol. 2025 Mar 14. doi: 10.1111/1346-8138.17709.
    PubMed    


  490. TORII H, Morita A, Yamamoto C, Dong J, et al
    Safety and effectiveness of ixekizumab in Japanese patients with psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis, and erythrodermic psoriasis: Post-marketing surveillance.
    J Dermatol. 2025 Mar 13. doi: 10.1111/1346-8138.17695.
    PubMed     Abstract available


  491. MORITA A, Imafuku S, Tada Y, Okubo Y, et al
    Deucravacitinib in plaque psoriasis: Safety and efficacy through 3 years in Japanese patients in the phase 3 POETYK PSO-1, PSO-4, and LTE trials.
    J Dermatol. 2025 Mar 11. doi: 10.1111/1346-8138.17685.
    PubMed     Abstract available


  492. AL-CHAER RN, Folkmann M, Martensson NL, Feldt-Rasmussen U, et al
    Cutaneous manifestations of Fabry disease: A systematic review.
    J Dermatol. 2025 Mar 7. doi: 10.1111/1346-8138.17690.
    PubMed     Abstract available


  493. KARABINOS A, Hrebenar P, Hyblova M, Tomkova E, et al
    A severe ABCC6-induced generalized arterial calcification of infancy overshadowed by the EGFR-associated neonatal inflammatory skin and bowel disease 2 in a Roma girl.
    J Dermatol. 2025 Mar 5. doi: 10.1111/1346-8138.17682.
    PubMed     Abstract available


  494. JINNIN M, Shimokawa T, Kishi A, Hayashi N, et al
    Topical sirolimus therapy for cutaneous vascular anomalies: A randomized phase II clinical trial.
    J Dermatol. 2025 Mar 5. doi: 10.1111/1346-8138.17688.
    PubMed     Abstract available


  495. HORISAKI K, Yoshikawa S, Omata W, Tsutsumida A, et al
    Comparison of efficacy and adverse events by treatment cycles of nivolumab and ipilimumab in Japanese melanoma patients: A single-center, retrospective study.
    J Dermatol. 2025 Mar 5. doi: 10.1111/1346-8138.17672.
    PubMed     Abstract available


  496. TAKEUCHI S, Zeze N, Imayama S, Nakahara T, et al
    Case of allergic contact dermatitis caused by polyurethane elastic cannula.
    J Dermatol. 2025 Mar 5. doi: 10.1111/1346-8138.17687.
    PubMed    


  497. DORFER S, Ablinger M, Wimmer M, Hummel JI, et al
    Repurposing diacerein for the treatment of chronic wounds in recessive-dystrophic epidermolysis bullosa patients by modulating matrix metalloproteinase-9 expression.
    J Dermatol. 2025;52:423-431.
    PubMed     Abstract available


  498. HAUBER B, Whichello C, Mauer J, Law E, et al
    Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment.
    J Dermatol. 2025;52:510-514.
    PubMed     Abstract available


  499. SILVER SM, Houghton K, Hitchens A, Ansquer VD, et al
    Real-world assessment of the patient profile, clinical characteristics, treatment patterns, and outcomes associated with erythropoietic and X-linked protoporphyria.
    J Dermatol. 2025;52:416-422.
    PubMed     Abstract available


  500. KUBO A
    History and prospects of Nagashima-type palmoplantar keratosis, the most common palmoplantar keratoderma in east Asian populations.
    J Dermatol. 2025;52:408-415.
    PubMed     Abstract available


  501. KIM MH
    Epidemiological insights into chronic urticaria, vitiligo, alopecia areata, and herpes zoster following COVID-19 infection: A nationwide population-based study.
    J Dermatol. 2025;52:499-504.
    PubMed     Abstract available


  502. LUO H, Chen Y, Li J, Yang Y, et al
    Inflammatory proteins and hidradenitis suppurativa: Insights from genetic correlation and Mendelian randomization.
    J Dermatol. 2025;52:481-492.
    PubMed     Abstract available


  503. DEMIRGIL F, Kugu N, Yilmaz Y
    Traumatic experiences, dissociative symptoms, and alexithymia in patients with alopecia areata.
    J Dermatol. 2025;52:452-459.
    PubMed     Abstract available


  504. KIM BR, Lee KH, Paik K, Kim M, et al
    Comorbid diseases in bullous pemphigoid: A population-based case-control study.
    J Dermatol. 2025;52:460-471.
    PubMed     Abstract available


  505. LI Z, Xie S, Xu X, Chen Z, et al
    Phenotypic and genotypic analysis of SERPINA12-related autosomal recessive palmoplantar keratoderma in southwestern China.
    J Dermatol. 2025;52:545-550.
    PubMed     Abstract available


  506. WANG L, Huang J, Fang L, Zhou Y, et al
    Kodamaea ohmeri infection can be the causative agent of secondary infections of intertrigo: A case study.
    J Dermatol. 2025;52:541-544.
    PubMed     Abstract available


  507. HAYASHI D, Kashiwada-Nakamura K, Noguchi H, Matsumoto T, et al
    Onychomycosis caused by Aspergillus species belonging to section Circumdati.
    J Dermatol. 2025;52:536-540.
    PubMed     Abstract available


  508. CHEN Y, Xie S, Geng J, Li Z, et al
    Biallelic pathogenic variants in the LSS gene cause congenital alopecia-cataract syndrome.
    J Dermatol. 2025;52:531-535.
    PubMed     Abstract available


  509. ULLAH K, Ahmed S, Cesarato N, Xiong X, et al
    Novel pathogenic variants in HR underlie atrichia with papular lesions in a cohort of 10 families.
    J Dermatol. 2025;52:515-519.
    PubMed     Abstract available


  510. GONG Z, Yang S, Ling S, Wang H, et al
    Dermatopathological features and successful treatment with topical antioxidant for ichthyosiform lesions in Mitchell syndrome caused by an ACOX1 variant.
    J Dermatol. 2025;52:445-451.
    PubMed     Abstract available


    February 2025
  511. SEGAWA Y, Takahashi T, Mikami Y, Takahashi T, et al
    A case of systemic sclerosis accompanying psoriasis successfully treated with brodalumab.
    J Dermatol. 2025 Feb 26. doi: 10.1111/1346-8138.17686.
    PubMed    


  512. IMAFUKU S, Satoh A, Arima H, Tsuruta N, et al
    Quality of life of patients with pustular psoriasis is inferior to that of patients with plaque psoriasis in Japan: A multicenter study with questionnaires, the short Form-36, and other patient-reported outcomes.
    J Dermatol. 2025 Feb 25. doi: 10.1111/1346-8138.17629.
    PubMed     Abstract available


  513. URATA K, Myangat TM, Kajihara I, Sawamura S, et al
    Increased circulating interleukin 36gamma DNA copies in psoriasis.
    J Dermatol. 2025 Feb 20. doi: 10.1111/1346-8138.17678.
    PubMed    


  514. KAWAMOTO M, Sakai T, Uchimura K, Shono T, et al
    Anaphylaxis triggered by dog contact and exhaustion in a dog-allergic patient with atopic dermatitis.
    J Dermatol. 2025 Feb 17. doi: 10.1111/1346-8138.17676.
    PubMed    


  515. KINOSHITA M, Ogawa Y, Shimada S, Abe R, et al
    Intravenous immunoglobulin inhibits neutrophil extracellular traps in Stevens-Johnson syndrome/toxic epidermal necrolysis.
    J Dermatol. 2025 Feb 14. doi: 10.1111/1346-8138.17675.
    PubMed    


  516. VAN BUCHEM-POST NF, Ouwerkerk W, Stalman EW, van Dam KPJ, et al
    Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy.
    J Dermatol. 2025 Feb 14. doi: 10.1111/1346-8138.17664.
    PubMed     Abstract available


  517. ABE N, Higashi Y, Tateishi C, Kanekura T, et al
    Efficacy of granulocyte and monocyte adsorptive apheresis on skin and joint manifestations of palmoplantar pustulosis with pustulotic arthro-osteitis: A multicentric, prospective, observational study.
    J Dermatol. 2025 Feb 12. doi: 10.1111/1346-8138.17667.
    PubMed     Abstract available


  518. OMASA H, Kakuta R, Terai H, Kawaida M, et al
    A case of epidermal growth factor receptor-mutant lung cancer with transformation from adenocarcinoma into small cell carcinoma suggested by histological investigation of skin metastasis.
    J Dermatol. 2025 Feb 11. doi: 10.1111/1346-8138.17666.
    PubMed    


  519. ELRADI M, Hoseiny HAM, Marei A, Boghdadi G, et al
    Intralesional candida antigen versus intralesional varicella zoster vaccine in treatment of molluscum contagiosum: A new promising alternative.
    J Dermatol. 2025 Feb 10. doi: 10.1111/1346-8138.17660.
    PubMed     Abstract available


  520. HORISAKI K, Yoshikawa S, Mori S, Omata W, et al
    Prognostic value of the CONUT score with immune checkpoint inhibitors as first-line therapy for metastatic malignant melanoma.
    J Dermatol. 2025 Feb 7. doi: 10.1111/1346-8138.17613.
    PubMed     Abstract available


  521. HAGINO T, Saeki H, Fujimoto E, Kanda N, et al
    Long-term real-world effectiveness of deucravacitinib in psoriasis: A 52-week prospective study stratified by prior apremilast or biologic therapy.
    J Dermatol. 2025 Feb 7. doi: 10.1111/1346-8138.17665.
    PubMed     Abstract available


  522. MA Y, Chachin M, Hirose T, Nakamura K, et al
    Prevalence and incidence of comorbidities in patients with atopic dermatitis, psoriasis, alopecia areata, and vitiligo using a Japanese claims database.
    J Dermatol. 2025 Feb 7. doi: 10.1111/1346-8138.17643.
    PubMed     Abstract available


  523. FUJII Y, Takeichi T, Yamashita Y, Okumura T, et al
    Concurrent wild-type transthyretin amyloidosis and psoriasis vulgaris in an elderly man.
    J Dermatol. 2025 Feb 7. doi: 10.1111/1346-8138.17670.
    PubMed    


  524. LV J, Li H, Zheng Y, Lv T, et al
    Treating tislelizumab-induced ulcerative lichenoid drug eruption with baricitinib in a patient with lung cancer.
    J Dermatol. 2025 Feb 7. doi: 10.1111/1346-8138.17662.
    PubMed    


  525. BONCIANI D, Della Bella C, Corra A, Galano A, et al
    The impact of antibiotic therapy in psoriasis patients with active streptococcal infection: A prospective study.
    J Dermatol. 2025 Feb 3. doi: 10.1111/1346-8138.17645.
    PubMed     Abstract available


  526. MIZUKAWA Y, Hama N, Niihara H, Miyagawa F, et al
    Guidelines for the management of drug-induced hypersensitivity syndrome 2023.
    J Dermatol. 2025 Feb 3. doi: 10.1111/1346-8138.17609.
    PubMed     Abstract available


  527. MORITA T, Hayama K, Ishii N, Koga H, et al
    Pemphigoid with autoantibodies exclusively reacting with gamma2-subunit of laminin-332 in a patient with psoriasis vulgaris.
    J Dermatol. 2025 Feb 1. doi: 10.1111/1346-8138.17650.
    PubMed    


  528. KAVVALOU E, Krasagakis K, Chlouverakis G, Xekouki P, et al
    Association of statins, gliptins, and antipsychotics with bullous pemphigoid: A case-control study in the Cretan population.
    J Dermatol. 2025;52:291-298.
    PubMed     Abstract available


  529. ITO T, Kukino R, Sarayama Y, Tanioka M, et al
    Wound, Pressure Ulcer, and Burn Guidelines-5: Guidelines for the management of lower leg ulcers and varicose veins, second edition.
    J Dermatol. 2025;52:e49-e69.
    PubMed     Abstract available


  530. ZENG Q, Lu W, Ye Y, Li M, et al
    Variations in RASA1 and EPHB4 in Chinese patients with capillary malformation-arteriovenous malformation.
    J Dermatol. 2025;52:377-382.
    PubMed     Abstract available


  531. YAMAMOTO T, Yamanaka K, Yamasaki K, Isaji H, et al
    Real-world safety and effectiveness of adalimumab in patients with pyoderma gangrenosum: Interim analysis of a post-marketing observational study in Japan.
    J Dermatol. 2025;52:270-280.
    PubMed     Abstract available


  532. YAMAMOTO T
    Erythroderma in the elderly.
    J Dermatol. 2025;52:221-227.
    PubMed     Abstract available


  533. LUO SY, Zhou KY, Wang QX, Feng L, et al
    Clinicopathological features of epithelioid hemangioma of 43 patients with long-term follow-up: A two-center retrospective study.
    J Dermatol. 2025;52:329-336.
    PubMed     Abstract available


  534. ENCARNACION MRN, Kawai R, Kuwabiraki H, Ban N, et al
    Clinical characteristics and outcomes of autoimmune blistering diseases in Japan.
    J Dermatol. 2025;52:299-308.
    PubMed     Abstract available


  535. KATAYAMA S, Izumi K, Ujiie I, Ujiie H, et al
    A case of rapidly progressive hair loss due to azathioprine, and the prevalence of NUDT15 variants among Japanese patients with autoimmune blistering diseases: A single-center retrospective observational study.
    J Dermatol. 2025;52:363-366.
    PubMed     Abstract available


  536. NARASAKI M, Kato J, Sato S, Hida T, et al
    Extramammary Paget's disease treated with of anti-programmed cell death protein 1 therapy after docetaxel therapy failure.
    J Dermatol. 2025;52:359-362.
    PubMed     Abstract available


  537. TAN H, Chen X, Chen Y, Ou X, et al
    Immune checkpoint inhibitor-associated bullous pemphigoid: A retrospective and real-world study based on the United States Food and Drug Administration adverse event reporting system.
    J Dermatol. 2025;52:309-316.
    PubMed     Abstract available


  538. MORIOKE S, Moriwaki M, Tanaka A, Hide M, et al
    A case of chronic spontaneous urticaria with wheals lasting for more than a week.
    J Dermatol. 2025;52:344-347.
    PubMed     Abstract available


  539. TOKURA Y, Yunoki M, Kondo S, Otsuka M, et al
    What is "eczema"?
    J Dermatol. 2025;52:192-203.
    PubMed     Abstract available


  540. HIDE M, Kishimoto M, Kotera I, Oh A, et al
    Analysis of disease burden in patients with hereditary angioedema from Japan by patient-reported outcomes.
    J Dermatol. 2025;52:256-269.
    PubMed     Abstract available


  541. MUROTA H, Matsumoto M, Arima K, Yoshida T, et al
    Current clinical practice of prurigo nodularis in Japan: A cross-sectional web-survey among dermatologists.
    J Dermatol. 2025;52:348-352.
    PubMed     Abstract available


    January 2025
  542. MORITO K, Kado S, Okada H, Sato A, et al
    Cutaneous squamous carcinoma with pulmonary metastasis with cavity formation successfully treated with nivolumab.
    J Dermatol. 2025 Jan 29. doi: 10.1111/1346-8138.17649.
    PubMed    


  543. HAGINO T, Onda M, Saeki H, Fujimoto E, et al
    Real-world 52-week effectiveness of deucravacitinib in psoriasis: A stratified analysis by age and body mass index.
    J Dermatol. 2025 Jan 28. doi: 10.1111/1346-8138.17617.
    PubMed     Abstract available


  544. SUGIYAMA A, Yano-Takamori A, Kojima K, Nishie H, et al
    Characteristics of suitable cases for treatment with nemolizumab based on clinical findings and cutaneous adverse events.
    J Dermatol. 2025 Jan 16. doi: 10.1111/1346-8138.17626.
    PubMed     Abstract available


  545. NISHIHARA K, Fujii K, Aoki M, Hirano Y, et al
    Combination treatment of cultured epithelial autograft and meshed full-thickness skin graft for giant congenital melanocytic nevus.
    J Dermatol. 2025 Jan 16. doi: 10.1111/1346-8138.17529.
    PubMed    


  546. TRUPIANO N, Young K, Echuri H, Maghfour J, et al
    Exploring itch in hidradenitis suppurativa with lessons from atopic dermatitis and psoriasis.
    J Dermatol. 2025 Jan 15. doi: 10.1111/1346-8138.17622.
    PubMed     Abstract available


  547. YONEYAMA M, Hagino T, Saeki H, Fujimoto E, et al
    A predictive factor of oral candidiasis in psoriasis patients treated with bimekizumab: Longer disease duration.
    J Dermatol. 2025 Jan 11. doi: 10.1111/1346-8138.17623.
    PubMed    


  548. HIGUCHI M, Hayashi R, Sato M, Oginezawa M, et al
    A case of toxic epidermal necrolysis like vancomycin-induced linear IgA bullous dermatosis without autoantibody for type VII collagen.
    J Dermatol. 2025 Jan 3. doi: 10.1111/1346-8138.17606.
    PubMed    


  549. AN R, Sun DJ, Lei HX, He AR, et al
    Effect of Epstein-Barr virus on macrophage M2/M1 migration and EphA2 expression in adverse drug reactions.
    J Dermatol. 2025;52:87-96.
    PubMed     Abstract available


  550. YAO QH, Zhi HL, Xia XJ, Liu ZH, et al
    The role of ingrown hairs in persistent kerion of children: A clinical study.
    J Dermatol. 2025;52:35-42.
    PubMed     Abstract available


  551. SUZUKI S, Kamata M, Uchida H, Shimizu T, et al
    Serum interleukin-10 level is increased and correlated positively with disease severity in patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid.
    J Dermatol. 2025;52:122-131.
    PubMed     Abstract available


  552. FUKUYAMA M, Kinoshita-Ise M, Ohyama M
    Long-term outcomes of intravenous corticosteroid pulse therapy for rapidly progressive alopecia areata: A single-center retrospective analysis of 106 cases and usefulness evaluation of a scoring system originally designed for half-year efficacy predic
    J Dermatol. 2025;52:112-121.
    PubMed     Abstract available


  553. TSUNEMI Y, Otsuka A, Nonaka Y
    Clinical inertia in onychomycosis treatment: results from the Illuminating Dialogues and Insights in Onychomycosis Management (IDIOM) survey.
    J Dermatol. 2025;52:97-111.
    PubMed     Abstract available


  554. SHIMIZU A, Mieko K, Yamaguchi K, Niwa O, et al
    Detection of human papillomavirus in plantar warts and its impact on outcome.
    J Dermatol. 2025;52:175-178.
    PubMed     Abstract available


  555. FUKAURA R, Ato M, Murase C, Miyamoto Y, et al
    Buruli ulcer: An epidemiological update from Japan.
    J Dermatol. 2025;52:3-10.
    PubMed     Abstract available


  556. MOCHIZUKI T, Anzawa K, Bernales-Mendoza AM, Shimizu A, et al
    Case of tinea corporis caused by a terbinafine-sensitive Trichophyton indotineae strain in a Vietnamese worker in Japan.
    J Dermatol. 2025;52:163-166.
    PubMed     Abstract available


  557. HIDA T, Idogawa M, Ishikawa A, Okura M, et al
    A case of familial progressive hyperpigmentation with or without hypopigmentation presenting with hypopigmented striae along the lines of Blaschko.
    J Dermatol. 2025;52:159-162.
    PubMed     Abstract available


  558. TSUNEMI Y, Naka W
    Exploratory study on short-term administration of oral fosravuconazole for tinea pedis.
    J Dermatol. 2025;52:79-86.
    PubMed     Abstract available


  559. WANG H, Wu B, Luo M, Han Y, et al
    Association of hidradenitis suppurativa (HS) with waist circumference: A bidirectional two-sample Mendelian randomization study of HS with metabolic syndrome.
    J Dermatol. 2025;52:155-158.
    PubMed     Abstract available


  560. KOC HA, Onal BS
    Relationship between acne vulgaris and attention deficit hyperactivity disorder in adolescent: A cross-sectional study.
    J Dermatol. 2025;52:50-55.
    PubMed     Abstract available


  561. MUTO Y, Kinjyo K, Asano Y
    Successful treatment of Darier's disease with apremilast and review of reported cases.
    J Dermatol. 2025;52:138-141.
    PubMed     Abstract available


    December 2024
  562. SAITO-SASAKI N, Aoki M, Fujii K, Yamamura K, et al
    Age over 90 years is an unfavorable prognostic factor for resectable cutaneous squamous cell carcinoma.
    J Dermatol. 2024 Dec 27. doi: 10.1111/1346-8138.17551.
    PubMed     Abstract available


  563. HYOBU R, Ito T, Sakai N, Okura M, et al
    Granular C3 dermatosis with pustular psoriasis-like skin rash.
    J Dermatol. 2024 Dec 27. doi: 10.1111/1346-8138.17604.
    PubMed    


  564. NATSUGA K
    Advanced phasing techniques in congenital skin diseases.
    J Dermatol. 2024 Dec 26. doi: 10.1111/1346-8138.17597.
    PubMed     Abstract available


  565. HAGINO T, Onda M, Saeki H, Fujimoto E, et al
    Predictive factors for responders to deucravacitinib treatment in patients with psoriasis.
    J Dermatol. 2024 Dec 26. doi: 10.1111/1346-8138.17601.
    PubMed     Abstract available


  566. NISHIO J, Hatta N, Ishii T, Yamamoto K, et al
    CYLD novel splicing mutation in a patient with CYLD cutaneous syndrome with basal cell carcinomas.
    J Dermatol. 2024 Dec 23. doi: 10.1111/1346-8138.17584.
    PubMed    


  567. SAEKI H, Ohya Y, Arakawa H, Ichiyama S, et al
    English version of clinical practice guidelines for the management of atopic dermatitis 2024.
    J Dermatol. 2024 Dec 20. doi: 10.1111/1346-8138.17544.
    PubMed     Abstract available


  568. KAMADA H, Arakawa N, Kato M, Tanji T, et al
    Nemolizumab-induced exacerbation of atopic dermatitis.
    J Dermatol. 2024 Dec 19. doi: 10.1111/1346-8138.17589.
    PubMed    


  569. NIKI M, Kubo Y
    A case of Bell palsy during the course of oral TYK2 inhibitor deucravacitinib therapy in psoriasis.
    J Dermatol. 2024 Dec 19. doi: 10.1111/1346-8138.17596.
    PubMed    


  570. NAKANO F, Kan T, Ushio Y, Ito H, et al
    A case of malignant melanoma in which adalimumab was effective for steroid-resistant uveitis caused by dabrafenib/trametinib combination therapy.
    J Dermatol. 2024 Dec 19. doi: 10.1111/1346-8138.17594.
    PubMed    


  571. AKIYAMA M
    Updated genetic background of generalized pustular psoriasis as an autoinflammatory keratinization disease.
    J Dermatol. 2024 Dec 19. doi: 10.1111/1346-8138.17585.
    PubMed     Abstract available


  572. IGARASHI A, Tsuji G, Murata R, Fukasawa S, et al
    A phase 2, randomized, double-blind, vehicle-controlled trial of tapinarof cream in Japanese pediatric patients with atopic dermatitis.
    J Dermatol. 2024 Dec 15. doi: 10.1111/1346-8138.17587.
    PubMed     Abstract available


  573. MORIWAKI Y, Shiraishi M, Shen Q, Du Z, et al
    Experimental method for creating skin with acquired appendage dysfunction.
    J Dermatol. 2024 Dec 15. doi: 10.1111/1346-8138.17579.
    PubMed     Abstract available


  574. MAEDA C, Kido I, Ohara Y, Kase M, et al
    A case of nevoid basal cell carcinoma syndrome with segmentally unilaterally arranged hypertrichosis and circumscribed palmar hypokeratosis histologically presenting as basal cell carcinoma.
    J Dermatol. 2024 Dec 15. doi: 10.1111/1346-8138.17593.
    PubMed    


  575. KATO J, Hida T, Idogawa M, Tokino T, et al
    The genomic landscape of cutaneous squamous cell carcinoma in Japan.
    J Dermatol. 2024 Dec 15. doi: 10.1111/1346-8138.17592.
    PubMed     Abstract available


  576. KIM R, Goto A, Kuroda H, Arichi I, et al
    Linear IgA/IgG bullous dermatosis presenting with refractory oral and esophageal erosions: A case report.
    J Dermatol. 2024 Dec 12. doi: 10.1111/1346-8138.17580.
    PubMed    


  577. YATSUZUKA K, Yoshida S, Miura N, Kohri N, et al
    Effectiveness of guselkumab for avelumab-induced psoriasis in urothelial carcinoma: A case report.
    J Dermatol. 2024 Dec 12. doi: 10.1111/1346-8138.17583.
    PubMed    


  578. HASHIMOTO T, Okuno S
    Practical guide for the diagnosis and treatment of localized and generalized cutaneous pruritus (chronic itch with no underlying pruritic dermatosis).
    J Dermatol. 2024 Dec 12. doi: 10.1111/1346-8138.17565.
    PubMed     Abstract available


  579. SONG H, Cheng Y, Wang X, Hong X, et al
    The evaluation of Congo red staining combined with fluorescence microscopy in the diagnosis of primary cutaneous amyloidosis.
    J Dermatol. 2024 Dec 12. doi: 10.1111/1346-8138.17562.
    PubMed     Abstract available


  580. SATOH T
    A new era for understanding and managing common pruritic skin conditions: How to define, diagnose, and treat?
    J Dermatol. 2024 Dec 12. doi: 10.1111/1346-8138.17574.
    PubMed    


  581. TADA Y, Armstrong AW, Imafuku S, Okubo Y, et al
    Deucravacitinib in Japanese patients with plaque, generalized pustular, or erythrodermic psoriasis: Patient-reported outcomes in the POETYK PSO-4 study.
    J Dermatol. 2024 Dec 6. doi: 10.1111/1346-8138.17570.
    PubMed     Abstract available


  582. TANAKA M, Miyagaki T, Kubo M, Okano T, et al
    Two cases of lymphoma arising in immune deficiency/dysregulation presenting as primary cutaneous anaplastic large cell lymphoma during oral tacrolimus therapy.
    J Dermatol. 2024 Dec 6. doi: 10.1111/1346-8138.17575.
    PubMed    


  583. HAGINO T, Saeki H, Fujimoto E, Kanda N, et al
    Bimekizumab for the treatment of genital, scalp, and nail psoriasis: A 52-week real-world study.
    J Dermatol. 2024 Dec 2. doi: 10.1111/1346-8138.17569.
    PubMed    


  584. PATHAK GN, Agarwal P, Wolfe SM, Patel KH, et al
    Pemphigus relapse: Mechanisms, risk factors, and agents associated with disease recurrence.
    J Dermatol. 2024;51:1533-1546.
    PubMed     Abstract available


  585. JALEEL T, Mitchell B, Burge R, Cohee A, et al
    Exploring racial and ethnic disparities in the hidradenitis suppurativa patient disease journey: Results from a real-world study in Europe and the USA.
    J Dermatol. 2024;51:1547-1558.
    PubMed     Abstract available


  586. MATSUO M, Zang X, Miyauchi T, Mizutani Y, et al
    A case of revertant mosaic-like normal-looking spots in a patient with erythroderma with IL36RN and CARD14 heterozygous mutations.
    J Dermatol. 2024;51:1669-1673.
    PubMed     Abstract available


  587. WIEDENMAYER N, Hogrefe K, Mihalceanu S, Winkler JK, et al
    Case report: A novel high-dose intravenous immunoglobulin preparation for the treatment of severe pemphigus vulgaris failing standard therapy.
    J Dermatol. 2024;51:1665-1668.
    PubMed     Abstract available


  588. TANG KY, Zhang HL, Zhang XY, Jin HZ, et al
    Clinical and laboratory features between anti-TIF1gamma dermatomyositis with and without malignancy: 37 case series and a review.
    J Dermatol. 2024;51:1646-1657.
    PubMed     Abstract available


  589. KIMURA A, Makino T, Kitayama S, Mizawa M, et al
    Immunohistopathological analyses of a case of pemphigus vegetans with antibodies against desmoglein 1 and desmocollins 1-3.
    J Dermatol. 2024;51:1711-1715.
    PubMed     Abstract available


  590. KWON O, Wallace M, Messina P, Szende A, et al
    Treatment patterns and healthcare resource utilization among patients with alopecia areata: A real-world chart review in South Korea.
    J Dermatol. 2024;51:1622-1633.
    PubMed     Abstract available


  591. LAN Q, Hua H, Zhou P
    Dystrophic epidermolysis bullosa characterized by mucosal lesions in a Chinese familial case with a novel compound heterozygous mutation of COL7A1.
    J Dermatol. 2024;51:1707-1710.
    PubMed     Abstract available


  592. LAI PT, Tseng HC
    Adopting adalimumab combined surgery in the management of moderate to severe hidradenitis suppurativa: Experience from a single medical center in southern Taiwan.
    J Dermatol. 2024;51:1615-1621.
    PubMed     Abstract available


  593. LI J, Xiao J, Xie X, Deng S, et al
    Individual joints involvement pattern in psoriatic arthritis: A cross-sectional study in China.
    J Dermatol. 2024;51:1607-1614.
    PubMed     Abstract available


  594. CAI L, Yan Y, Li Y, Lin J, et al
    Two cases of eosinophilic pustular folliculitis successfully treated with abrocitinib.
    J Dermatol. 2024;51:1694-1697.
    PubMed     Abstract available


  595. OCHIAI S, Anzawa K, Yamaguchi R, Takamiya Y, et al
    Surface material analysis for human papillomavirus detection in nail Bowen's disease caused by HPV type 58.
    J Dermatol. 2024;51:1690-1693.
    PubMed     Abstract available


    November 2024
  596. FUJISHIGE A, Seko N
    Safety and effectiveness of secukinumab subcutaneous injection in Japanese patients with psoriasis vulgaris and psoriatic arthritis: A post-marketing surveillance.
    J Dermatol. 2024 Nov 29. doi: 10.1111/1346-8138.17499.
    PubMed     Abstract available


  597. LUO W, Yang X, Ren Y, Tao X, et al
    Cutaneous zosteriform endometrial cancer metastasis.
    J Dermatol. 2024 Nov 27. doi: 10.1111/1346-8138.17536.
    PubMed    



  598. Correction to "Automatic evaluation of nail psoriasis severity index using deep learning algorithm".
    J Dermatol. 2024 Nov 26. doi: 10.1111/1346-8138.17556.
    PubMed    


  599. LIU SW, Wu SE, Chen YH, Soong CY, et al
    Educational video assistance in shared decision-making for psoriasis: Effectiveness and outcomes.
    J Dermatol. 2024 Nov 25. doi: 10.1111/1346-8138.17550.
    PubMed     Abstract available


  600. ALHASSAN E, Christianakis S, DeClerck B, Crew AB, et al
    Cutaneous lupus erythematosus following immunoglobulin therapy in dermatomyositis.
    J Dermatol. 2024 Nov 25. doi: 10.1111/1346-8138.17553.
    PubMed    


  601. SAKAI H, Minami-Hori M, Kuwahara S
    Malignancies in patients with psoriasis during and after biological therapy: A single-center experience.
    J Dermatol. 2024 Nov 16. doi: 10.1111/1346-8138.17554.
    PubMed     Abstract available


  602. ADACHI T, Matsui T, Okata-Karigane U, Takahashi C, et al
    Delayed and immediate cutaneous adverse events during pembrolizumab combination chemotherapy against cervical cancer: Case series.
    J Dermatol. 2024 Nov 11. doi: 10.1111/1346-8138.17521.
    PubMed     Abstract available


  603. TSAI TF, Tada Y, Kung C, Zhong Y, et al
    Indirect comparison of deucravacitinib and other systemic treatments for moderate to severe plaque psoriasis in Asian populations: A systematic literature review and network meta-analysis.
    J Dermatol. 2024 Nov 11. doi: 10.1111/1346-8138.17448.
    PubMed     Abstract available


  604. SAKIYAMA T, Miyake T, Furuta K, Kabashima K, et al
    A case of toxic epidermal necrolysis with hand-foot syndrome-like rash following tirabrutinib treatment.
    J Dermatol. 2024 Nov 11. doi: 10.1111/1346-8138.17541.
    PubMed    


  605. HAGINO T, Saeki H, Fujimoto E, Kanda N, et al
    Effectiveness of long-term bimekizumab treatment and predictive factors for responders in moderate-to-severe psoriasis: A 52-week real-world study.
    J Dermatol. 2024 Nov 5. doi: 10.1111/1346-8138.17532.
    PubMed     Abstract available


  606. KATSUMI T, Hayashi R, Takei S, Ansai O, et al
    Reevaluating hybrid neurofibroma/schwannoma: Predominance of schwannoma features despite CD34 positivity and initial neurofibroma diagnosis.
    J Dermatol. 2024;51:1461-1469.
    PubMed     Abstract available


  607. SATOH T, Murota H, Aoyama Y, Hashimoto T, et al
    Prurigo chronica multiformis: Expert consensus of the Japanese Dermatological Association.
    J Dermatol. 2024;51:e376-e383.
    PubMed     Abstract available


  608. MORITA A, Okubo Y, Imafuku S, Terui T, et al
    Spesolimab, the first-in-class anti-IL-36R antibody: From bench to clinic.
    J Dermatol. 2024;51:1379-1391.
    PubMed     Abstract available


  609. MESINKOVSKA N, King B, Zhang X, Guttman-Yassky E, et al
    Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis.
    J Dermatol. 2024;51:1414-1424.
    PubMed     Abstract available


  610. OTA M, Nobeyama Y, Asahina A
    Clinical course of psoriatic arthritis treated with biologics delineated with ultrasonography.
    J Dermatol. 2024;51:1476-1480.
    PubMed     Abstract available


  611. TSUNEMI Y, Otsuka A, Nonaka Y
    Patient-physician perception gaps in setting treatment goals and communication including shared decision making: Results from the survey illuminating dialogues and insights in onychomycosis management (IDIOM survey).
    J Dermatol. 2024;51:1441-1453.
    PubMed     Abstract available


    October 2024
  612. MUKAIYAMA R, Yamamoto T
    Hematologic diseases in patients with cutaneous sarcoidosis.
    J Dermatol. 2024 Oct 28. doi: 10.1111/1346-8138.17525.
    PubMed    


  613. MAEDA S, Imazaki K, Shimizu K, Oishi K, et al
    BRAF/MEK inhibitor-induced tumor lysis syndrome in a patient with malignant melanoma.
    J Dermatol. 2024 Oct 22. doi: 10.1111/1346-8138.17507.
    PubMed    


  614. HUYNH TN, Yamazaki F, Konrad RJ, Nishikawa Y, et al
    Circulating CD31 and resistin levels reflect different stages of coronary atherosclerosis in patients with psoriasis.
    J Dermatol. 2024 Oct 22. doi: 10.1111/1346-8138.17450.
    PubMed     Abstract available


  615. CETINARSLAN T, Aydogdu I, Ermertcan AT
    Oral administration of ruxolitinib in psoriasis vulgaris: A case report of plaque psoriasis accompanied by myelofibrosis secondary to polisitemia vera successfully treated with oral ruxolitinib.
    J Dermatol. 2024 Oct 20. doi: 10.1111/1346-8138.17510.
    PubMed     Abstract available


  616. CHOON SE, Foley PA, Asawanonda P, Fujita H, et al
    Asia-Pacific consensus recommendations on the management of generalized pustular psoriasis.
    J Dermatol. 2024 Oct 10. doi: 10.1111/1346-8138.17471.
    PubMed     Abstract available


  617. CHEN Y, Geng J, Xiao Y, Zhou X, et al
    A case of peeling skin syndrome type 1 with novel CDSN gene variation successfully treated with upadacitinib.
    J Dermatol. 2024 Oct 8. doi: 10.1111/1346-8138.17489.
    PubMed     Abstract available


  618. WANG B, Yang J, Wang Y, Liang FM, et al
    Clinical and genetic insights into ABCA12 variants in three Chinese families with ichthyosis: Genotype-phenotype correlation.
    J Dermatol. 2024 Oct 3. doi: 10.1111/1346-8138.17484.
    PubMed     Abstract available


  619. OKAMURA K, Saito T, Arai Y, Suto H, et al
    Effective management of coexisting bullous pemphigoid and psoriasis with bimekizumab.
    J Dermatol. 2024 Oct 3. doi: 10.1111/1346-8138.17490.
    PubMed    


  620. UESUGI-UCHIDA S, Fujimoto M, Asano Y, Endo H, et al
    Predictors of clinical features in early-onset severe systemic sclerosis: An analysis from a multicenter prospective observational Japanese cohort.
    J Dermatol. 2024;51:1290-1297.
    PubMed     Abstract available


  621. FUKAURA R, Koizumi H, Akashi N, Imai S, et al
    Buruli ulcer with satellite lesions: A case report from Japan.
    J Dermatol. 2024;51:e360-e362.
    PubMed    


  622. HISADA S, Takeuchi S, Tozawa T, Yamada Y, et al
    Cross-sectional study using the University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Tract Instrument 2.0 (UCLA SCTC GIT 2.0) for gastrointestinal disorders of systemic sclerosis.
    J Dermatol. 2024;51:1329-1334.
    PubMed     Abstract available


  623. WANG R, Li R, Wang M
    Unexpected B lymphocytes depletion in a patient with pemphigus vulgaris after a single dose of 50 mg rituximab.
    J Dermatol. 2024;51:e365-e366.
    PubMed    


  624. FUKUYAMA K, Yaguchi T
    Longitudinal melanonychia caused by Cladophialophora boppii: Dermoscopic findings prompting the suspicion of fungal melanonychia.
    J Dermatol. 2024;51:e356-e357.
    PubMed    


  625. ZHENG J
    Regarding the risk factors of rituximab-induced thrombocytopenia in patients with autoimmune bullous diseases.
    J Dermatol. 2024;51:e349.
    PubMed    


  626. KUSANO M, Ohashi T, Hiraiwa T, Hashimoto T, et al
    Scarring alopecia and nail loss in a patient with epidermolysis bullosa acquisita.
    J Dermatol. 2024;51:e333-e334.
    PubMed    


  627. BAI J, Wang S, Chen X, Fang H, et al
    Secukinumab treatment for inflammatory linear verrucous epidermal nevus.
    J Dermatol. 2024;51:e344-e345.
    PubMed    


  628. IRIE K, Takada M, Yamamoto T
    Guselkumab-induced paradoxical exacerbation of extra-palmoplantar lesions in a patient with palmoplantar pustulosis.
    J Dermatol. 2024;51:e342-e343.
    PubMed    


  629. HAMADA R, Funasaka Y, Saeki H, Serizawa N, et al
    Author reply to the letter regarding 'Dietary habits in adult Japanese patients with vitiligo'.
    J Dermatol. 2024;51:e370-e371.
    PubMed    


  630. ISHIDA H, Noriki S
    A study of 25 cases tested with the dermatophyte test strip after oral foslavuconazole treatment for tinea unguium.
    J Dermatol. 2024;51:e331-e332.
    PubMed    


  631. BAO HY, Wu XG
    Regarding the dietary habits in adult Japanese patients with vitiligo.
    J Dermatol. 2024;51:e369.
    PubMed    


  632. SUMIOKI A, Saito K, Nishida H, Nishizono A, et al
    Intractable Nocardial mycetoma with possible colonisation by Candida species.
    J Dermatol. 2024;51:1364-1367.
    PubMed     Abstract available


  633. CHO R, Nakajima S, Kaku Y, Tezuka J, et al
    Proteasome inhibitor-associated histiocytoid Sweet's syndrome: Clinical and histological similarities to Nakajo-Nishimura syndrome suggest a potential mechanism.
    J Dermatol. 2024;51:1355-1359.
    PubMed     Abstract available


  634. OBARA K, Amoh Y
    A case of AA amyloidosis complicated by proliferating pilomatricoma and a review of the literature.
    J Dermatol. 2024;51:1360-1363.
    PubMed     Abstract available


  635. LUO X, Ruan Z, Liu L
    Causal relationship between metabolic syndrome and hidradenitis suppurativa: A two-sample bidirectional Mendelian randomization study.
    J Dermatol. 2024;51:1335-1349.
    PubMed     Abstract available


  636. MINAKAWA S, Matsuzaki Y, Higashino T, Yamada N, et al
    A case of Hailey-Hailey disease with novel ATP2C1 gene variant (c.G925C) showing unusual phenotype.
    J Dermatol. 2024;51:e346-e348.
    PubMed    


  637. JIN S, Yue C, Wang S, Wang P, et al
    Oral abrocitinib in the treatment of refractory dissecting cellulitis of the scalp: A case report.
    J Dermatol. 2024;51:e329-e330.
    PubMed    


    September 2024
  638. YAMAMOTO J, Kambayashi Y, Kuroki S, Asano Y, et al
    Segmental lichen aureus: A case report of zosteriform distribution and severe pain with literature review.
    J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17486.
    PubMed    


  639. SUZUKI S, Hama N, Suzuki R, Yuki A, et al
    Two cases of lichen planus pigmentosus inversus improved by topical tacrolimus application and the avoidance of tight clothing.
    J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17485.
    PubMed    


  640. YAMAMOTO R, Kokubu H, Ikuno Y, Kato M, et al
    Anti-transcription intermediate factor 1-gamma antibody-positive dermatomyositis with refractory skin ulcers and rapid cancer progression.
    J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17482.
    PubMed    


  641. ZHENG B, Zhang Z, Zhou X, Li M, et al
    A mutation in the SREBF1 gene resulting in autosomal-dominant ichthyosis Follicularis, Atrichia, and photophobia syndrome.
    J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17474.
    PubMed    


  642. TSUKAMOTO T, Iwata Y, Ohmiya N, Sugiura K, et al
    A case of familial Mediterranean fever complicated by IgA vasculitis and psoriasis vulgaris.
    J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17470.
    PubMed    


  643. MORIMOTO K, Iwamoto Y, Kanazawa A, Okiyama N, et al
    Simultaneous skin infection of Mycobacterium chelonae and Nocardia thailandica.
    J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17478.
    PubMed    


  644. KAN Y, Horimoto K, Uhara H
    Successful treatment of nail psoriasis by switching to a TYK2 inhibitor after cyclosporine.
    J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17469.
    PubMed    


  645. ITAMOTO S, Miyazawa H, Natsuga K, Yamaga M, et al
    Association between nail psoriasis and obesity: A cross-sectional study at a single institution.
    J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17481.
    PubMed    


  646. YOUN SW, Jo SJ, Park CJ, Kim DH, et al
    Bimekizumab efficacy and safety in Korean patients with moderate to severe plaque psoriasis: A phase 3, randomized, placebo-controlled, double-blinded study.
    J Dermatol. 2024 Sep 27. doi: 10.1111/1346-8138.17446.
    PubMed     Abstract available


  647. KITAYAMA S, Takemoto K, Matsui Y, Makino T, et al
    Remission of intercellular IgG/IgA dermatosis after treatment for cervical cancer.
    J Dermatol. 2024 Sep 24. doi: 10.1111/1346-8138.17473.
    PubMed    


  648. OGAWA Y, Maejima E, Takeichi T, Okamoto T, et al
    Generalized pustular psoriasis patient with a heterozygous hypomorphic MPO variant refractory to intravenous spesolimab.
    J Dermatol. 2024 Sep 20. doi: 10.1111/1346-8138.17464.
    PubMed     Abstract available


  649. FUKUDA A, Ogata D, Oshima Y, Nakano E, et al
    Grade 3 acute kidney injury caused anti-glomerular basement membrane nephritis during immune checkpoint inhibitor treatment for melanoma.
    J Dermatol. 2024 Sep 13. doi: 10.1111/1346-8138.17460.
    PubMed    


  650. KOYAMA A, Li L, Yamamoto T, Taira H, et al
    Psoriasis treatment and biologic switching: The association with clinical characteristics and laboratory biomarkers over a 13-year retrospective study.
    J Dermatol. 2024 Sep 13. doi: 10.1111/1346-8138.17465.
    PubMed     Abstract available


  651. IGARASHI A, Tsuji G, Fukasawa S, Murata R, et al
    Tapinarof cream for the treatment of atopic dermatitis: Efficacy and safety results from two Japanese phase 3 trials.
    J Dermatol. 2024 Sep 13. doi: 10.1111/1346-8138.17451.
    PubMed     Abstract available


  652. HORISAKI K, Yoshikawa S, Omata W, Tsutsumida A, et al
    Comparison of efficacy between anti-PD-1 antibody monotherapy and nivolumab plus ipilimumab therapy as first-line immunotherapy for advanced mucosal melanoma in Japanese patients: A single-center, retrospective cohort study.
    J Dermatol. 2024 Sep 13. doi: 10.1111/1346-8138.17445.
    PubMed     Abstract available


  653. LUO Z, Lyu Y, Dong W, Mei Z, et al
    Coexistence of Basan syndrome and cutaneous basal cell carcinoma: Genetic and clinical perspectives.
    J Dermatol. 2024 Sep 10. doi: 10.1111/1346-8138.17443.
    PubMed    


  654. SATO T, Nakazono M, Ohyachi K, Okaniwa A, et al
    HPV 51-associated inguinal SCC on an atopic dermatitis patient treated with cyclosporine.
    J Dermatol. 2024 Sep 10. doi: 10.1111/1346-8138.17454.
    PubMed    


  655. OKUSE M, Soekawa M, Itakura A, Kawamura T, et al
    Perspectives of Japanese patients on psoriatic disease burden: Results from "Psoriasis and Beyond," the Global Psoriatic Disease Survey.
    J Dermatol. 2024 Sep 10. doi: 10.1111/1346-8138.17424.
    PubMed     Abstract available


  656. KATO H, Kano S, Yoshimitsu M, Nakagawa Y, et al
    Comparative analysis of one-step and two-step full thickness skin grafting and secondary intention healing for skin defects after surgical management of plantar malignant melanoma.
    J Dermatol. 2024 Sep 4. doi: 10.1111/1346-8138.17398.
    PubMed     Abstract available


  657. KAWANO N, Nakashima C, Otsuka A
    A case of eczematous paradoxical reactions on the extremities during tildrakizumab treatment for plaque psoriasis.
    J Dermatol. 2024 Sep 4. doi: 10.1111/1346-8138.17441.
    PubMed    


  658. MORITA A, Okubo Y, Imafuku S, Tada Y, et al
    Expert consensus on systemic therapy for plaque psoriasis with limited skin involvement in JAPAN: Results from a DELPHI study.
    J Dermatol. 2024 Sep 4. doi: 10.1111/1346-8138.17444.
    PubMed     Abstract available


  659. NOBEYAMA Y
    Rosacea in East Asian populations: Clinical manifestations and pathophysiological perspectives for accurate diagnosis.
    J Dermatol. 2024;51:1143-1156.
    PubMed     Abstract available


  660. MIYACHI H, Sato D, Sakamaki K, Togawa Y, et al
    Impact of new antifungal medications on onychomycosis prescriptions and costs in Japan: A nationwide claims database study.
    J Dermatol. 2024;51:1172-1179.
    PubMed     Abstract available


  661. KITANO T, Koiwai T, Fujikawa K, Mori S, et al
    Ozenoxacin suppresses sebum production by inhibiting mTORC1 activation in differentiated hamster sebocytes.
    J Dermatol. 2024;51:1187-1198.
    PubMed     Abstract available


  662. TORCHIA D
    Mosaic KRAS mutations cause an atypical variant of phacomatosis spilosebacea.
    J Dermatol. 2024;51:1262-1263.
    PubMed    


  663. KATO J, Hida T, Idogawa M, Tokino T, et al
    Genomic profiles of Merkel cell carcinoma in Japan.
    J Dermatol. 2024;51:1259-1261.
    PubMed    


  664. HAMMADI AA, Parmar NV, Farghaly M, Dallal SA, et al
    A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database.
    J Dermatol. 2024;51:1157-1171.
    PubMed     Abstract available


  665. HIGUCHI S, Noguchi H, Matsumoto T, Nojo H, et al
    Terbinafine-resistant tinea pedis and tinea unguium in Japanese military personnel.
    J Dermatol. 2024;51:1256-1258.
    PubMed    


  666. FU S, Lu H, Song XZ
    Multiple lupus vulgaris.
    J Dermatol. 2024;51:e289-e290.
    PubMed    


  667. KUZUMI A, Yoshizaki A, Matsuda K, Nagai K, et al
    Coexistence of systemic sclerosis and cryopyrin-associated periodic syndrome.
    J Dermatol. 2024;51:1240-1244.
    PubMed     Abstract available


  668. MUTO Y, Fujimura T, Takahashi A, Namikawa K, et al
    Analysis of surgical margins and prognostic factors in dermatofibrosarcoma protuberans after wide local excision: A multicenter study of 116 Japanese patients.
    J Dermatol. 2024;51:1225-1232.
    PubMed     Abstract available


  669. WATANABE T, Watanabe Y, Asai C, Asami M, et al
    Retrospective study of the clinical significance of the neutrophil-to-lymphocyte ratio in 79 patients with palmoplantar pustulosis.
    J Dermatol. 2024;51:1208-1215.
    PubMed     Abstract available


  670. YASUNAGA S, Oya K, Ishii Y, Anju K, et al
    Milia-like appearance of vulvar syringoma.
    J Dermatol. 2024;51:e308-e309.
    PubMed    


  671. OYA K, Ishii Y, Takeyama S, Homma Y, et al
    COVID-19-associated pemphigus foliaceus exacerbated by toll-like receptor 7 agonist.
    J Dermatol. 2024;51:e304-e305.
    PubMed    


  672. KAMIGA M, Hayashi S, Ikegami T, Tokoro S, et al
    Hereditary angioedema with a normal C1 inhibitor in Japanese man.
    J Dermatol. 2024;51:e298-e299.
    PubMed    


  673. SAKIYAMA T, Nakamizo S, Kabashima K
    Comparative analysis of CAII and GCDFP-15 expression in sweat glands unveiling the pathophysiology of acquired idiopathic generalized anhidrosis.
    J Dermatol. 2024;51:e310-e311.
    PubMed    


  674. SONG D, Yi Q, Zhuang K, Yang L, et al
    Unilateral heliotrope rash: A call for recognizing its warning significance in anti-MDA5 antibody-associated dermatomyositis.
    J Dermatol. 2024;51:e319-e320.
    PubMed    


  675. MOLTRASIO C, Tricarico PM, Ronald MR, Lucas B, et al
    Genetic mutations in pyoderma gangrenosum, hidradenitis suppurativa, and associated autoinflammatory syndromes: Insights into pathogenic mechanisms and shared pathways.
    J Dermatol. 2024;51:e324-e325.
    PubMed    


  676. KUROKAMI Y, Yamashita C, Yokoi K, Tonomura K, et al
    A rare case of metastatic extramammary Paget disease developing transfusion-related acute lung injury during chemotherapy.
    J Dermatol. 2024;51:e312-e313.
    PubMed    


  677. TAKAYAMA E, Yoshioka A
    Herpes simplex virus infection with a marginal Nikolsky sign in an immunocompromised patient.
    J Dermatol. 2024;51:e314-e315.
    PubMed    


  678. MASUYUKI R, Sato E, Imafuku S
    A case of bullous pemphigoid following administration of anti-IL-31 receptor A antibody.
    J Dermatol. 2024;51:1252-1255.
    PubMed     Abstract available


    August 2024
  679. BERGMANN MS, Loft N, Schwarz CW, Kaur-Knudsen D, et al
    HLA-C*06:02 in Danish patients with psoriasis and response to biological treatment.
    J Dermatol. 2024 Aug 27. doi: 10.1111/1346-8138.17415.
    PubMed     Abstract available


  680. KONDO M, Goto D, Habe K, Yamazoe N, et al
    Changes in skin bacterial flora during the healing process of ulcer caused by self-destruction of lymph nodes due to tuberculous lymphadenitis.
    J Dermatol. 2024 Aug 19. doi: 10.1111/1346-8138.17433.
    PubMed     Abstract available


  681. HAMADA M, Hida T, Idogawa M, Tange S, et al
    Mosaic SUFU mutation associated with a mild phenotype of multiple hereditary infundibulocystic basal cell carcinoma syndrome.
    J Dermatol. 2024 Aug 19. doi: 10.1111/1346-8138.17434.
    PubMed     Abstract available


  682. HSIEH DM, Shang P, Gao Y, Zhao J, et al
    Successful treatment with spesolimab for generalized pustular psoriasis in an elderly patient with TRPM4 mutation.
    J Dermatol. 2024 Aug 19. doi: 10.1111/1346-8138.17431.
    PubMed    


  683. SAITO H, Omatsu J, Takasaki Y, Osuji Y, et al
    Perianal cutaneous malakoplakia in a patient with anti-MDA5 dermatomyositis.
    J Dermatol. 2024 Aug 19. doi: 10.1111/1346-8138.17430.
    PubMed    


  684. IGARASHI A, Tsuji G, Fukasawa S, Murata R, et al
    Tapinarof cream for the treatment of plaque psoriasis: Efficacy and safety results from 2 Japanese phase 3 trials.
    J Dermatol. 2024 Aug 16. doi: 10.1111/1346-8138.17423.
    PubMed     Abstract available


  685. HIGASHINO T, Konomi M, Kubo A, Horinosono H, et al
    Coincidence of acral peeling skin syndrome and Nagashima-type palmoplantar keratosis in a Japanese pedigree with acral skin peeling.
    J Dermatol. 2024 Aug 12. doi: 10.1111/1346-8138.17422.
    PubMed     Abstract available


  686. HAGINO T, Onda M, Saeki H, Fujimoto E, et al
    Effectiveness of bimekizumab for genital, nail, and scalp lesions with psoriasis: A 24-week real-world study.
    J Dermatol. 2024 Aug 12. doi: 10.1111/1346-8138.17427.
    PubMed     Abstract available


  687. MATSUO M, Niwa H, Iwata H
    A case of metastasis of giant basal cell carcinoma in oculocutaneous albinism.
    J Dermatol. 2024 Aug 12. doi: 10.1111/1346-8138.17425.
    PubMed    


  688. TAKAHASHI H, Morimoto H, Sugimura Y, Honda T, et al
    Primary localized cutaneous nodular amyloidosis of the scalp arising from folliculitis decalvans.
    J Dermatol. 2024 Aug 10. doi: 10.1111/1346-8138.17418.
    PubMed    


  689. MINAKAWA F, Yamamoto T, Aoyama Y
    Simultaneous distinct cutaneous fungal infections with chromoblastomycosis due to Exophiala xenobiotica and hyalohyphomycosis due to Scedosporium apiospermum in a patient with severe cellular immunodeficiency.
    J Dermatol. 2024 Aug 5. doi: 10.1111/1346-8138.17412.
    PubMed     Abstract available


  690. NODA T, Takeichi T, Tanahashi K, Muro Y, et al
    A case of pachyonychia congenita with a hotspot variant at Arg127 in KRT16: Disease severity assessment using AlphaMissense technology.
    J Dermatol. 2024;51:1134-1136.
    PubMed    


  691. KLUIJVER LG, Wensink D, Wagenmakers MAEM, Huidekoper HH, et al
    Quality of life in children with erythropoietic protoporphyria: a case-control study.
    J Dermatol. 2024;51:1068-1078.
    PubMed     Abstract available


  692. MATSUDA Y, Miyake T, Toda H, Tachibana K, et al
    The treatment effect of endovascular therapy for chronic limb-threatening ischemia with systemic sclerosis.
    J Dermatol. 2024;51:1108-1112.
    PubMed     Abstract available


  693. SHIN SH, Kim JY, Kim SC, Kim JH, et al
    Comparative study of efficacy and safety: Biosimilar rituximab versus originator rituximab in the treatment of pemphigus.
    J Dermatol. 2024;51:1104-1107.
    PubMed     Abstract available


  694. OKUBO A, Hanada M, Kodama S, Taniguchi N, et al
    Long-term follow-up study of the efficacy of fosravuconazole in the treatment of onychomycosis in elderly patients.
    J Dermatol. 2024;51:1091-1097.
    PubMed     Abstract available


  695. INOUE T, Watabe D, Furukawa M, Goto M, et al
    Prevalence and risk factors for onychomycosis in acute care dermatology wards.
    J Dermatol. 2024;51:1079-1082.
    PubMed     Abstract available


  696. NARUSE S, Takashima S, Fujita Y, Kataoka H, et al
    Successful treatment of multicentric Castleman's disease associated with dystrophic epidermolysis bullosa using anti-interleukin-6 receptor antibody.
    J Dermatol. 2024;51:e268-e269.
    PubMed    


  697. LEE KH, Jeong JH, Park CJ, Kim YS, et al
    Resolution of extensive plantar verruca vulgaris but not facial verruca plana following nonavalent human papillomavirus vaccine: A case report and literature review.
    J Dermatol. 2024;51:e279-e281.
    PubMed    


  698. FUKAURA R, Takeichi T, Noda T, Seishima M, et al
    A novel splicing CYLD variant associated with trichoepithelioma papulosum multiplex demonstrating intrafamilial severity variability.
    J Dermatol. 2024;51:e274-e276.
    PubMed    


  699. YANO D, Ohsawa I, Suga Y, Mitsuishi T, et al
    Unusual clinical presentation of extragenital condyloma acuminatum.
    J Dermatol. 2024;51:e277-e278.
    PubMed    


  700. IKUMI N, Fujita H
    Long-term control of spondylitis by short-term ixekizumab treatment in a patient with palmoplantar pustulosis.
    J Dermatol. 2024;51:e255-e256.
    PubMed    


  701. NORIMATSU Y, Saku A, Kawashima H, Minagawa T, et al
    Polyarteritis nodosa with splenic rupture and multiple cerebral infarctions.
    J Dermatol. 2024;51:e259-e260.
    PubMed    


  702. MATSUZAKI E, Kajihara I, Tomiguchi M, Kimura T, et al
    Effectiveness of trabectedin for radiation-induced angiosarcoma of the breast refractory to several anticancer drugs.
    J Dermatol. 2024;51:e257-e258.
    PubMed    


  703. MISAKI M, Takeichi T, Omi M, Ito Y, et al
    Localized epidermolysis bullosa simplex caused by a previously unreported substitution in the linker 12 domain of keratin 14.
    J Dermatol. 2024;51:e264-e265.
    PubMed    


  704. YANG XS, Wang TT, Ding YX, Chen YH, et al
    Concentrated growth factor therapy as cosmetic treatment in discoid lupus erythematosus.
    J Dermatol. 2024;51:1125-1128.
    PubMed     Abstract available


  705. HUA H, Li M, Zhai X, Zhou S, et al
    Sleep quality correlates with effectiveness of ultrapulse fractional CO(2) laser in the treatment of facial atrophic acne scars.
    J Dermatol. 2024;51:1120-1124.
    PubMed     Abstract available


  706. ZHAO A, Wang Y, Jia N, Lu F, et al
    Mosaic GJB2 mutations in widespread porokeratotic adnexal ostial nevus: Report of two patients.
    J Dermatol. 2024;51:1129-1133.
    PubMed     Abstract available


  707. GUO Z, Guo M, Gui G, Liu Y, et al
    Emergence of verrucous psoriasis post-secukinumab therapy.
    J Dermatol. 2024 Aug 1. doi: 10.1111/1346-8138.17402.
    PubMed    


    July 2024
  708. IM D, Ueda K, Niwa H, Tanaka K, et al
    A case of bullous pemphigoid associated with psoriasis showing no tissue-bound immunoglobulin G on the inflamed skin.
    J Dermatol. 2024 Jul 29. doi: 10.1111/1346-8138.17408.
    PubMed    


  709. VAN DER VELDEN JJAJ, van Gisbergen MW, Kamps MAF, Janssen R, et al
    Variants in the L12 linker domain of KRT10 are causal to atypical epidermolytic ichthyosis.
    J Dermatol. 2024 Jul 29. doi: 10.1111/1346-8138.17395.
    PubMed     Abstract available


  710. BUENO-MOLINA RC, Hernandez-Rodriguez JC, Zulueta-Dorado T, Pereyra-Rodriguez JJ, et al
    Pyrin-associated autoinflammation with neutrophilic dermatosis: A case report.
    J Dermatol. 2024 Jul 28. doi: 10.1111/1346-8138.17390.
    PubMed     Abstract available


  711. ZUO Y, Zhang Y, Qu Z, Wang B, et al
    Defactinib inhibits FAK phosphorylation and regulates psoriasis via attenuating hyperproliferation of keratinocytes.
    J Dermatol. 2024 Jul 25. doi: 10.1111/1346-8138.17366.
    PubMed     Abstract available


  712. OKAZAKI T, Takahashi T, Asano Y
    Pancreatitis, panniculitis, and polyarthritis (PPP) syndrome associated with acute-on-chronic pancreatitis: A case report.
    J Dermatol. 2024 Jul 25. doi: 10.1111/1346-8138.17406.
    PubMed    


  713. CHEN J, Luo Y, Duan Y, Wang L, et al
    A double-blind pilot study of oral baricitinib in adult patients with lupus erythematosus panniculitis.
    J Dermatol. 2024 Jul 19. doi: 10.1111/1346-8138.17354.
    PubMed     Abstract available


  714. OHATA C, Anezaki H, Yanase T, Katayama E, et al
    Real-world safety and efficacy of biologics in elderly patients with psoriasis: A multicenter observational study.
    J Dermatol. 2024 Jul 19. doi: 10.1111/1346-8138.17385.
    PubMed     Abstract available


  715. WINKLER M, Albrecht JD, Sauer C, Kordass T, et al
    Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type: A case series and review of the literature.
    J Dermatol. 2024 Jul 19. doi: 10.1111/1346-8138.17339.
    PubMed     Abstract available


  716. MIURA G, Watanabe M, Kosumi H, Nohara T, et al
    Blaschkoid granulomatous pigmented purpuric dermatosis in childhood.
    J Dermatol. 2024 Jul 17. doi: 10.1111/1346-8138.17379.
    PubMed    


  717. SEKI T, Makino T, Hayashi M, Kitayama S, et al
    Repigmentation from the epidermis around the acrosyringium in vitiligo universalis.
    J Dermatol. 2024 Jul 15. doi: 10.1111/1346-8138.17388.
    PubMed    


  718. WAKI Y, Nobeyama Y, Nakagawa H, Asahina A, et al
    Author reply to does dermatophytosis of the feet cause acral melanoma?
    J Dermatol. 2024 Jul 12. doi: 10.1111/1346-8138.17377.
    PubMed    



  719. Correction to "Cutaneous adverse events following COVID-19 vaccination: A case series of 30 Japanese patients and a review of 93 Japanese studies".
    J Dermatol. 2024 Jul 8. doi: 10.1111/1346-8138.17362.
    PubMed    


  720. AL-BUSANI H, Namiki T, Yokoyama K, Miura K, et al
    A combination of PET-CT and thallium-201 scintigraphy has a diagnostic potential in detecting systemic sarcoidosis in a patient with malignant melanoma.
    J Dermatol. 2024 Jul 4. doi: 10.1111/1346-8138.17372.
    PubMed    


  721. INOZUME T, Fukushima S, Fukuda T, Harada K, et al
    Does dermatophytosis of the feet cause acral melanoma?
    J Dermatol. 2024 Jul 4. doi: 10.1111/1346-8138.17378.
    PubMed    


  722. KWAN YH, Oh CC
    Brown pigmentation on skin post intravenous ferric carboxymaltose.
    J Dermatol. 2024 Jul 4. doi: 10.1111/1346-8138.17376.
    PubMed    


  723. JINSHAN Z, Yong Q, Fangqi C, Juanmei C, et al
    The role of TNF-alpha as a potential marker for acute cutaneous lupus erythematosus in patients with systemic lupus erythematosus.
    J Dermatol. 2024 Jul 4. doi: 10.1111/1346-8138.17355.
    PubMed     Abstract available


  724. ARRIETA VINAIXA A, Alonso Usero V, Moro R
    Extensive cornified Darier's disease: A rare presentation.
    J Dermatol. 2024;51:e225-e226.
    PubMed    


  725. OHTSUKI M, Okubo Y, Saeki H, Igarashi A, et al
    Safety and effectiveness of apremilast in Japanese patients with psoriatic disease: Results of a post-marketing surveillance study.
    J Dermatol. 2024;51:950-963.
    PubMed     Abstract available


  726. RAN X, Ran Y
    The horizontal and vertical pathological perspectives of black dot ringworm hair.
    J Dermatol. 2024;51:e223-e224.
    PubMed    


  727. RIINA L, Jari J, Laura H, Suvi-Paivikki S, et al
    Erythema nodosum in northern Finland between 1996 and 2019: A register-based study.
    J Dermatol. 2024;51:1017-1021.
    PubMed     Abstract available


  728. YOKOI S, Iwata Y, Sugiura K
    A retrospective clinicopathological study of erythema nodosum.
    J Dermatol. 2024;51:985-990.
    PubMed     Abstract available


  729. KIKUCHI N, Yamamoto T
    Serum cytokine profiles in a case of post-cesarean pyoderma gangrenosum.
    J Dermatol. 2024;51:e245-e246.
    PubMed    


  730. NIIMURA Y, Kamata M, Ishikawa T, Nagata M, et al
    308-nm excimer light is effective for palmoplantar pustulosis regardless of the presence or absence of focal infection: Single-center real-world experience of treatment for palmoplantar pustulosis.
    J Dermatol. 2024;51:977-984.
    PubMed     Abstract available


  731. NAKA W, Tsunemi Y
    Effects of additional oral fosravuconazole l-lysine ethanolate therapy following inadequate response to initial treatment for onychomycosis: A multicenter, randomized controlled trial.
    J Dermatol. 2024;51:964-972.
    PubMed     Abstract available


  732. BAX C, Aghdasi C, Fiorentino D
    Novel therapeutic targets in dermatomyositis.
    J Dermatol. 2024;51:920-926.
    PubMed     Abstract available


  733. OKAZAKI T, Takahashi T, Asano Y
    Eosinophilic annular erythema successfully treated with dupilumab: A case report.
    J Dermatol. 2024;51:e249-e250.
    PubMed    


  734. FUKASAWA T, Yoshizaki-Ogawa A, Sato S, Yoshizaki A, et al
    The role of B cells in systemic sclerosis.
    J Dermatol. 2024;51:904-913.
    PubMed     Abstract available


  735. KOGA H, Teye K, Hamada T, Katsumi T, et al
    A case of intermediate recessive dystrophic epidermolysis bullosa with a novel COL7A1 mutation.
    J Dermatol. 2024;51:e231-e232.
    PubMed    


  736. MATSUMOTO C, Terada N, Harada Y, Takahashi M, et al
    Intractable pemphigus foliaceus after COVID-19 mRNA vaccination.
    J Dermatol. 2024;51:e233-e234.
    PubMed    


  737. ZHANG X, Xiao Y, Li X, Wang J, et al
    Ofatumumab subcutaneous injection successfully treated patients with pemphigus vulgaris relapse post rituximab.
    J Dermatol. 2024;51:1026-1030.
    PubMed     Abstract available


  738. LIU Y, Chen L, Xie Y, Deng S, et al
    A case of Bacille Calmette-Guerin-induced generalized lupus vulgaris in a Mendelian susceptibility to mycobacterial disease patient with a novel STAT1 variant.
    J Dermatol. 2024;51:e229-e230.
    PubMed    


  739. SOMPOCHPRUETIKUL K, Khongcharoensombat T, Chongpison Y, Rittirongwattana W, et al
    Whey protein and male acne: A double-blind, randomized controlled trial.
    J Dermatol. 2024;51:1022-1025.
    PubMed     Abstract available


  740. PIZZICHETTA MA, Corsetti P, Stanganelli I, Ghigliotti G, et al
    More than one shade of pink as a marker of early amelanotic/hypomelanotic melanoma.
    J Dermatol. 2024;51:999-1003.
    PubMed     Abstract available


    June 2024
  741. LIU L, He Y, Hu Q, Sun K, et al
    Vulvar lichen sclerosus in girls and adult females: A single-center retrospective study of 744 patients in China.
    J Dermatol. 2024 Jun 28. doi: 10.1111/1346-8138.17352.
    PubMed     Abstract available


  742. DANCE B, Dardare A, Fleming J, Siow SF, et al
    The impact of cutaneous neurofibromas on quality of life and mental health in neurofibromatosis type 1.
    J Dermatol. 2024 Jun 24. doi: 10.1111/1346-8138.17276.
    PubMed     Abstract available


  743. KIRATIKANON S, Maneenut A, Noppakun N, Kumtornrut C, et al
    Effects of spironolactone on skin biophysical properties in women with acne treated with oral spironolactone.
    J Dermatol. 2024 Jun 19. doi: 10.1111/1346-8138.17333.
    PubMed     Abstract available


  744. FAN H, Yan L, Tan Y, Feng J, et al
    Bevacizumab-associated toxic epidermal necrolysis in a patient with liver cancer.
    J Dermatol. 2024 Jun 19. doi: 10.1111/1346-8138.17285.
    PubMed    


  745. LIN F, Wang Y, Zheng Y, Hong W, et al
    Target area treatment ratio of varied lesions in the cultured pure melanocyte transplantation repigmentation of vitiligo: A retrospective study.
    J Dermatol. 2024 Jun 19. doi: 10.1111/1346-8138.17320.
    PubMed     Abstract available


  746. TSAI YY, Chen YJ, Chang LS, Wu CC, et al
    Skin colonization by Staphylococcus aureus in hemodialysis patients with pruritus and the effect of Staphylococcus aureus-secreted alpha-toxin on filaggrin expression.
    J Dermatol. 2024 Jun 18. doi: 10.1111/1346-8138.17326.
    PubMed     Abstract available


  747. ITO K, Akatsuka T, Morimura S, Hamada T, et al
    Primary cutaneous follicle center lymphoma localized on the back for 22 years.
    J Dermatol. 2024 Jun 18. doi: 10.1111/1346-8138.17345.
    PubMed    


  748. MITSUYAMA S, Higuchi T, Nabekura T, Wakamatsu K, et al
    Improvement of psoriasis vulgaris in a patient with obesity after bariatric and metabolic surgery: A case letter.
    J Dermatol. 2024 Jun 18. doi: 10.1111/1346-8138.17342.
    PubMed    


  749. HA GU, Kim JH, Ha DL, Lee H, et al
    Ultrasonographic evaluation of nail matrix topography for preservative nail surgery of nail unit melanoma.
    J Dermatol. 2024 Jun 14. doi: 10.1111/1346-8138.17340.
    PubMed     Abstract available


  750. SUZUKI S, Kamata M, Ito M, Watanabe A, et al
    Spesolimab improved pustules on the palms and soles that were refractory to tumor necrosis factor inhibitors and interleukin-17 inhibitors in a patient with generalized pustular psoriasis: A case report.
    J Dermatol. 2024 Jun 14. doi: 10.1111/1346-8138.17337.
    PubMed    


  751. HIRAI Y, Sakurai J, Yoshida S, Kikuchi T, et al
    Phase I/II clinical trial of brentuximab vedotin for pretreated Japanese patients with CD30-positive cutaneous T-cell lymphoma.
    J Dermatol. 2024 Jun 14. doi: 10.1111/1346-8138.17324.
    PubMed     Abstract available


  752. KAWAMOTO M, Kawakami Y, Hirai Y, Kubota S, et al
    Disseminated Lomentospora prolificans infection presenting with multiple cutaneous lesions in an immunocompromised host: A case report and literature review.
    J Dermatol. 2024 Jun 12. doi: 10.1111/1346-8138.17322.
    PubMed    


  753. KOMATSU S, Kamiya T, Kato J, Uhara H, et al
    A small melanoma of the finger characterized predominantly by nest proliferation and a parallel furrow pattern.
    J Dermatol. 2024 Jun 11. doi: 10.1111/1346-8138.17332.
    PubMed    


  754. HEERFORDT IM, Framke E, Windfeld-Mathiasen J, Mogensen M, et al
    Reevaluating the role of interferon-beta in psoriasis pathogenesis: A registry-based self-controlled study.
    J Dermatol. 2024 Jun 11. doi: 10.1111/1346-8138.17338.
    PubMed     Abstract available


  755. PAIK K, Kim BR, Youn SW
    Automatic evaluation of Nail Psoriasis Severity Index using deep learning algorithm.
    J Dermatol. 2024 Jun 7. doi: 10.1111/1346-8138.17313.
    PubMed     Abstract available


  756. WATABE D, Amano H
    Development of psoriasis during obinutuzumab treatment in a patient with follicular lymphoma.
    J Dermatol. 2024 Jun 7. doi: 10.1111/1346-8138.17317.
    PubMed    


  757. YAMASHITA T, Shimizuhira C, Hiwa R, Fukuoka M, et al
    A case of generalized pustular psoriasis following discontinuation of apremilast.
    J Dermatol. 2024 Jun 3. doi: 10.1111/1346-8138.17314.
    PubMed    


  758. KUBA-FUYUNO Y, Kido-Nakahara M, Tsuji G, Sakai S, et al
    Proposal of a cutaneous lupus erythematosus-like keratinocyte model in vitro under local conditions using interferon-alpha and Poly I:C and its use in examining the therapeutic effects of tyrosine kinase 2 inhibitor.
    J Dermatol. 2024 Jun 3. doi: 10.1111/1346-8138.17318.
    PubMed    


  759. DA ROSA GP, Vide J, Azevedo F, Mota A, et al
    Skin hyperpigmentation heralding an ectopic adrenocorticotropic hormone production.
    J Dermatol. 2024 Jun 3. doi: 10.1111/1346-8138.17323.
    PubMed    


  760. PARADISI A, Ciobotariu I, Quattrini L, Ricci F, et al
    Linear atrophoderma of Moulin.
    J Dermatol. 2024;51:e183-e184.
    PubMed    


  761. MATSUDA KM, Sugimoto E, Ako Y, Kitamura M, et al
    Reliability, validity, and sensitivity of the Japanese version of the University of California Los Angeles scleroderma clinical trial consortium gastrointestinal tract instrument: Application to efficacy assessment of intravenous immunoglobulin admini
    J Dermatol. 2024;51:741-751.
    PubMed     Abstract available


  762. LIANG S, Fang Y, Zhao Z, Wang B, et al
    Hematological parameters as diagnostic biomarkers for patients with rosacea.
    J Dermatol. 2024;51:791-798.
    PubMed     Abstract available


  763. IWASAKI T, Shimoda-Komatsu Y, Ida Y, Shimoyamada H, et al
    A case of chromomycosis due to Cladosporium halotolerans: Successful identification of previously unreported pathogen with a molecular approach.
    J Dermatol. 2024;51:e220-e222.
    PubMed    


  764. SCHAFER F, Beltran C, Miranda R, Villaseca MA, et al
    Anetoderma: Unusual clinical presentation of granuloma annulare.
    J Dermatol. 2024;51:e209-e210.
    PubMed    


  765. ASAI J, Maruyama A, Katoh N
    Lupus miliaris disseminatus faciei successfully treated with topical adapalene and benzoyl peroxide.
    J Dermatol. 2024;51:e214-e215.
    PubMed    


  766. HIOKI C, Oda Y, Moriwaki S, Fukunaga A, et al
    Effect of lanadelumab on attack frequency and QoL in Japanese patients with hereditary angioedema: Report of five cases.
    J Dermatol. 2024;51:873-877.
    PubMed     Abstract available


  767. WADA S, Nakano E, Nakajima M, Kishikawa S, et al
    Congenital dermatofibrosarcoma protuberans on the scalp enlarging and shrinking repeatedly.
    J Dermatol. 2024;51:e196-e197.
    PubMed    


  768. KOIZUMI S, Doi R, Aitake U, Lei X, et al
    Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane-based regimens.
    J Dermatol. 2024;51:e203-e204.
    PubMed    


  769. NAKATANI K, Noborio R, Nomura Y, Ueki Y, et al
    A case of anti-laminin gamma1 (p200) pemphigoid developed after dipeptidyl peptidase-4 inhibitor administration.
    J Dermatol. 2024;51:869-872.
    PubMed     Abstract available


  770. TAKAHAGI S, Matsuo Y, Kanamoto M, Kawamoto I, et al
    Pemphigus vulgaris relapsed with serological shift from single-positive desmoglein-3 antibodies to single-positive desmoglein-1 antibodies.
    J Dermatol. 2024;51:e198-e200.
    PubMed    


  771. OMI M, Takeichi T, Ito Y, Yoshikawa T, et al
    Two patients with Hailey-Hailey disease with novel pathogenic ATP2C1 variants suggesting possible genotype/phenotype correlations.
    J Dermatol. 2024;51:e185-e187.
    PubMed    


    May 2024
  772. TERAOKA M, Yonekura S, Takegami T, Murata T, et al
    Effective treatment of topical corticosteroid-resistant dermatitis with delgocitinib in a pediatric patient with Netherton syndrome.
    J Dermatol. 2024 May 28. doi: 10.1111/1346-8138.17311.
    PubMed    


  773. TAKESHIMA R, Kamata M, Suzuki S, Ito M, et al
    Interleukin-23 inhibitors decrease Fibrosis-4 index in psoriasis patients with elevated Fibrosis-4 index but not inteleukin-17 inhibitors.
    J Dermatol. 2024 May 28. doi: 10.1111/1346-8138.17277.
    PubMed     Abstract available


  774. SUGIURA S, Yamamoto B, Fujimoto N
    A case of erosive pustular dermatosis of the scalp with ulcerative colitis successfully treated with upadacitinib.
    J Dermatol. 2024 May 28. doi: 10.1111/1346-8138.17282.
    PubMed    


  775. PAPA V, Li Pomi F, Borgia F, Vaccaro M, et al
    Alarmins in cutaneous malignant melanoma: An updated overview of emerging evidence on their pathogenetic, diagnostic, prognostic, and therapeutic role.
    J Dermatol. 2024 May 22. doi: 10.1111/1346-8138.17278.
    PubMed     Abstract available


  776. AKATSUKA T, Matsuoka A, Norimatsu Y, Morimura S, et al
    A case of IgG4-related disease presenting as skin tumors in the bilateral cheeks.
    J Dermatol. 2024 May 17. doi: 10.1111/1346-8138.17271.
    PubMed    


  777. TADA Y, Sugiura Y, Kamishima M, Tanaka Y, et al
    Safety and effectiveness of guselkumab in Japanese patients with psoriasis: 20-week interim analysis of a postmarketing surveillance study.
    J Dermatol. 2024 May 15. doi: 10.1111/1346-8138.17255.
    PubMed     Abstract available


  778. NAKANO E, Takahashi A, Ogata D, Namikawa K, et al
    Real-world efficacy and safety of BRAF-targeted therapy for patients with advanced melanoma: A single-center retrospective study in Japan.
    J Dermatol. 2024 May 8. doi: 10.1111/1346-8138.17263.
    PubMed     Abstract available


  779. JO SJ, Park CJ, Bang CH, Jeong KH, et al
    Effectiveness of calcipotriol/betamethasone dipropionate aerosol foam in patients with small versus large plaque psoriasis in routine practice in South Korea.
    J Dermatol. 2024 May 8. doi: 10.1111/1346-8138.17253.
    PubMed     Abstract available


  780. TAIRA H, Ito Y, Yamamoto T, Koyama A, et al
    Elevated serum vasohibin-1 levels in atopic dermatitis: Implications for disease chronicity.
    J Dermatol. 2024 May 6. doi: 10.1111/1346-8138.17259.
    PubMed     Abstract available


  781. WAKI Y, Nobeyama Y, Nakagawa H, Asahina A, et al
    High prevalence of dermatophytosis of the feet in acral melanoma of the foot.
    J Dermatol. 2024 May 6. doi: 10.1111/1346-8138.17256.
    PubMed     Abstract available


  782. AITAKE U, Ishizuki S, Lei X, Izumi T, et al
    Long-term control of giant primary acral melanoma without amputation surgery.
    J Dermatol. 2024 May 6. doi: 10.1111/1346-8138.17267.
    PubMed    


  783. TAKAYAMA E, Kuwahara S, Yoshioka A, Tateishi C, et al
    Granular C3 dermatosis-A report of two cases and a mini-review of literature.
    J Dermatol. 2024 May 6. doi: 10.1111/1346-8138.17257.
    PubMed     Abstract available


  784. WADA M, Ota S, Sugawara-Mikami M, Yaguchi T, et al
    Primary cutaneous nocardiosis caused by Nocardia beijingensis in an immunocompetent host in Japan.
    J Dermatol. 2024 May 6. doi: 10.1111/1346-8138.17266.
    PubMed    


  785. WATANABE K, Otsuki M, Ohara Y, Wakasa T, et al
    White patches due to complete loss of melanocytes in vulvar lichen sclerosis: Concomitant presence of vitiligo or not?
    J Dermatol. 2024 May 6. doi: 10.1111/1346-8138.17265.
    PubMed    


  786. SHI Y, Wan S, Song X
    Role of neurogenic inflammation in the pathogenesis of alopecia areata.
    J Dermatol. 2024;51:621-631.
    PubMed     Abstract available


  787. GRAM SB, Brusgaard K, Bygum A, Christensen AH, et al
    Plantar keratoderma and curly hair as a diagnostic clue of cardiomyopathy risk.
    J Dermatol. 2024;51:e143-e144.
    PubMed    


  788. IM D, Ueda K, Niwa H, Tanaka K, et al
    Low pH condition impairs BP-IgG binding to the basement membrane zone.
    J Dermatol. 2024;51:643-648.
    PubMed     Abstract available


  789. FUSHIDA N, Horii M, Fujii K, Mizumaki K, et al
    Clinical features of patients with connective tissue disease with anti-human upstream binding factor antibodies: A single-center retrospective study.
    J Dermatol. 2024;51:704-713.
    PubMed     Abstract available


  790. TAO S, Cao P, Jin M, Suo P, et al
    Integrated analysis of long non-coding RNAs and mRNAs associated with condyloma acuminatum.
    J Dermatol. 2024;51:671-683.
    PubMed     Abstract available


  791. CHOI S, Kwon SH, Sim WY, Lew BL, et al
    Long-term efficacy and safety of dutasteride 0.5 mg in Korean men with androgenetic alopecia: 5-year data demonstrating clinical improvement with sustained efficacy.
    J Dermatol. 2024;51:684-690.
    PubMed     Abstract available


  792. PIZZICHETTA MA, Polesel J, Perrot JL, Rubegni P, et al
    The combination of dermoscopy and reflectance confocal microscopy increases the diagnostic confidence of amelanotic/hypomelanotic lentigo maligna.
    J Dermatol. 2024;51:714-718.
    PubMed     Abstract available


  793. MIYAMOTO J, Kawashima Y, Hayakawa M, Fusumae T, et al
    Successful treatment of onychomatricoma with minimally invasive surgical procedures based on its pathogenesis: A case report.
    J Dermatol. 2024;51:719-721.
    PubMed     Abstract available


  794. PASCOLINI G, Di Zenzo G, Morani P, Didona B, et al
    Ectoderm-derived findings in Ayme-Gripp syndrome.
    J Dermatol. 2024;51:e162-e163.
    PubMed    


  795. SHIMOMURA-ISHIHARA M, Takeichi T, Noda T, Koizumi H, et al
    Natal teeth, hypoplasia of the first toe, and growth retardation in a patient with severe epidermolysis bullosa simplex.
    J Dermatol. 2024;51:e175-e177.
    PubMed    


  796. OGURA Y, Kondo S, Suzuki T, Otsuka M, et al
    DiGeorge syndrome presenting with palmoplantar pustules: Comparative analysis of serum IL-22, NETs and IL-8 with usual palmoplantar pustulosis.
    J Dermatol. 2024;51:731-734.
    PubMed     Abstract available


  797. MATSUO M, Niwa H, Koga H, Ishii N, et al
    A case of paraneoplastic pemphigus associated with follicular lymphoma positive only for anti-desmoglein 3 antibody.
    J Dermatol. 2024;51:e164-e165.
    PubMed    


  798. WAKI Y, Nobeyama Y, Chujo S, Asahina A, et al
    Bullous pemphigoid exacerbated by nivolumab and temporally rescued with therapeutic plasma exchange.
    J Dermatol. 2024;51:e149-e150.
    PubMed    


  799. WATANABE Y, Nobeyama Y, Asahina A
    A case of postoperative pyoderma gangrenosum on penis caused by patient himself.
    J Dermatol. 2024;51:e154-e155.
    PubMed    


  800. MAENG JE, Son SW, Lee SJ, Kim JC, et al
    Pulsed-dye laser as an effective treatment for recalcitrant granulomatous rosacea and a potential regulator of CXCL9 expression.
    J Dermatol. 2024;51:722-726.
    PubMed     Abstract available


    April 2024
  801. SATO M, Yamamoto T
    Cutaneous manifestations of adult-onset Still's disease: A comparative study between young-onset and elderly-onset groups.
    J Dermatol. 2024 Apr 29. doi: 10.1111/1346-8138.17235.
    PubMed     Abstract available


  802. MINAMI Y, Shinkuma S, Yokoyama T, Shinoda S, et al
    A case of generalized pustular psoriasis complicated with SLE successfully treated with spesolimab.
    J Dermatol. 2024 Apr 28. doi: 10.1111/1346-8138.17243.
    PubMed    


  803. HIGASHI Y, Imafuku S, Tsuruta N, Murotani K, et al
    Systemic therapy for psoriasis and the risk of cutaneous infections.
    J Dermatol. 2024 Apr 25. doi: 10.1111/1346-8138.17245.
    PubMed     Abstract available


  804. SONG WJ, Yoon HS
    Impact of residual skin lesions and previous biologic treatment failure on patient-reported outcomes in patients with psoriasis receiving biologic treatment.
    J Dermatol. 2024 Apr 25. doi: 10.1111/1346-8138.17249.
    PubMed     Abstract available


  805. SUGIURA R, Hashimoto T, Ishizuka Y, Okuzawa M, et al
    Matrix metalloproteinase-9 and neutrophil elastase from infiltrating neutrophils with neutrophil extracellular DNA traps in linear IgA bullous dermatosis: A case report.
    J Dermatol. 2024 Apr 22. doi: 10.1111/1346-8138.17244.
    PubMed    


  806. TANAKA A, Yuasa A, Kamei K, Nagano M, et al
    Cost-effectiveness analysis of abrocitinib compared with standard of care in adult moderate-to-severe atopic dermatitis in Japan.
    J Dermatol. 2024 Apr 22. doi: 10.1111/1346-8138.17234.
    PubMed     Abstract available


  807. MINAGAWA A, Koga H, Matsunaga K, Hamada A, et al
    Difference in computer-assistance effects on human doctor accuracy in diagnosing acral and non-acral pigmented skin tumors.
    J Dermatol. 2024 Apr 18. doi: 10.1111/1346-8138.17240.
    PubMed    


  808. FUJIOKA K, Kita M, Iwata M, Moriue T, et al
    Multiple cutaneous focal mucinosis in a patient with atopic dermatitis.
    J Dermatol. 2024 Apr 17. doi: 10.1111/1346-8138.17213.
    PubMed    


  809. KIM DS, Kim JC, Baek DJ, Kang HY, et al
    Successful repigmentation of hypopigmented scars with micropunch grafting with a skin-seeding technique.
    J Dermatol. 2024 Apr 17. doi: 10.1111/1346-8138.17216.
    PubMed     Abstract available


  810. TAKAHASHI-WATANABE M, Fujimura T, Amagai R, Ohuchi K, et al
    Radiation-induced cutaneous squamous cell carcinoma showing a significant response to pembrolizumab: A case report.
    J Dermatol. 2024 Apr 17. doi: 10.1111/1346-8138.17221.
    PubMed     Abstract available


  811. ZHANG L, Jin L, Zhao Y, Cai H, et al
    A case of monoclonal gammopathy of cutaneous significance with multiple organs involvement: Comment on "Concurrent acquired cutis laxa and necrobiotic xanthogranuloma without paraproteinemia".
    J Dermatol. 2024 Apr 17. doi: 10.1111/1346-8138.17236.
    PubMed    


  812. TAKAHASHI T, Takahashi T, Ikawa T, Terui H, et al
    Serum levels of AGGF1: Potential association with cutaneous and cardiopulmonary involvements in systemic sclerosis.
    J Dermatol. 2024 Apr 15. doi: 10.1111/1346-8138.17233.
    PubMed     Abstract available


  813. BABA A, Yamada K, Kanekura T
    Cutaneous adverse events following COVID-19 vaccination: A case series of 30 Japanese patients and a review of 93 Japanese studies.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17188.
    PubMed     Abstract available


  814. LIU Q, Su H, Hong C, Han J, et al
    Toxic epidermal necrolysis complicated with primary cutaneous aspergillosis: A report of four cases.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17226.
    PubMed     Abstract available


  815. HAYAKAWA K, Irisawa R, Umefune R, Mae K, et al
    Marked effect of larotrectinib on primary cutaneous secretory carcinoma: A case report.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17218.
    PubMed    


  816. SITTIWATTANAWONG P, Kantikosum K, Charoenchaipiyakul K, Pootongkam S, et al
    In-vivo and ex-vivo tests for culprit drugs identification in severe cutaneous adverse drugs reactions.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17207.
    PubMed     Abstract available


  817. SUGIURA R, Hashimoto T, Okuno S, Satoh T, et al
    Expression of phosphorylated-Janus kinase 1 and IL-4Ralpha by dermal basophils and epidermal keratinocytes in atopic dermatitis-associated prurigo nodules: A case report.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17229.
    PubMed    


  818. HANAMI Y, Yamamoto T
    Erythema nodosum of the extremities following dupilumab treatment in a patient with atopic dermatitis.
    J Dermatol. 2024 Apr 8. doi: 10.1111/1346-8138.17199.
    PubMed    


  819. UHARA H, Kiyohara Y, Isei T, Nagase K, et al
    Safety and effectiveness of avelumab in patients with Merkel cell carcinoma in general clinical practice in Japan: Post-marketing surveillance.
    J Dermatol. 2024;51:475-483.
    PubMed     Abstract available


  820. LIM S, Sidky L, Eliott E, Cobos G, et al
    A gyrate pattern of discoid lupus erythematosus.
    J Dermatol. 2024;51:e106-e107.
    PubMed    


  821. HAMADA R, Funasaka Y, Saeki H, Serizawa N, et al
    Dietary habits in adult Japanese patients with vitiligo.
    J Dermatol. 2024;51:491-508.
    PubMed     Abstract available


  822. PAN X, Dong Z
    Yellow urticaria following plasma transfusion.
    J Dermatol. 2024;51:e108-e109.
    PubMed    


  823. KIM KH, Kwon SH, Sim WY, Lew BL, et al
    Therapeutic maintenance effect of finasteride 1 mg every other month regimen in androgenetic alopecia and study on the difference in response to finasteride treatment: A prospective cohort study.
    J Dermatol. 2024;51:552-557.
    PubMed     Abstract available


  824. TSUNEMI Y, Otsuka A, Nonaka Y
    Receipt survey of prescription continuation rates for patients with onychomycosis and web-based survey of dermatologists on prescribing policies for onychomycosis therapeutics.
    J Dermatol. 2024;51:526-531.
    PubMed     Abstract available


  825. FAJUYIGBE D, Sewraj P, Connetable S, Molamodi K, et al
    Weekly hair washing: The recommended solution for women with afro-textured hair to alleviate dandruff and scalp discomfort.
    J Dermatol. 2024;51:518-525.
    PubMed     Abstract available


  826. CHATPROEDPRAI S, Tiasiri N, Chantawarangkul K, Wananukul S, et al
    Pediatric drug reaction with eosinophilia and systemic symptoms: A 12-year retrospective study in a tertiary center.
    J Dermatol. 2024;51:509-517.
    PubMed     Abstract available


  827. AO S, Huang G, Tang X, Zhu Z, et al
    Anti-immunoglobulin E provides an additional therapy to conventional steroids for Kimura's disease.
    J Dermatol. 2024;51:602-606.
    PubMed     Abstract available


  828. SUN X, Zhang J, Yang Q, Lin J, et al
    Treatment of epidermolysis bullosa simplex with dupilumab.
    J Dermatol. 2024;51:e131-e132.
    PubMed    


  829. SAKAMOTO K, Fujihiro M, Sakamoto A, Yamada C, et al
    A case of nonpigmented fixed-drug eruption with eosinophilic intraepidermal vesicle formation.
    J Dermatol. 2024;51:e120-e122.
    PubMed    


  830. USUI-TANIGUCHI M, Kawakami Y, Toi Y, Kaji T, et al
    Pruritic folliculitis of pregnancy with granular deposition of immunoglobulin G along the basement membrane zone.
    J Dermatol. 2024;51:e125-e126.
    PubMed    


  831. LEE SG, Kim SC, Kim JH
    Risk factors of rituximab-induced thrombocytopenia in patients with autoimmune bullous diseases.
    J Dermatol. 2024;51:597-601.
    PubMed     Abstract available


    March 2024
  832. YOKOTA K, Takenouchi T, Fujisawa Y, Fukushima S, et al
    Long-term follow-up results from KEYNOTE-041: Phase 1b study of pembrolizumab in Japanese patients with advanced melanoma.
    J Dermatol. 2024 Mar 26. doi: 10.1111/1346-8138.17002.
    PubMed     Abstract available


  833. IKUMI N, Hayama K, Kitamura N, Terui T, et al
    Higher prevalence of nail psoriasis in patients with psoriatic arthritis receiving biologic therapy: A single center cross sectional study.
    J Dermatol. 2024 Mar 20. doi: 10.1111/1346-8138.17196.
    PubMed    


  834. FUJIMOTO A, Hayashi R, Iguchi S, Abe R, et al
    Can dermatologists reach their full potential in teledermatology? A validation study of diagnostic performance of skin diseases in live video conferencing teledermatology.
    J Dermatol. 2024 Mar 20. doi: 10.1111/1346-8138.17197.
    PubMed     Abstract available


  835. XIE L, Lopes Almeida Gomes L, Stone CJ, Faden DF, et al
    An update on clinical trials for cutaneous lupus erythematosus.
    J Dermatol. 2024 Mar 15. doi: 10.1111/1346-8138.17161.
    PubMed     Abstract available


  836. TEBOUL A, Arnaud L, Chasset F
    Recent findings about antimalarials in cutaneous lupus erythematosus: What dermatologists should know.
    J Dermatol. 2024 Mar 14. doi: 10.1111/1346-8138.17177.
    PubMed     Abstract available


  837. HAGINO T, Saeki H, Fujimoto E, Kanda N, et al
    Real-world effectiveness and safety of bimekizumab in Japanese patients with psoriasis: A single-center retrospective study.
    J Dermatol. 2024 Mar 14. doi: 10.1111/1346-8138.17186.
    PubMed     Abstract available


  838. HEMMI A, Okamura K, Nikaido M, Saito T, et al
    Post-COVID-19 vaccination diffuse cutaneous sarcoidosis.
    J Dermatol. 2024 Mar 14. doi: 10.1111/1346-8138.17194.
    PubMed    


  839. CHIU YJ, Li CY, Wang TH, Ma H, et al
    Comparative transcriptomic analysis reveals differences in gene expression and regulatory pathways between nonacral and acral melanoma in Asian individuals.
    J Dermatol. 2024 Mar 12. doi: 10.1111/1346-8138.17187.
    PubMed     Abstract available


  840. HASEGAWA M, Chasset F, Chong BF, Fiorentino DF, et al
    International exchange on the clinical practice and research of rheumatic skin diseases: A report of the 5th International Conference of Cutaneous Lupus Erythematosus.
    J Dermatol. 2024 Mar 7. doi: 10.1111/1346-8138.17153.
    PubMed     Abstract available


  841. TAKADA M, Kikuchi N, Yamamoto T
    Umbilical psoriasis is not relevant to psoriatic arthritis.
    J Dermatol. 2024 Mar 5. doi: 10.1111/1346-8138.17189.
    PubMed     Abstract available


  842. TAKAYAMA E, Takai T, Fujimoto M, Yoshioka A, et al
    Bowen disease with sebaceous differentiation arising from clonal seborrheic keratosis.
    J Dermatol. 2024 Mar 5. doi: 10.1111/1346-8138.17180.
    PubMed     Abstract available


  843. KITAYAMA S, Katsuumi K, Takatsuka S, Shimizu T, et al
    Clinical features of skin metastasis from breast cancer: A retrospective observational study in Japan.
    J Dermatol. 2024 Mar 3. doi: 10.1111/1346-8138.17176.
    PubMed    


  844. UCHIYAMA A, Kosaka K, Ishikawa M, Inoue Y, et al
    Real-world effectiveness and safety of abrocitinib in 12 Japanese patients with atopic dermatitis and transcriptome analysis with peripheral blood.
    J Dermatol. 2024 Mar 3. doi: 10.1111/1346-8138.17173.
    PubMed     Abstract available


  845. OYA K, Nakamura Y, Shen LT, Ishizuki S, et al
    Soluble PD-L1 predicts tumor response and immune-related adverse events in patients with advanced melanoma treated with anti-PD-1 antibodies.
    J Dermatol. 2024 Mar 3. doi: 10.1111/1346-8138.17183.
    PubMed     Abstract available


  846. KIRCHLER CA, Fritz A, Spiegelfeld C, Mullegger RR, et al
    19-month follow-up survey on women with atopic eruption of pregnancy postpartum: An encouraging outlook.
    J Dermatol. 2024;51:467-469.
    PubMed    


  847. ODAWARA M, Mezaki M, Yoshimura T, Takaoka A, et al
    Epidermal turnover and iron metabolism in senile lentigo.
    J Dermatol. 2024;51:453-457.
    PubMed     Abstract available


  848. HE MJ, Wang YJ, Ran DL, Fu DS, et al
    Relationship between bullous pemphigoid and malignancy: A Mendelian randomization study.
    J Dermatol. 2024;51:403-408.
    PubMed     Abstract available


  849. KWON IJ, Kim SE, Kim SC, Lee SE, et al
    Efficacy of oral JAK1 or JAK1/2 inhibitor for treating refractory pruritus in dystrophic epidermolysis bullosa: A retrospective case series.
    J Dermatol. 2024;51:441-447.
    PubMed     Abstract available


  850. YU DA, Kim SR, Cho SI, Kwon O, et al
    Endocrine and metabolic comorbidities in primary cicatricial alopecia: A nationwide population-based study.
    J Dermatol. 2024;51:429-440.
    PubMed     Abstract available


  851. RAO L, Yang M, Chen H, Feng YY, et al
    Monkeypox 2023 in China: Dermatologist in the frontline with dermoscopic and reflectance confocal microscopy findings.
    J Dermatol. 2024;51:e81-e82.
    PubMed    


  852. ZHOU Y, Xiao Y, Wang Y, Li W, et al
    Refractory atypical IgA pemphigus successfully treated with apremilast.
    J Dermatol. 2024;51:e86-e87.
    PubMed    


  853. AKASAKA E, Rokunohe D, Nakano H, Yamatani S, et al
    A case of adult-onset localized recessive dystrophic epidermolysis bullosa, harboring the novel COL7A1 mutation p.G2754E and the previously reported mutation p.R1763.
    J Dermatol. 2024;51:e74-e76.
    PubMed    


  854. SUGIOKA K, Kondo M, Yamanaka K
    Elephantiasis verrucous lesions on psoriatic plaque improved with anti-IL-23p19 antibody therapy.
    J Dermatol. 2024;51:e77-e78.
    PubMed    


  855. KOBAYASHI A, Terui H, Takahashi T, Mizuashi M, et al
    A case of lymphangiectatic variant of giant pilomatricoma with bullous appearance: evaluation through magnetic resonance imaging.
    J Dermatol. 2024;51:e79-e80.
    PubMed    


  856. TSUJI H, Ichiki N, Niwa H, Iwata H, et al
    Bullous pemphigoid following hand, foot, and mouth disease.
    J Dermatol. 2024;51:e68-e69.
    PubMed    


    February 2024
  857. HASHIZUME H, Ishikawa Y, Hata A
    Increased Demodex mites after dupilumab therapy in facial skin: A case report.
    J Dermatol. 2024 Feb 29. doi: 10.1111/1346-8138.17150.
    PubMed    


  858. KOJIMA R, Miyake K, Shinohara R, Kushima M, et al
    Association between filaggrin gene mutations and the clinical features of molluscum contagiosum: The Yamanashi Adjunct Study of the Japan Environment and Children's Study.
    J Dermatol. 2024 Feb 27. doi: 10.1111/1346-8138.17157.
    PubMed     Abstract available


  859. KAMEDA E, Matsuzawa T, Togawa Y, Hashimoto R, et al
    Amelanotic melanoma in oculocutaneous albinism type 4 detected using violet-light dermoscopy.
    J Dermatol. 2024 Feb 27. doi: 10.1111/1346-8138.17164.
    PubMed    


    October 2023
  860. SU Z, Slivka P, Paulsboe S, Chu K, et al
    Importance of PLD2 in an IL-23 driven psoriasiform dermatitis model and potential link to human psoriasis.
    J Dermatol. 2023;50:1321-1329.
    PubMed     Abstract available


  861. OHYAMA M, Kamei K, Yuasa A, Anderson P, et al
    Economic burden of alopecia areata: A study of direct and indirect cost in Japan using real-world data.
    J Dermatol. 2023;50:1246-1254.
    PubMed     Abstract available


  862. ZHOU J, Bian H, Wu N
    Protein inhibitor of activated STAT3 (PIAS3) attenuates psoriasis and associated inflammation.
    J Dermatol. 2023;50:1262-1271.
    PubMed     Abstract available


    August 2023
  863. KAMINAKA C, Sakata M, Nishiguchi M, Kunimoto K, et al
    Clinical evaluation of needle-free electronic pneumatic hyaluronic acid injection treatment for facial atrophic acne scars: A prospective, randomized comparative trial.
    J Dermatol. 2023;50:971-981.
    PubMed     Abstract available


  864. SERMSWAN P, Sriharat R, Saithong S, Laowansiri M, et al
    A cross-sectional study examining the prevalence of antibiotic-resistant Cutibacterium acnes isolated from patients with acne in Bangkok, Thailand.
    J Dermatol. 2023;50:1008-1013.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum